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ABSTRACT 
 
Analysis of Folate Imbalance in the Cerebrospinal Fluid of 
Hydrocephalic Human Neonates and its Possible Effects on the 
Development of Cerebral Cortex 
Hydrocephalus (HC) is an accumulation of CSF (cerebrospinal fluid) within the brain 
and/or subarachnoid space resulting from an imbalance in the production or 
absorption of CSF. HC can results in raised intracranial pressure and associated 
developmental and neurological deficits. Currently, the only control measure is birth 
termination and the only treatment option is surgical fluid diversion (shunting) to 
reroute the CSF and relieve the intracranial pressure. Inspite of surgical drainage, 
hydrocephalic patients have major neurological deficits and abnormal cortical 
development. Delivery and availability of folate to the developing cerebral cortex is 
critical for normal development and function. Previous study reported an association 
of HC with an imbalance in the 5-formyltetrahydrofolate dehydrogenase (Aldh1L1, 
FDH) (folate binding protein) in the CSF of the hydrocephalic Texas rats. This 
imbalance was further associated with a cell cycle arrest in neural stem/progenitor 
cells and deficient cortical development. It was observed that the system could be 
“unlocked” with a maternal supplement combining two folates (tetrahydrofolic acid 
and 5-formyltetrahydrofolic acid) but not including folic acid which reduced the 
incidence of HC in rats as well as improved the overall brain development.  
The major objective of present study was to test whether CSF from human infants 
contains a similar folate handling system and whether it is also perturbed in human 
HC. The second objective was to study the biomarkers in the CSF which can be used 
as diagnostic standards for determining the incidence of HC as well as to understand 
the severity and pathophysiology of the HC. CSF samples of infants were collected 
from various hospitals by lumbar puncture or ventricular tap. Hydrocephalic CSF 
samples were categorized into four groups according to the onset and cause of HC 
condition (fetal onset hydrocephalus (FOH), late onset hydrocephalus (LOH), post 
haemorhagic hydrocephalus (PHH) and spina bifida with hydrocephalus (SB/HC)). 
Western blotting, LCMS/MS, microarrays, flame photometry, tissue culture and 
x 
 
immunocytochemistry were used to determine the amount of folate enzyme, folate 
metabolites and biochemical markers in the CSF of hydrocephalic infants.  
In present study a significant decrease in FDH was found in the CSF of human 
hydrocephalic infants compared to normal. Human data matches and extends previous 
animal data, decrease in FDH in the CSF of affected hydrocephalic humans is very 
similar to that observed in hydrocephalic rats. Electrolytic balance in CSF is essential 
for the normal functioning of cells/neurons. In present study decline in CSF sodium 
was found in FOH and LOH in contrast raised sodium and potassium was observed in 
PHH and SB/HC infants. Raised potassium in PHH and SB/HC may reveal central 
nervous system damage in these conditions. LOH is distinguished by a significant 
decrease in osmolarity, a novel finding of this study which is reflected in decreased 
sodium content. Why this condition results in such major osmolarity changes rather 
than other HC conditions requires further investigation.  
Present study observed increase in total protein in the CSF from LOH infants 
compared to normal indicating inflammation. In current study sFas receptor, Fas 
ligand, HGF, SCF, VEGF, IL-6, TNF-α, IGF-1 were examined in HC infants. 
Increased sFas receptor concentration was found in PHH and SB/HC infants 
compared to normal indicating parenchymal damage. The HGF increase was found in 
PHH, furthermore SCF increase was found in SB/HC infants. Increased HGF and 
SCF production indicates brain damage as well neuronal repair and recovery of 
damaged nerve cells. IL-6 showed increase in hydrocephalic infants compared to 
normal, with the highest level found in LOH and SB/HC infants. The TNF-α and IGF-
1 did not show significant association with the HC condition as the levels of these 
cytokines were very low or undetectable in all CSF samples. Increased cytokine 
expression indicates neuroinflammatory response and brain parenchymal damage in 
the infants. 
Specific proteins are released from brain cells into CSF in response to brain 
parenchymal damage in diseased condition. Brain cell specific damaged products in 
CSF can potentially be used in the early prognosis of HC and in the differential 
diagnosis of HC. In current study GFAP, vimentin, MBP and CNPase were 
investigated in the CSF of hydrocephalic infants. GFAP prescence in the CSF of PHH 
and SB/HC infants indicates damage to astrocytes. High levels of MBP in PHH and 
xi 
 
SB/HC infants indicate loss of oligodendrocytes and/or possible demyelination in the 
brain. Furthermore CNPase reduction was found in FOH and LOH infants, it can be 
suggested that in FOH and LOH production of new oligodendrocytes in the brain 
might be inhibited due to reduction in CNPase. In the current study, effect of in vitro 
exposure of postnatal glial cells to CSF from FOH and LOH was observed. Astrocytes 
and microglial cells in culture were treated with different percentages (5%, 10% and 
20%) of CSF from normal, FOH and LOH infants. Treatment with 20% CSF from 
LOH infants caused significant effect on the proliferation of astrocytes and 
morphology of astrocytes and microglial cells. Imbalance in electrolytes, osmolarity 
and cytokines in LOH might be responsible for the observed effect of CSF on 
astrocytes and microglial cells. Current study demonstrates that CSF role is critical 
and it altered composition effect differentially on the developing brain depending on 
the cause and age of onset of HC in human infants. Detection of CSF component 
which are responsible for pathophysiological changes occurring in the HC condition 
will be important to develop potential treatment strategies to prevent the unalterable 
damage.  
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
TABLE OF CONTENTS 
1 Introduction…………………………………………………................... 1 
 1.1 The central nervous system ………………………………................ 2 
  1.1.1 Development of the central nervous system …............. 3 
 1.2 Ventricular system of brain ……………………………………........ 6 
  1.2.1            Brain ventricle abnormalities ……………………......... 7 
 1.3 Choroid plexus …………………………………………………....... 8 
  1.3.1            Formation of choroid plexus………………………....... 9 
 1.4 Cerebrospinal fluid ……………………………………………........ 14 
  1.4.1            Background ……………………………………............ 14 
  1.4.2            CSF production………………………………………... 14 
  1.4.3            CSF absorption……………………………………....... 14 
  1.4.4            CSF function……………………………………........... 15 
  1.4.5            CSF composition…………………………………......... 16 
  1.4.6            CSF proteins……………………………………........... 16 
  1.4.7            Electrolytes in CSF…………………………………..... 16 
 1.5 Biomarkers in CSF………………………………………………...... 18 
 1.6 Hydrocephalus…………………………………………………….... 26 
  1.6.1            Classification of HC………………………………….... 26 
  1.6.2         Clinical features of HC ………………......................... 29 
  1.6.3         Diagnosis of HC…………………………………......... 30 
  1.6.4         Management of HC …………………………………... 31 
  1.6.5         Genetics of HC ……………………………………...... 32 
  1.6.6         Experimental model of HC ………………………....... 33 
  1.6.7         The limitations in understanding the pathogenesis of       
        HC.................................................................................... 
34 
 1.7 Folate metabolism and brain development………………………..... 34 
  1.7.1        Dietary source of folate…………………………........... 35 
  1.7.2        Folate transport in the central nervous system……....... 35 
  1.7.3        Folate association with developmental disorder………. 35 
  1.7.4        Folate metabolic pathway and HC…………………….. 36 
 1.8 Objectives of study…………………………………………….......... 37 
2 Materials and Methods…………………………………………………. 40 
 2.1 Materials.............................................................................................. 40 
  2.1.1            Chemicals……………………………............................ 40 
  2.1.2            Solutions………………………………………….......... 40 
  2.1.3            Biological samples……………………………….......... 42 
 2.2 Methods…………............................................................................... 44 
xiii 
 
  2.2.1            Biochemical analysis…………………………………... 44 
  2.2. 2           Western blotting……………………………………….. 46 
  2.2.3            Microarray…………………………………………....... 47 
  2.2.4            Metabolom ………………………………………….... 47 
  2.2.5            Tissue culture………………………………………...... 51 
  2.2.5.1         Astrocytes and microglial culture …………………...... 51 
  2.2.5.2         Cell proliferation assay…………………………........... 52 
  2.2.5.3         Fluorescence staining…………………………….......... 53 
 2.3 Statistical analysis…………………………………………………... 54 
 Results……………………………………………………………………. 55 
3  Folate metabolism imbalance in CSF…………………………….... 55 
 3.1 Introduction and objectives………………………………………..... 55 
 3.2 Results……………………………………………………………..... 56 
  3.2.1            Analysis of 10-formyltetrahydrofolate dehydrogenase     
                    (FDH) and metabolites imbalance in CSF from normal  
                    and HC infants................................................................ 
 
56 
  3.2.2            Measurement of 1C metabolic pathway imbalance in    
                    CSF.................................................................................. 
 
60 
 3.3 Discussion………………………………………………………....... 65 
4  Electrolytes, osmolarity and pH imbalance in CSF ……………....... 68 
 4.1 Introduction and objectives…………………………………………. 68 
 4.2 Results……………………………………………………………..... 69 
  4.2.1           CSF electrolytes measurement of normal and HC    
                   infants............................................................................... 
 
69 
  4.2.2           CSF pH and osmolarity measurements in HC and  
                   normal infants.................................................................. 
 
70 
 4.3 Discussion…………………………………………………………... 76 
5  Cytokines analysis in CSF …………………………….................... 79 
 5.1 Introduction and objectives…………………………………………. 79 
 5.2 Results…………………………………………………………......... 80 
  5.2.1            CSF total protein concentration in normal and HC     
                    infants.............................................................................. 
 
80 
  5.2.2            CSF cytokines concentration in normal and HC infant.. 80 
 5.3 Discussion………………………………………………………....... 88 
6  Brain damaged protein biomarkers in CSF ………………………… 92 
 6.1 Introduction and objectives…………………………………………. 92 
 6.2 Results………………………………………………………………. 93 
  6.2.1            Experiments to investigation of the brain damage    
                    protein markers in the CSF from normal and HC       
                    infants……...................................................................... 
 
 
93 
xiv 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6.3 Discussion........................................................................................... 103 
7 Effect of human CSF on glial cells.............................................................. 106 
 7.1 Introduction and objectives………………………………………..... 106 
 7.2 Results……………………………………………………………..... 109 
  7.2.1          Effects of CSF on the proliferation and viability of  
                  astrocytes and microglial cells.......................................... 
7.2.2          Morphology of astrocytes and microglial cell after    
                  treatment with CSF........................................................... 
 
109 
 
110 
 7.3 Discussion…………………………………………………………... 115 
8 General Discussion………………………………………………............ 117 
 8.1 Discussion………………………………………………………....... 117 
 8.2 Conclusions………………………………………………………..... 124 
 8.3 Future aims…………………………………………………….......... 125 
9 References………………………………………………………............... 127 
Appendices……………………………………………………………………........ 
xv 
 
LIST OF FIGURES 
   
   
Figure 1.1 Schematic representation of the development of spinal cord and 
brain from the neural tube in human embryo....................................... 10 
Figure 1.2 Neurulation process and defects of neurulation in human embryo 
during development……………………………………….................. 
 
11 
Figure 1.3 Cellular mechanism of cortical development in mouse……………....  12 
Figure 1.4 Model showing the molecular mechanism of the development of 
cerebral cortex in Mice……………………………………………..... 13 
Figure 1.5 Diagram to show the interfaces between CSF, blood and 
brain………................................................................................... 24 
Figure 1.6 Diagrammatic representation of the flow of CSF in the 
brain………................................................................................... 25 
Figure 1.7 Estimates of the ionic compositions of plasma, CSF and in the 
choroid plexus…………………………………………………........... 38 
Figure 1.8 Infant with HC condition showing enlarged head and sunset 
eyes…............................................................................................. 38 
Figure 1.9 A flow chart showing the interaction between the substrates of folate 
metabolisim………….......................................................................... 39 
Figure 3.1 Western blot for 10-formyl tetrahydrofolate dehydrogenase (FDH) 
in the CSF obtained from normal and HC infants………………….... 58 
Figure 3.2 Western blot for 10-formyl tetrahydrofolate dehydrogenase (FDH) 
in the CSF obtained from PHH infants before and after shunt……..... 59 
Figure 3.3 LC-MS/MS analysed folate metabolites (i)………………………….. 63 
Figure 3.4 LC-MS/MS analysed folate metabolites (ii)………………………..... 64 
Figure 4.1 Flame Photometry measured sodium in CSF………………………... 73 
Figure 4.2 Flame Photometry measured potassium in CSF……………………... 73 
Figure 4.3 Flame Photometry measured magnesium in CSF……………………. 74 
Figure 4.4 Flame Photometry measured calcium in CSF……………………….. 74 
Figure 4.5 Mini pH electrode measured pH of CSF…………………………...... 75 
Figure 4.6 Osmometer measured osmolarity of CSF……………………………. 75 
Figure 5.1 Total protein in CSF analysed by Lowry assay……………………… 83 
Figure 5.2 Microarrays measured cytokines in CSF (i). Comparative cytokines  
xvi 
 
levels in the normal and HC groups a. sFas receptor b. Fas ligand...... 85 
Figure 5.3 Microarrays measured cytokines in CSF (i). Comparative cytokines 
levels in the normal and HC groups c. SCF d.  HGF e. VEGF............ 86 
Figure 5.4 Microarrays measured cytokines in CSF (ii). Comparative cytokines 
levels in the normal and HC groups f. IGF-1 g. TNF α h. IL-6........... 87 
Figure 6.1 Western blot for GFAP………………………................................... 95 
Figure 6.2 Semiquantitative analysis of the 53KDa band labelled with anti-
GFAP antibody…………………………………………..................... 96 
Figure 6.3 Western blot for Vimentin………………………………………….... 97 
Figure 6.4 Semiquantitative analysis of the 55KDa band labelled with anti-
vimentin antibody………………………………………………......... 98 
Figure 6.5 Western blot for MBP………………………………………………... 99 
Figure 6.6 Semiquantitative analysis of the 40KDa band labelled with anti- 
MBP antibody..................................................................................... 100 
Figure 6.7 Western blot for CNPase…………………………………………...... 101 
Figure 6.8 Semiquantitative analysis of the 45KDa band labelled with anti- 
CNPase antibody…………………………………………………….. 102 
Figure 7.1 MTT assay measured the survival and proliferation of rat astrocytes 
when cultured with human CSF from normal, FOH and LOH 
infants…………………....................................................................... 111 
Figure 7.2 MTT assay measured the survival and proliferation of rat microglial 
cells when cultured with human CSF from normal, FOH and LOH 
infants…………................................................................................... 112 
Figure 7.3 Fluroscence microscopy image showing the affect of 20% CSF 
(Normal, FOH and LOH) treatment on the morphology of 
astrocytes.............................................................................................. 113 
Figure 7.4 Fluroscence microscopy image showing the affect of 20% CSF 
(Normal, FOH and LOH) treatment on the morphology of microglial 
cells………………………………………………………………....... 114 
 
 
 
 
 
xvii 
 
LIST OF TABLES 
   
Table 2.1 Clinical variables of normal and hydrocephalic infants.…………... 48 
Table 2.2 Serial dilutions of BSA stock (5 mg/ml)…………………………... 49 
Table 2.3 List of antibodies used for Western blotting ……………………… 50 
Table 2.4 List of antibodies used for Fluroscence staining of cells………….. 50 
Table 3.1 Folate metabolites in CSF…………………………………………. 62 
Table 4.1 CSF electrolytes levels in normal and HC infants………………… 71 
Table 4.2 CSF osmolarity and pH in normal and HC infants………………... 72 
Table 5.1 CSF total protein and cytokines levels in normal and HC infants… 84 
 
 
 
APPENDICES 
 
Appendix 1 The standard graphs of electrolytes as generated by Flame Photometry.. 
Appendix 2 The standard graphs of cytokines as generated by Microarray………....... 
Appendix 3 Perform for CSF samples collection and parents consent form ………...... 
Appendix 4 Publications……………………………………………………………...... 
 
 
 
 
 
 
 
 
 
 
 
 
xviii 
 
LIST OF ABBREVIATIONS 
ApoER2 Apolipoprotein E receptor 2 
ASTN Astrotactin 
AQP1 Aquaporin-1 
BBB Blood-brain barrier 
BCSFB Blood CSF-barrier 
BDNF Brain derived neurotrophic factor 
BSA Bovine serum albumin 
CAM Cell adhesion molecules 
CBP Calcium binding protein 
Cdk5 Cyclin-dependent protein kinase 5 
CH Congenital hydrocephalus 
CNR Cadherin-related neuronal receptor 
CNPase 2’, 3’-cyclic nucleotide 3’-phosphodiesterase 
CP Cortical plate 
CR Cajal-Retzius 
CSF Cerebro-spinal fluid 
CT Computerized Tomography 
DAB1 Disable 
DAPI 4', 6-Diamidino-2-Phenylindole  
DMSO Dimethyl Sulfoxide 
DMEM Dulbecco's Modified Eagle Medium  
ECL Enhanced Chemiluminescence 
E-CSF Embryonic-cerebrospinal fluid 
FOH Fetal onset hydrocephalus 
EDTA Ethylenediaminetetraacetic acid 
FAKs Focal adhesion kinases 
FDH 5-formyl tetrahydrofolate dehydrogenase 
FITC Fluorescein isothiocyanate 
FGF Fibroblast growth factor 
FOH Fetal onset hydrocephalus 
GABA γ-Aminobutyric acid 
GF Growth Factor 
xix 
 
GFAP Glial fibrillary acidic protein 
GE Germinal epithelium 
HC Hydrocephalus 
HGF Hepatocyte growth factor 
HRP Horseradish peroxidase  
H-Tx Rat Hydrocephalus Texas Rat 
ICP Intra-cranial pressure 
IF Interstitial fluid 
IFNγ Interferon gamma 
IGF Insulin-like growth factor 
IL Interleukin 
IP Intra-peritoneal 
IQ Intelligence Quotient 
IZ Inetermediate zon 
LC-MS/MS Liquid chromatography–tandem mass spectrometry 
LDL Low-density lipoprotein 
LDLR Low-density lipoprotein receptor 
LIF Leukemia inhibitory factor 
LIS1 Lissencephaly I of the Miller-Dieker type 
LOH Late onset hydrocephalus 
LRP LDL receptor-related protein 
MAP Microtubule-associated protein 
MBP Myeline basic protein 
MRI Magnetic resonance imaging 
MTT 3-(4`, 5`-dimethylthiazol-2`-yl)-2, 5-dipheyltertazolium bromide 
NGF Nerve growth factor 
NHS National Health Service 
NPH Normal pressure hydrocephalus 
NRG Neuroglin 
NSE Neuron-specific enolase 
NT-3 Neurotrophin-3 
NT-4 Neurotrophin-4 
P1 Postnatal day 1 
xx 
 
Par3 Partitioning defective protein 3 
Pals1 Protein associated with Lin 7 
PBS Phosphate buffer saline 
PDL Poly D-lysine 
PFA Para-formaldehyde 
PHH Post haemorhagic hydrocephalus 
PVDF Poly vinylidine difluoride 
r.p.m Revolutions per minute 
SB/HC Spina bifida with hydrocephalus 
SEM Standard error of the mean 
SCF Stem cell factor 
Src Sarcoma 
SVZ Sub-ventricular zone 
TGF- Transforming growth factor-beta 
TNF-α Tumor necrosis factor alpha 
TBR-1 T-box, brain, 1 
UK NRES United Kingdom National Research Ethics Service 
VEGF Vascular endothelial growth factor 
Μl Microliter 
Cl- Chloride 
Na+ Sodium ion 
Mg2+ Magnesium ion 
K+ Potassium ion 
Ca2+ Calcium ion 
mm
3
 Millimeter cube 
Nm Nanometer 
mg/ml Milligram per milliliter 
mOsm/Kg Milliosmole/Kilogram 
Ma Milliampere 
IgG Immunoglobulin G 
mg/dl Milligram per deciliter 
pg/ml Picogram/ml 
mg/ml Milligram/ml 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1                                                                                                   Introduction  
1 
 
CHAPTER 1 
  
INTRODUCTION 
Hydrocephalus (HC) is a complex and diverse pathological state caused by an 
abnormal buildup of cerebrospinal fluid (CSF) within the brain ventricular system 
and/or in the subarachnoid space, which can lead to severe lifelong neurological 
problems. The aetiology of HC is unclear although some evidence of genetic 
predisposition has been reported (Zhang et al., 2006). HC is a global neurological 
problem that occurs approximately in 1:500 to 1:5000 live human births and is 
accompanied with an abnormal development of the cerebral cortex (Pattisapu, 2001). 
The most severe form of HC is congenital HC, hydrocephalic babies born with greatly 
enlarged head and extremely thin cortical mantles. The role of CSF in the 
development is currently under considerable review (Gato and Desmond, 2009; 
Lehtinen et al., 2011; Zappaterra and Lehtinen, 2012). CSF acts as a growth medium 
for the differentiation and proliferation of neural progenitor cells during development 
and has a direct role through physiological defects in the deficient brain development 
in HC (Kohn et al., 1981; Cai et al., 2000; Mashayekhi et al., 2002; Cains et al., 
2009). Postnatal HC is characterized by high intracranial pressure due to the buildup 
of CSF within the brain ventricular system. CSF accumulation in HC condition 
resulting in stretching and compression of the brain parenchyma and loss of perfusion 
(McAllister and Chovan, 1998; Pattisapu, 2001). 
The pathophysiology of HC in neonates remains poorly understood since they do not 
suffer raised intracranial pressure even though there is an accumulation of CSF in the 
ventricular system accompanied by expansion of the ventricles, but the neonatal head 
can expand as the skull plates are not fused and this appears to open alternate fluid 
drainage pathways which are not available once the skull begins to seal. Currently the 
only control measure is birth termination and the only treatment option is surgical 
fluid diversion in order to relieve the intracranial pressure. Surgical diversion 
procedures are unsophisticated may have contravening effect, this does not address 
the cause, neither recover brain damage nor alleviate the neurological deficits. 
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Surgery alleviates some of the neurological problems associated with the fluid 
accumulation, raised intracranial pressure, life-threatening compression and stretching 
of the brain parenchyma. However many neurological deficits are not alleviated as 
these appear to be primarily due to abnormal cortical development in utero (Vachha 
and Adams, 2003; Hetherington et al., 2006). 
The presence of symptoms does not indicate the nature or severity of the HC or brain 
damage. Improvements in prenatal diagnosis and treatment may raise the quality of 
life for children with HC through decrease mortality and morbidity. In order to 
achieve this, much better understanding of the underlying etiology and biological 
basis of the condition is required. The literature in both human and experimental 
animal studies is not clear and much work is required to understand the consequences 
of raised pressure. This is due to the dismissal of CSF as a mechanical support fluid 
rather than a fluid with any physiological importance. Recent research indicates 
somewhat more important function for this fluid mainly in the brain during 
development (Gato and Desmond, 2009; Lehtinen et al., 2011; Zappaterra and 
Lehtinen, 2012). The general aim of current study was to investigate the CSF from 
normal and hydrocephalic human infants in an attempt to better understand the 
underlying pathophysiology of HC in infants.  
1.1. The central nervous system: 
Amongst all the system, nervous system is the most well-organized and complex 
system. Nervous system is divided into central and peripheral nervous system. Central 
nervous system is composed of brain and spinal cord encased by the meninges and 
skull, whereas the peripheral nervous system consist of the whole nervous tissues 
which form the sensory and motor pathways to all organs, tissues and muscles within 
the body as well as the connection to the sensory system interfacing with the external 
world. These functions can also be distinguished as unconscious automatic functions 
mediated by the autonomic centers within the brain stem and spinal cord and 
conscious control mediated through the somatic nervous system integrated with the 
cerebral cortex. Higher functions of thinking, learning, memory etc. reside in the 
cerebral cortex, which is responsible for all higher functions in the human beings.  
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1.1.1. Development of the central nervous system: 
Development and formation of the central nervous system is a complicated process 
that results from the interaction of genetic and environmental factors (Hynd and 
Willis, 1988; Capone, 1996). Over one third of the entire set of genes is expressed in 
the central nervous system in mammalian species due to an intrinsic complexity of the 
central nervous system both structural and functional. During the period of 
development and growth, brain is most vulnerable to insult than any other organ of 
the body (Dobbing and Sands, 1979). Throughout the life, brain continues to develop 
(Bayer et al., 1982) but the most considerable development occurs in the embryonic 
period and first year of life after birth (Aylward, 1997; Nowakowski and Hayes, 
1999).  
Brain development process divided into five major periods. The first period begins 
rapidly after conception that includes proliferation, migration and differentiation 
processes critical for neurulation and formation of a sealed neural tube. The second 
period is characterised by population and development of the spinal cord and brain 
stem as well as expansion of the cephalic vesicles. The third period is characterized 
by proliferation and migration of neurons to populate the layers of the cerebral cortex 
and cerebellum. The fourth period occurs after birth and involves gliogenesis, 
myelination and migration into the cortex of interneurons as well as the formation of 
connections and synaptogenesis. The fifth period occurs in adolescents and involves 
reorganization of the cortex (Price et al., 2011).  
The embryo is composed of three layers of cells called endoderm, mesoderm and 
ectoderm. The nervous system evolves from the ectoderm, cells of the ectoderm 
arrange to form the neural plate (Tortora, 2005). Neural plate give rise to neural crest 
cells and neural tube, central nervous system is formed from neural tube while neural 
crest cells transformed into the peripheral nervous systems. Neural tube differentiates 
into five distinctive morphological regions (telencephalon, diencephalon, 
mesencephalon and myelencephalon) that later develop into brain and spinal cord 
(Figure 1.1).  
In mammals, neural tube closure occurs at several places along the anterior-posterior 
axis (O’Rahilly and Müller, 1994). Due to the failure to closure of the neural tube, 
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various defects can occur (Figure 1.2). Failure to close the posterior end of neural tube 
(or the consequent split of the posterior neuropore) results in a spina bifida, failure in 
closure of the anterior end of neural tube leads to anencephaly and the failure in 
closure of entire neural tube results in lethal craniorachischisis. Collectively neural 
tube defects affect in about 1 in 500 human live births (Golden and Chernoff, 1993; 
Van Allen et al., 1993). 
Neural tube closure in humans is a very complex process and controlled by both 
genetic and environmental factors. Genes such as sonic hedgehog and Pax3 are 
necessary for the formation of the mammalian neural tube but dietary factors such as 
folic acid and cholesterol also prove to be vital. It has been found that 50% of neural 
tube closure defects could be controlled after taking supplemental folic acid (vitamin 
B12) by pregnant women, and it is recommended by the U.S. Public Health Service to 
take 0.4 mg of folate daily by all women of child bearing age in order to decrease the 
risk of neural tube defects (Milunsky et al., 1989; Czeizel and Dudas, 1992; Centers 
for Disease Control, 1992). 
Cellular mechanism of cerebral Cortex Development:  
The formation and development of the brain occurs in a precise sequenced schedule 
with more primitive and simple brain region (e.g., limbic system, forebrain) develop 
before more complex structures (e.g., cerebral cortex) (Rakic, 1995; Rakic, 1998). 
The neurons in neocortex are organized into six layers differing in composition of 
neuronal cell type, density and connectivity, generated in an inside to outside pattern. 
Pyramidal cells are the main projecting neurons with a characteristic dendritic 
arborisation pattern and triangular in shape (Parnavelas et al., 1989) and project 
myelinated axons outside the cortex (Jones and Peters, 1984). Non-pyramidal cells are 
a heterogeneous group of cells, which show a broad range of molecular and 
morphological identities (Fairen et al., 1984). 
In mice, formation of the neocortex initiates at embryonic day 9.5 (E 9.5) with the 
appearance of cerebral vesicles from the dorsal surface of the neural tube. Cells 
proliferation occurs near the center of the telencephalic neural tube known as the 
ventricular zone (VZ). A subset of neuroepithelial cells from VZ exiting from the cell 
cycle links with radial glial cells that have processes, which extend upto the pial 
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surface (Rakic, 1972). Radial glial cells are neural stem cells which either divide in 
the VZ, migrates directly to the cortex and generating neurons or develop into 
intermediate progenitors that move towards the sub ventricular zone (SVZ). The 
intermediate progenitors in the SVZ go through a predetermined controlled number of 
cell divisions generating cortical neurons. The number of neurons is encoded 
genetically and specific for each species. Greater the number of neurons in the cortex 
and larger the number of neurogenic divisions which leads to more expansion of the 
cortex during development (Noctor et al., 2004). Finally, at the end of neurogenesis 
radial glia transform into astrocytes by retracting their apical process (Levitt et al., 
1981; Rakic, 2003).  
Initially, neuronal migraton into the cortex sets up the primordial plexiform layer or 
preplate, a sandwich of two layers are formed one is located under the pial surface 
called the superficial marginal zone (or layer I) and other is subplate situated in the 
deep cortical wall (Figure 1.3) (Marin-Padilla, 1971; Uylings et al., 1990). Further 
neurons move through the subplates and form the cortical plate (CP) under the 
marginal zone (Caviness and Rakic, 1978). Cajal-Retzius cells are present inside the 
marginal zone (layer I) which provide signals for the movements of cortical plate 
neurons including the extracellular glycoprotein reelin (Frotscher, 1997). Neurons are 
formed in the ganglionic eminence and move toward the cortex by tangential 
migration (Anderson et al., 1997) formed interneurons that connect to the other cells 
of the cortical layers. Cortical neurons in the deep layer (layers 5 and 6) contain 
projection neurons that connect areas of the cortex to each other or to subcortical 
structures (Figure 1.3) (Thomson and Lamy, 2007). Thus, each cortical layer has 
important function and loss of any layer through deficient development could result in 
loss of higher processing abilities. 
Molecular mechanism of Cerebral Cortex Development:  
The process of corticogenesis is regulated by several factors including neuregulin, 
ErbB4 (Anton et al., 1997; Rio et al., 1997), cell adhesion molecules (Asou et al., 
1992; Ono et al., 1994), putative ligands (Stitt and Hatten, 1990; Fishell and Hatten, 
1991; Zheng et al., 1996), extracellular matrix molecules (Husmann et al., 1992) and 
their cell surface receptors (Galileo et al., 1992). Several genes are potential 
pharmacological targets including reelin (D’Arcangelo et al., 1995), Cdk5 (Ohshima 
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et al., 1996), p35 (Chae et al., 1997), Dab1 (Howell et al., 1997; Sheldon et al., 1997; 
Ware et al., 1997), Tbr-1 and D1x-1/2 genes in mice (Anderson et al., 1997) and in 
humans doublecortin gene (des Portes et al., 1998; Gleeson et al., 1998) and LIS1 
gene (Reiner et al., 1993). Reelin is vital for migration of neurons (Lambert de 
Rouvroit  and Goffinet, 2001) but it has also been thought to provide an end signal to 
the moving neurons and for them to disconnect from the radial glia by its interaction 
with α3-β1 integrin (Dulabon et al., 2000; Nadarajah et al., 2001) (Figure 1.4). The 
receptors for reelin include cadherin-related receptors (CNRs) (Senzaki et al., 1999) 
and LDL receptor family members (Trommsdorff et al., 1999; D’Arcangelo et al., 
1999; Hiesberger et al., 1999). After binding of reelin with CNR receptor initiates 
phosphorylation of the cytoplasmic second messenger mDab-1, probably through a 
CNR associated tyrosine kinase Fyn (Senzaki et al., 1999) or through the LDL 
receptor (Figure 1.4) (D’Arcangelo et al., 1999; Hiesberger et al., 1999).  
Growth factors are also important for cortical development including FGF (fibroblast 
growth factor) (Iwata et al., 2009), NT-3 (Neurotrophin 3) (Castellani and Bolz, 
1999), NT-4 (Neurotrophin 4) (Brunstrom et al., 1997), BDNF (Brain derived 
neurotrophic factor) (Ringstedt, 1997), HGF (Hepatocyte growth factor) (Sun et al., 
2002), NRG (neuroglin) and its receptor ErbB (Anton et al., 1997; Rio et al., 1997). In 
mammals neural progenitors apical complexes are formed by homologs of C. elegans, 
Par3 (partitioning defective protein 3) and Pals1 (protein associated with lin-seven 1) 
(Margolis and Borg, 2005). Proliferation of progenitor cells promoted by insulin-like 
growth factor 1 (Igf1) (Hodge et al., 2004; Popken et al., 2004). It was suggested that 
the apical complex act together with growth factor signaling pathways by direct 
contacts between Pten (phosphatase and tensin homolog) and Par3 (Van Stein et al., 
2005; Pinal et al., 2006; Wu et al., 2007; Feng et al., 2008). In case of apical complex 
disruption through Pals1 resulting in weak pS6 signaling, premature exit of cell cycle, 
quick cell death and all this leads to nearly the absence of almost complete cerebral 
cortex (Kim et al., 2010).  
1.2. Ventricular system of brain:  
Greek physician Herophilus (335-280 BC) first described the brain ventricular system 
more than 2000 years ago (Tascioglu, 2005). The ventricular system forms from the 
neural tube and cerebral vesicles (Gray and Clemente, 1985; O` Rahilly and Muller, 
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1994; Bayer and Altman, 2008). It consists of four ventricles, two lateral ventricles 
located within the cerebral hemispheres, a third ventricle situated within the 
diencephalon and a fourth ventricle lying between the cerebellum and pons (Millen 
and Wollam, 1962; Pollay and Curl, 1967; Milhort et al., 1971). Each lateral ventricle 
communicates with the single midline third ventricle through interventricular foramen 
of Monro (De Lahunta, 1983; Herndon and Brumback, 1989a; Braund, 1994). The 
third ventricle interacts with the fourth ventricle through the cerebral aqueduct of 
Sylvius (De Lahunta, 1983). The fourth ventricle forms an inner canal of the upper 
cervical spinal cord by narrowing caudally and it opens into the subarachnoid space 
through the foramina of Lushka and Megendie that envelopes the brain (Milhorat, 
1987; Herndon and Brumback, 1989a; Fishman, 1992; Braund, 1994; Davson and 
Segal, 1996). Finally, CSF is absorbed by specialized structures called arachnoid villi 
or granulations as well as lymphatic drainage sites and returned to the venous 
circulation (Gray and Clemente, 1985; O` Rahilly and Muller, 1994; Bayer and 
Altman, 2008) (Figure 1.6). The subarachnoid CSF act as a sink for brain extracellular 
solutes and considerable portion of CSF cycles through the brain interstitial space. 
CSF enters the parenchyma along paravascular spaces that encircle the brain and 
penetrating the arteries and draining of interstitial fluid takes place from the 
paravenous drainage pathways (Iliff et al., 2012). 
1.2.1. Brain ventricle abnormalities: 
Some of the most common birth defects affect the ventricular system and can have 
severe consequences for brain structure and function for example:  
Cranial Neural Tube Closure Defect: 
During embryonic development due to failure of neural tube closure, fluid is not 
retained or leaks from the opening (Moore, 2006). This has consequences for 
expansion of the cerebral vesicles (Desmond and Hass, 2000) with damage to the 
spinal cord and poor brain development (Copp et al., 2003; Copp and Greene, 2010). 
Hydrocephalus (HC): 
HC is a pathological condition characterised by buildup of CSF in the brain ventricles 
and expansion of the brain ventricles. It has been linked with deficient development of 
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cortex (Pattisapu, 2001; Mashayekhi et al., 2002; Vachha and Adam, 2005; 
Hetherington et al., 2006). 
Neurodevelopment disorders with distorted structure of the brain ventricle: 
In addition to neural tube closure defects and HC, a broad variety of other 
neurodevelopment disorders has been linked with abnormalities in the size and shape 
of brain ventricles. Schizophrenia, autisim, idiopathic syndrome, mental retardation 
problems, fragile X syndrome, Down syndrome, attention deficient hyperactivity 
disorder and other learning disorders have all been associated with brain fluid 
problem (Piven et al., 1995; Reiss et al., 1995; Castellanos et al., 1996; Frangou et al., 
1997; Sanderson et al., 1999; Kurokawa et al., 2000; Wright et al., 2000; Gilmore et 
al., 2001; Hardan et al., 2001; Shenton et al., 2001; Rehn and Rees, 2005; Nopoulos et 
al., 2007). 
1.3. Choroid plexus :  
Choroid plexus is situated in all the four ventricles of the brain and produced CSF 
(Chodobski and Szmydynger-Chodobska, 2001). CSF is moved through the 
ventricular system by bulk flow, CSF production from the choroid plexus is at a rate 
of 0.3ml/min in adult humans. Approximately 75% of fluid secretion source is 
choroid plexus situated in the lateral ventricles with a further 10% CSF from the third 
ventricle, 5% from the fourth ventricle and the remainder from other sources 
including interstitial fluid (Johanson, 2002). The choroidal epithelium synthesizes a 
large amount of bioactive peptides, choroidal tissue expressed receptors for several of 
these peptides. It is expected that the peptides formed by the choroid plexus not only 
act on brain parenchymal cells but also control the function of the choroid plexus 
itself. In addition to the discharge of solute and water, the choroid plexus also convey 
nutrients and humoral mediators which are necessary for the development and 
function of the central nervous system, e.g., leptin (Chodobski and Szmydynger-
Chodobska, 2001). The choroid plexus plays an important role in response to brain 
injury and repair process (Oldendorf and Davson, 1967). 
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1.3.1. Formation of choroid plexus:  
Choroid plexus formation takes place during embryogenesis. Ependymal cells lining 
the ventricular wall differentiate to form choroid plexus and project into the ventricles 
(Ek et al., 2005). The choroidal epithelium continuous with the ependyma of the 
ventricle, but choroidal epithelium is distinct in structure and function from the 
ependymal cells. CSF in the ventricles is separated from the surrounding brain 
parenchyma by the ependyma, while the CSF present outer of the ventricles is 
separated from brain parenchyma by the pial-glial lining (Chodobski and 
Szmydynger-Chodobska, 2001). In mammals, there are four distinct choroid plexus; 
one on the floor of each lateral ventricle and one each on the respective roofs of the 
third and fourth ventricles. In mammals, sheet-like choroid plexus is present in the 
lateral ventricles whereas villus-like branched arrangement is in the third and fourth 
ventricle (Cserr, 1971). Choroid plexus in the fourth ventricle develops first, later the 
choroid plexus of both lateral and the third ventricle formed (Dziegielewska et al., 
2001). Due to relatively high rates of metabolism, protein synthesis and fluid output 
by choroid plexus, choroid plexus perfusion rate is greater than the average cerebral 
blood flow (Faraci et al., 1994; Szmydynger-Chodobska et al., 1994; Yacavone et al., 
1994). A limiting factor in the production of CSF is flow of blood in the choroid 
plexus (Cserr, 1971).  
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Figure 1.1: Schematic representation of the development of spinal cord and 
brain from the neural tube in human embryos. Upper row represents the lateral 
views and lower row represents the dorsal views, a, b and c is the sequence of stages 
of embryonic development. (a) Intially neural tube partitioned into three regions of 
the brain and spinal column. (b) Three vesicles of the brain formed from the neural 
tube, identified as the prosencephalon (forebrain), mesencephalon (midbrain) and 
rhomboncephalon (hindbrain). (c) The next stage of brain development after the 
formation of three vesicles is subdivisions of the prosencephalon (forebrain) vesicle 
into the myelencephalon and metencephalon (Adapted from: Dan et al., 2006). 
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Figure 1.2: Neurulation process and defects of neurulation in the human embryo 
during development. (a) Dorsal and transverse view of 22-days old human embryo: 
showing neurulation process initiates. (b) Dorsal view of 23 days old embryo: 
showing neurulation process proceed at the anterior end,  neuropore region close, the 
posterior end of neuropore remains open (c) Normal newborn showing different 
regions of neural tube closure. (d) Anencephalic newborn that is due to the failure of 
closure of the anterior end of neuropore or region 2. (e) Spina bifida is caused due to 
the failure of closure of the posterior end of neural tube or region 5 (Adapted from: 
Van Allen et al., 1993). 
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Figure 1.3: Cellular mechanism of cortical development in mouse. E8.5 stage: 
Neural tube wall composed of a pseudostratified neuroepithelium (blue cells). Cells 
have processes that are in contact with outer and inner surfaces of the neural tube. The 
migration of the nucleus occurs according to the cell cycle and mitosis, at the 
ventricular surface M phase occurs and at the pial surface S-phase occurs (nuclei in 
green colour are 2n, nuclei in orange colour are 4n). E10 stage: From the germinal 
neuroepithelium, first cells delaminate which forms the VZ (ventricular zone) and 
pre-plate. The pre-plate contain Cajal–Retzius neurons (light green coloured cells) 
and subplate neurons (orange coloured cells). Cells in the VZ after exit from cell 
cycle (from neuroblast) (cells in dark blue colour) these cells move along radial glia 
cells (red coloured cells in the VZ) from the VZ and form the cortical plate zone. 
Layer II-VI formed by the neuroblasts, neuroblast split the pre-plate, subplate neurons 
remains adjacent to the VZ while the Cajal–Retzius cells are in contact with the pial 
surface. Cells start accumulation from inside-to-out pattern beginning with layer VI 
(purple cells) and ending with layer II neurons (pink cells) (WM, white matter) 
(Adapted from: Uher and Golden, 2000). 
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Figure 1.4: Model showing the molecular mechanism of the development of 
cerebral cortex in mice. At E12 stage cortical plate separates the preplate into two 
types of cell groups: one is pioneer neurons that lie in the marginal zone and the other 
type is subplate cells. At an early stage, cortical plate fails to organize properly in 
reelin and Dab-1 deficient mice but organize normally in Cdk5 or p-35deficient mice. 
In the second step gradient forms in an inside to outside pattern by cortical plate 
neurons, older neurons organize at bottom while younger cells stay at top, this pattern 
is defective in reelin/Dab1 and Cdk5/p35 deficient mice (Adapted from: Lambert de 
Rouvroit and Goffinet, 1998a).  
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1.4.  Cerebrospinal fluid (CSF):  
1.4.1. Background:  
Andreas Versalius (1514-1564) came up with a remarkably accurate explanation 
during the Renaissance period (1450-1600) about the cerebral ventricles and the 
choroid plexus in humans and calculating that CSF volume was approximately one-
sixth of the total brain volume (Clarke and Dewhurst, 1972), calculation more or less 
confirmed by modern magnetic resonance imaging (MRI) giving a figure of 18% of 
the whole brain volume (Luders et al., 2002). Physiology of CSF is based on three 
main premises after investigation of 100 years; (1) the active formation of CSF, (2) 
the absorption of CSF (passive) and (3) the CSF flow in one direction from the place 
of formation to the absorption site (Figures 1.5) (Taketomo and Saito, 1965; Milhorat, 
1975; Chodobski and Szmydynger-Chodobska, 2001; Luciano and Dombrowski, 
2007).  
1.4.2. CSF production: 
Production of CSF from the choroid plexus is at the rate of approximately 
0.002 ml/min in rats and 0.35 ml/min in humans (De Lahunta, 1983; Milhorat, 1987; 
Davson and Segal, 1996). The daily CSF production is about three to four times more 
than the total volume of CSF in the ventricular system (Milhorat, 1987; Davson and 
Segal, 1996). CSF production is age-dependent, in the young human brain, CSF 
production rate is about 500 ml/day or about 340 μl/min (Edsbagge et al., 2004; 
Weller et al., 2009), this amount decreases to about 250 ml/day in the elderly person 
(May et al., 1990). The adult brain contains a stable volume of about 140 ml of CSF, 
of which 30 ml present in the ventricles and about 110 ml present in the subarachnoid 
spaces (Weller et al., 2009). CSF is totally replaced about three times in every 24 
hours in humans (Preston, 2001). With age the ability of CSF formation and release 
by the choroid plexus undergoes frequent reduction (Silverberg et al., 2001; Preston et 
al., 2003; Redzic et al., 2005; Masseguin et al., 2005). 
1.4.3. CSF absorption: 
CSF moves from the subarachnoid space to the arachnoid villi that exit into the 
sagittal venous sinus and the facial lymphatics. Cortical and spinal subarachnoid 
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spaces are the main exit routes of the bulk CSF (arachnoid villi and spinal nerve 
roots) (Herndon and Brumback, 1989). Weed (1917) has reported that the 
development of the choroid plexus and opening of the subarachnoid space occur 
together. In the initial stage of development even before complete maturation of 
choroid plexus, it could produce CSF which is critical to open and retain the 
arachnoid pathways (Pollay et al., 1983; Davson et al., 1987).  
1.4.4. CSF function: 
CSF provides stable environment to the brain and assists in the elimination of waste 
products from the central nervous system (Kazemi and Johnson, 1986). CSF has vital 
role in maintaining the function of brain throughout life, CSF plays a specific role in 
the brain at different stages of lifetime periods i.e., embryonic, fetal and adult. During 
early central nervous development, the brain increase in the volume with parallel 
increase in embryonic CSF (E-CSF) volume (Gato and Desmond, 2009). 
Development of the brain mechanism is regulated by different factors that act in an 
autocrine/paracrine manner. A physiological sealed cavity is formed after closing of 
the anterior end of the neuropore, which is composed of embryonic cerebrospinal 
fluid (E-CSF). Trapped amniotic fluid in sealed cavity is called E-CSF, which is in 
contact with neuroepithelial cells situated in the apical surface (Gato et al., 2004). 
Mitotic division of the neuroepithelium is under the influence of the CSF composition 
(Ozawa et al., 1996; Wilke et al., 1997; Walshe and Mason, 2000; Trokovic et al., 
2005). An osmotic gradient and brain expansion occured through CSF pressure by 
exerting a tension state in neuroepithellium, which stimulate the proliferation of 
neuroepithelial cells and suggested the presence of tension receptors (Parvas and 
Bueno, 2010). Significant abnormalities in the neuronal organization of a developing 
brain occured by reducing drainage of the CSF from the brain ventricular system 
(Desmond and Jacobson, 1977).  
Miyan et al., (2006) observed that the composition of CSF and its properties change 
during different stages of development. CSF composition also changes with the flow 
of CSF along its pathway from the lateral ventricles to third ventricle then in the 
subarachnoid space by the addition of different components specifically from the 
choroid plexus and circumventricular organs (Miyan et al., 2006; Salehi and 
Mashayekhi, 2006).  
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1.4.5. CSF composition: 
Human CSF is a clear, colourless and acellular fluid, proteins and ions are the main 
components in CSF (May et al., 1990). CSF continually streams from the choroid 
plexus, supplying proteins and micronutrients as well as ions and water to the delicate 
neuronal microenvironment (Johanson, 1993; Chodobski and Szmydynger-
Chodobska, 2001). Simultaneously, in the opposite direction many catabolites and 
protein breakdown products in brain extracellular fluid diffuse into CSF from which 
clearance is needed to assure optimal neuronal status (Milhorat, 1987).  
1.4.6. CSF proteins: 
Protein in the CSF is a main component of CSF for understanding the pathology of 
brain at the embryonic, fetal and adult stages. CSF has higher proteins in lumbosacral 
region as compared to cisternal CSF (Fishman and Chan, 1980). In newborn protein is 
up to 150 mg per dL (1.5 g per L) (Fishman, 1992) whereas in adult protein range is 
18 to 58 mg per dL (0.18 to 0.58 g per L) (Conly and Ronald, 1983). Protein 
concentration is the most sensitive marker in the CSF for understanding the 
pathophysiology of the central nervous system. Proteins are added along the 
ventricular route as CSF move through the brain (Frick and Scheid-Seydel, 1958; 
Davson, 1967; Cutler et al., 1968). Albumin, transferrin, fetuins, alpha-fetoprotein, 
IgG and alpha 1-antitrypsin are the major proteins in CSF (Dziegielewska et al., 
1981). Protein concentration increased in CSF due to different causes e.g., an 
inflammatory condition reducing the pathway of CSF through the arachnoid villi or a 
subarachnoid space and tumor or a disc prolaps etc. (Reiber, 1994). Protein can leak 
into the CSF because of blood brain barrier (BBB) damaged (Fishman, 1992). CSF 
protein increased most commonly in multiple sclerosis, Guillain Barré syndrome, 
haemorrhage, infections, tumors, hormonal imbalance and use of some medicines 
(Dougherty and Roth, 1986; Khurana, 1996). 
1.4.7. Electrolytes in CSF: 
CSF is important in maintaining a stable environment within the brain. In addition to 
mechanical function of CSF, ionic composition has a profound influence on the 
central nervous system function. The ionic composition of CSF remains constant 
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despite wide fluctuation in plasma ionic composition (Kazemi and Johnson, 1986). 
Chloride (Cl-), sodium (Na+) and magnesium (Mg2+) levels in the CSF are little higher 
than plasma, whereas  potassium (K+), calcium (Ca2+) and glucose are lower as 
compared to plasma (Figure 1.7) (Guyton and Hall, 2000). High concentration of 
Na+and K+ is in the choroid plexus epithelium compared to plasma and CSF. This 
high level of Na+ and K+ leads to hypertonicity in the cells of choroid plexus. 
Aquaporin-1 (AQP1) channels for water and Na+ dependent acid/base transporters are 
highly expressed on the cells of the choroid plexus that may be involved in the 
secretion of CSF (Odessky et al., 1954; Harris and Sonnenblick, 1955; Breyer and 
Kanig, 1970; Heipertz et al., 1979). Electrolytes levels in the CSF show no significant 
gradient at different region of the neural axis (Hunter and Smith, 1960; Pallis et al., 
1965) as has been found for CSF proteins. Electrolyte transporters are present on 
choroid plexus epithelium both at basolateral (plasma-facing) and apical (CSF-facing) 
membrane to regulate the CSF formation by altering ion movement (Johnson et al., 
2008).  
Function of electrolytes in the CSF: 
Sodium (Na+):  
Na+ plays a main role in the osmoregulation and production of CSF (Crone and 
Christensen, 1981). It was found that acetazolamide inhibits or decrease the 
movement of Na+ into the CSF. The movement of Na+ from blood to the brain 
increase by vasopressin. Acetazolamide is an inhibitor of carbonic anhydrase while 
vasopressin is stimulator of carbonic anhydrase (Bradbury and Davson, 1965). 
Carbonic anhydrase is found to be implicated in the production of CSF in the 
choroidal epithelium (De Lahunta, 1983). Na+K+ ATPase pumps transfer Na+ ion into 
the neuroepithelium, previous studies suggested that Na+ enter into the CSF from 
inside to the outside after the formation of trans-neuroepithelial electric potential that 
managed the morphogenesis process (Hotary and Robinson, 1991; Shi and Borgens, 
1994; Borgens and Shi, 1995). 
Potassium (K+): 
K+ plays an important role for the normal function of neurons and neurotransmitters 
release. K+ concentration in the CSF is lower than plasma because of the limited 
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transfer of K+ ion across the BBB. K+ is slightly less permeable than Na+ across the 
choroid plexus epithellium in contrast K+ show high permeability in the blood 
capillaries (Rosenberg, 1990).  
Magnesium (Mg+) and Chloride (Cl-): 
Mg+ and Cl- play an essential role in the neuronal conduction (Maren, 1992). Previous 
studies have reported that the administration of acetazolamide leads to reduce the rate 
of CSF formation and inhibits the Cl- transfer into the CSF (Wilson and Stevens, 
1977; Jackson et al., 1996).  
Bicarbonate (HCO3-):  
Active transport of hydrogen or HCO3- ions or both across the BBB and blood CSF 
barrier direct the CSF acid-base status (Severinghaus et al., 1963; Pappenheimer, 
1970). The acid base metabolism of the cerebral compartment may influence the 
cerebral function (Posner and Plum, 1967). pH of CSF is lower than the blood pH in 
healthy infants (Manfredi, 1962; Albert et al., 1966; Krauss et al., 1972). 
1.5. Biomarkers in CSF  
Biological features are measured and evaluated as indicator of biological process, 
development of disease or responses to certain medicines are called biomarkers. 
Different biomarkers are present in CSF such as CSF pigment markers, metabolic 
markers, blood specific markers, cell–type–specific markers, biomarkers for 
widespread of central nervous system damage and inflammatory/immunological 
markers.  
a. CSF pigment markers: 
Under normal pathological condition, CSF is clear but abnormal colour is due to the 
following conditions: 
Turbidity: CSF become turbid by elevated numbers of RBC (>400 RBC per mm
3
) or 
WBC (>200 WBC per mm
3
) in the CSF (Greenlee, 1990). Turbidity in the CSF also 
appears because of high bacterial or fungal counts in the CSF or by epidural fat that is 
aspirated at the time of the lumbar puncture (Mealy, 1962).  
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CSF pleocytosis: CSF pleocytosis is an increase in the CSF WBC count. WBC count 
of >500/mm
3 
with neutrophils prescence in bacterial meningitis and a WBC count of 
monocytes occur in viral meningitis case (Hegenbarth et al., 1990; Bamberger and 
Smith, 1990; Domingo et al., 1990; Lessing and Bowler, 1995; Andersen et al., 1995; 
White and Hoch, 1996; Gutierrez-Macias et al., 1999).  
Xanthochromia: Discoloration of the CSF into yellow, orange, or pink colour is 
called xanthochromia. Discoloration of CSF mostly caused by the lysis of RBCs, 
which leads to the breakdown of haemoglobin to oxyhaemoglobin, bilirubin and 
methemoglobin. If CSF contain RBCs and remain in the CSF for more than two hours 
can cause xanthochromia (Dougherty and Roth, 1986).  
b. Metabolic biomarkers: 
The intial, middle or end products of the metabolic pathway is called metabolic 
biomarkers. The central metabolic pathways are collectively used by many types of 
cell and can be good signals of impairment, but are not precise marker for any specific 
cell type or exact pathological process (Tisdall and Smith, 2006). The oxidative state 
of the brain is reflected by the lactate pyruvate ratio (Davis, 1990). Glucose in the 
CSF is often used as an indicator to make a difference between the bacterial 
meningitis and viral meningitis (Spanos et al., 1989; Bonsu and Harper, 2004). In case 
of bacterial meningitis, glycolysis by both white cells and pathogen resulting in 
decrease of glucose in the CSF (Niu and Duma, 1990).  
c. Blood and brain derived proteins  in CSF: 
Some proteins in CSF are derived from the blood as well as from the brain but brain 
derived fraction (choroid plexus) of protein in the CSF are more than blood derived 
fraction. For example: 
Angiotensin converting enzyme: Angiotensin converting enzyme in CSF is mainly 
blood-derived but its increased concentration in CSF is due to disruption of blood 
CSF barrier and brain-derived fraction (Reiber, 1997). 
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Transthyretin: Source of transthyretin in CSF is mainly choroid plexus (Herbert et 
al., 1986). Transthyretin is 18 times more present in the blood as compared to CSF 
(Reiber, 1997).  
Soluble intercellular adhesion molecule: In CSF 30 % soluble intercellular adhesion 
molecule is brain-derived and 70% fraction is blood derived. Its importance is 
because of its metabolic interferences in the pathological process (Lewczuk et al., 
1998; Lewczuk et al., 2000). 
d. Blood specific protein in CSF: 
Blood specific proteins are mostly present in the blood contaminated CSF. Four major 
blood specific markers are haemoglobin, catalase, peroxiredoxin and carbonic 
anhydrase I, all of these proteins are released from the red blood cell after lysis. Blood 
contamination may occur artifactually during sample collection but it may also due to 
disruption of the blood brain barrier (You et al., 2005). Lysophosphatidic acid (LPA) 
is present in plasma and serum (Aoki et al., 2002). Yung et al., (2011) found that the 
LPA prescence in CSF is responsible for fetal onset HC associated with haemorrhage.  
e. Central nervous system specific biomarkers: 
Brain expresses cell specific markers (Petzold, 2005) due to the damage in various 
pathological conditions, these specific markers released into the extracellular fluid 
and from the extracellular fluid transferred into the CSF. Concentrations of markers in 
the CSF and the severity of brain damage are closely associated with each other 
(Dang et al., 2005; Lai et al., 2006; Kirchhoff et al., 2006).  
S-100B protein: S-100B is in high concentrations in glial and Schwann cells. After 
cell degradation S-100B increased into the CSF and serum, it has a diagnostic 
relevance (Otto et al., 1997; Sindic et al., 1982) in diseased condition. 
Tau protein: Tau protein is important for the stability of the neurons, but is also 
found to be expressed in the glial cells. CSF levels of tau increase in 
neurodegenerative and inflammatory diseases (Jensen et al., 1995; Vigo-Pelfrey et al., 
1995; Otto et al., 1997; Urakami et al., 1999; Kapaki et al., 2000).  
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Glial fibrillay acidic protein (GFAP): GFAP is expressed in high concentrations in 
astrocytes and known as marker for differentiation of astrocytes. GFAP in CSF is a 
specific indicator of the astrocytes damage in the central nervous system (Eng et al., 
1971).  
Vimentin: Vimentin found in a variety of cells including astrocytes, fibroblasts, 
endothelial cells, macrophages, neutrophils, lymphocytes (Evans, 1998), fibroblasts, T 
and B-lymphocytes (Franke et al., 1987). In brain at earlier stage vimentin is 
expressed by radial glia cells (precursor of astrocytes), at later stage mature astrocytes 
(radial glia cells transformed into astrocytes) express GFAP (Dahl, 1981; Schnitzer et 
al., 1981; Bignami et al., 1982).  
Myelin Basic Protein (MBP): MBP encoded by a gene expressed by 
oligodendrocytes, in myelin sheath MBP composes of 30% of the total protein 
(Kamholz et al., 1986; Campagnoni, 1988). MBP is found in the CSF due to myelin 
damage, demyelinating disorders and brain injury (Whitaker et al., 1980; Whitaker, 
1998).  
CNPase (2’, 3’-cyclic nucleotide 3’-phosphodiesterase): CNPase is a protein 
accounting for approximately 4% of myelin protein content (Vogel and Thompson, 
1988; Reinikainen et al., 1989). It hydrolyses 2’, 3’-cyclic nucleotide derivatives of 
adenine, guanine, cytidine and uridine to 2’– nucleotides (Sims and Carnegie, 1976).  
Neuron-specific enolase (NSE): NSE is expressed in neurons and neuroendocrine 
cells. NSE is observed in CSF (Jacobi and Reiber, 1988; Vanengelen et al., 1992) or 
in blood (Schaarschmidt et al., 1994) due to the degradation of neurons after cerebral 
hypoxia, head/brain trauma and/or brain infarction.  
f. Inflammatory and immunological biomarker: 
Inflammation, infection or injury in the central nervous system may lead to release of 
specific cytokines that provide protection or damage to the brain depending on the 
timing and the amount of its production (Falsig et al., 2008). Cytokines show 
modifications in response to developmental abnormalities, physiological states and 
neurological disorders (Kasaian and Neet, 1989; Jones et al., 1991; Kitazawa and 
Tada, 1994; Suzaki et al., 1997; Arnold et al., 1999; Johanson et al., 1999; Nicholson, 
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1999; Moinuddin and Tada, 2000; Proescholdt et al., 2000; Xia et al., 2000; Johanson 
and Jones, 2001). Central nervosus system is very sensitive, specifically neonates are 
very vulnerable to inflammatory damage (Volpe, 2001; Folkerth, 2006).  
Interleukins (IL): Interleukin 1 beta (IL-1β) and interleukin 6 (IL-6) are an effective 
mediators in infection and injury (Dinarello, 1998). IL-1β is mainly formed by blood 
macrophages, monocytes, dendritic cells and some other cells (Dinarello, 1996; 
Sasaki et al., 2002). Astrocytes are the main source of IL-6 in the central nervous 
system in case of injury and inflammation (Gruol and Nelson, 1997). In the central 
nervous system IL-6 exerts neurotrophic effects and is a mediator of the acute phase 
reaction and inflammation (Chai et al., 1996). IL-6 concentration protects neurons 
from NMDA toxicity (Ali et al., 2000), IL-6 overproduction interferes with the 
integrity of the BBB (Brett et al., 1995).  
Transforming growth factor β1 ((TGF- β1): TGF-β1 is produced by many kinds of 
cells including fibroblasts. TGF- β1 is mainly derived from platelets that spread into 
the subarachnoid space at the time of subarachnoid haemorrhage (Mathiesen et al., 
1993). TGF-β1 is a multifunctional polypeptide involved in wound healing by fibrosis 
of granular tissue (Bennett and Schultz, 1993; Quaglino et al., 1999). Central nervous 
system lesions damaged the BBB, trigger the release of TGF-β1 (Assoian et al., 1983) 
and up-regulate the TGF-β1 expression in macrophages, astrocytes and other injury 
responsive cells  including vascular endothelium, meninges and choroid plexus 
(Logan et al., 1992; Berry et al., 1999). 
Interferon Gamma (IFN-γ): IFN-γ plays an important role for the regulation of 
immune and inflammatory response (Degliantoni et al., 1985). It was suggested in 
previous studies that IFN-γ activates T cells to contribute in the pathogenesis of 
myelin disorders, e.g. multiple sclerosis (Hirsch et al., 1985; Panitch et al., 1987; 
Mana et al., 2006). IFN γ is involved in the regulation of the inflammatory response 
by activation of T-cells and macrophages (Degliantoni et al., 1985) which may result 
in gliosis, apoptosis and myelin loss (Hirsch et al., 1985; Corbin et al., 1996; 
Baerwald and Popko, 1998; Folkerth, 2005; Town et al., 2005; Mana et al., 2006). 
Stem cell factor (SCF): Stem cell factor also known as steel factor or kit-ligand (KL) 
that binds to the c-Kit receptor (CD117). SCF can present in both form as a membrane 
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bound and soluble protein (Silva et al., 2006). SCF and its receptor, c-kit, are highly 
expressed in the nervous system during development and in adulthood stage (Zhang 
and Fedoroff, 1999). SCF is necessary for survival of neuron (Zhang and Fedoroff, 
1997; Erlandsson et al., 2004), neural stem cell migration and neurogenesis (Jin et al., 
2002). Mostly SCF produced is in the soluble form and is produced predominantly by 
neurons in the normal adult brain. Increased expression of SCF has been found in 
neural cells after brain injury (Zhang and Fedoroff, 1997).  
Vascular endothelial growth factor (VEGF): VEGF is present in astrocytes, 
neurons, endothelium, and inflammatory cells (Jin et al., 2000; Matsuzaki et al., 
2001). VEGF regulate angiogenesis during development and after tissue injury 
(Ferrara, 2000; Tonnesen et al., 2000). The vascular effects of VEGF include 
proliferation, survival of endothelial cells (Gerber et al., 1998), increase in vascular 
permeability (Ferrara, 2000) and induction of growth and branching of existing blood 
vessels (Silverman et al., 1999).  
Hepatocyte growth factor (HGF): HGF is a glycoprotein that stimulates the 
morphogenesis, growth and motility of various epithelial and endothelial cells (Gohda 
et al., 1988; Zarnegar and Michalopoulos, 1989). HGF acts as a trophic factor for the 
regeneration of organ (Matsumoto and Nakamura, 1996). In the CSF HGF 
concentrations are lower compared to the levels of HGF in the serum (Massaro et al., 
1994; Massaro et al., 1997). Abnormal levels of HGF detected in the CSF in brain 
injury, development, regeneration and malignant process (Bottaro et al., 1991; Honda 
et al., 1995; Miyazawa et al., 1998).  
Fas ligand (FasL) and Fas receptor: Soluble Fas (sFas) ligand has antiapoptotic 
properties. Previous studies reported the prescence in several neurological disorders, 
mainly in autoimmune disorders, malignant diseases and neurodegeneration (Mogi et 
al., 1996; Zipp et al., 1998; Streffer et al., 1998).  
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Figure 1.5: Diagram to show the interfaces between CSF, blood and brain. 
Arrows point toward the CSF formation at the choroid plexus and presence of 
interstitial fluid at the brain capillary. The CSF absorptions occurs in arachnoid villi 
(SAS, subarachnoid space) (Adapted from: Terlizzi and Platt, 2006). 
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Figure 1.6: Diagrammatic representation of the flow of CSF in the brain. CSF is 
produced from the choroid plexus situated in the lateral, third and fourth ventricles. 
CSF drains from the ventricles and from the fourth ventricle enter into the 
subarachnoid space (SAS). Finally, CSF moves out from its circulatory pathway 
through arachnoid villi into the superior sagittal sinus situated above the cortex 
between the cerebral hemispheres (Adapted from: Miyan et al., 2001). 
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1.6. Hydrocephalus (HC): 
The word ‘‘hydrocephalus’’ originated from Greek, ‘‘hydro’’ meaning water and 
‘‘cephalus’’ (pronounced “Kephalus”) meaning head. In humans, HC condition 
occurs in 2 to 3 individuals per thousand live births. HC is a pathological condition 
resulting from build-up of CSF within the ventricle of the brain and/or in the 
subarachnoid space. CSF accumulation may be due to an imbalance between the CSF 
production, CSF absorption or to a blockage in the normal flow of CSF (Matsumoto 
and Tamaki, 1991; Rekate, 1997; McAllister and Chovan, 1998).  
HC is mostly a CSF reabsorption failure rather than CSF formation problem, e.g., 
hypersecretion by choroid plexus (Gudeman et al., 1979). The noticeable effects of 
the HC condition, if remain  untreated can lead to raised intracranial pressure due to 
ventricle expansion, blood brain barrier dysfunction, compression and stretching of 
brain parenchyma, ischemia, anoxia and cerebral edema that normally results in death 
(Rekate, 1997; McAllister and Chovan, 1998; Pattisapu, 2001; Crews et al., 2004). 
The large ventricles and decreased thickness of cerebral cortex are two marked 
anatomical changes occurring in the HC brain of newborn infants (Levene and 
Lifford, 1995) leading to damage of the central nervous system, fibrosis and sclerosis 
occurred in the periventricular layers, ependyma and choroid plexus epithelium 
(Weller and Wisniewski, 1969; Milhorat, 1972; Frim et al., 1998). The most 
destructive type of HC is fetal onset HC which affects between 1:500 to 1:5000 live 
human births (Pattisapu, 2001; Sipek et al., 2002), and is associated with defective 
cerebral cortex development leading to severe neurological disorders (Cains et al., 
2009). 
1.6.1. Classification of HC: 
a. Types on the basis of CSF flow: 
HC can be classified as communicating or noncommunicating HC based on CSF flow 
whether there is a normal circulation of CSF and ventricular system of brain is in 
contact with subarachnoid space. Communicating or noncommunicating HC indicates 
physical blockage in the CSF movement or free CSF flow between ventricles and 
subarachnoid space (Epstein and Johanson, 1987). 
Chapter 1                                                                                                   Introduction  
27 
 
i. Communicating HC: 
Communicating or non-obstructive HC is caused due to an abnormal absorption of 
CSF instead of blockage in the CSF flow pathway. 
ii. Noncommunicating HC: 
Noncommunicating HC is also known as obstructive HC, it occurs when the CSF 
flow is blocked along the pathway of CSF circulation at one or more points, 
preventing the CSF flow from the ventricular system into the subarachnoid space.  
b. Types on the basis of onset of HC: 
HC classified into two types based on onset of HC: 
i. Congenital HC 
ii. Acquired HC 
Congenial and acquired HC can be communicating or non-communicating.  
i. Congenital HC (CH): 
CH is present at birth and develops by the interaction of genetic and environmental 
factors but this does not mean that it is hereditary (Fernell et al., 1986; Bajpai, 1997; 
Persson et al., 2005). Approximately 55% of HC are congenital (Milhorat, 1978) and 
is often linked with the developmental abnormalities. CH is very complex disorder, 
particularly its development and progression is dynamic and not completely 
understand. It is estimated that CH may develop at embryonic stage, consequently 
leads to deficient proliferation and differentiation of neural stem cells (Adams et al., 
1982; Fernell et al., 1986).  
Aetiology of CH: 
The accurate cause of CH cannot be determined but the identified causes include: 
Aqueductal Stenosis (non-communicating): The most widespread cause of CH is an 
obstruction in the CSF pathway between the third and fourth ventricles called 
aqueductal stenosis. Blockage might be occurred due to infection, haemorrhage or a 
tumour.  
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Neural Tube Defect (communicating): Due to the failure of closure of neural tube, 
spinal cord remains open at the time of birth that leads to leakage of CSF and this 
condition is called spina bifida.  
Arachnoid Cysts (non-communicating): HC occurred due to formation of 
Arachnoid Cysts. Arachnoid Cysts are mostly situated at the back of the brain and in 
the third ventricle area. These cysts may obstruct the CSF flow that leads to HC.  
Dandy-Walker Syndrome (non-communicating): In this syndrome, size of the 
fourth ventricle becomes bigger and the failure of the development of cerebellum 
occurs. In some cases, Dandy-Walker syndrome may also lead to abnormal 
development of other brain parts.  
Risk factor for CH: 
Diagnosis and management of CH in patients at an early stage is very critical. Higher 
percentage of CH is in male than female (Wiswell et al., 1990), and no significant 
racial differences was found in the onset of CH. Lack of prenatal care and alcohol 
consumption increased the risk of CH (Swayze et al., 1997; Carmichael et al., 2002). 
Alteration of genes expression during embryogenesis (Reece et al., 2006) could 
influence the migration and differentiation of neurons that may lead to CH. Due to 
inadequate research exact mechanisms of CH is difficult to understand. 
ii. Acquired HC: 
Acquired HC develops at any stage of life after birth due to various neurological 
problems.  
Aetiology of acquired HC: 
Acquired Hydrocephalus can be caused by: 
Intraventricular Haemorrhage (communicating): Intraventricular haemorrhage 
mostly commonly occurred in premature newborn. Small blood vessels in the lining 
of the ventricular system rupture that leads to CSF absorption failure and 
accumulation.  
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Meningitis (communicating): Meningitis occured due to bacterial or viral infection 
of meninges of the brain and spinal cord. Meningitis causes inflammation and 
scarring of meninges that can block the CSF flow and leads to HC.  
Ventriculitis (non-communicating): Ventriculitis is an inflammation or infection of 
the ventricles, most commonly occured in infants and is often associated with 
meningitis. 
Head Injury (communicating): Brain tissues, nerves or blood vessels can damage 
due to head injury. Bleeding may enter the CSF pathway leading to inflammation.  
Brain Tumours (non-communicating): Tumours in the brain usually occur in the 
backside of the brain (posteriorfossa). As a tumour progress, it compresses the 
ventricle leading to CSF flow obstruction.  
Choroid plexus papilloma (CPP) (communicating): CPP is uncommon and very 
slow-growing disorder. In CPP tumour is usually sited in the choroid plexus 
positioned in the ventricular system, it may obstruct the flow of CSF and raise the 
intracranial pressure. 
Normal Pressure Hydrocephalus (NPH) (Non-communicating): NPH is a type of 
communicating HC in which enlargement of the ventricles occured without high 
pressure of CSF. NPH commonly occurs in the elder people. NPH is mostly 
accompanied with dementia, gait disturbance and incontinence (Hakim and Adams, 
1965; Bergsneider et al., 2005; Marmarou et al., 2007). 
External hydrocephalus (EH): CSF accumulation between the dura matter and the 
brain without dilation of brain ventricle leads to EH (Harbeson, 1939; Anderson et al., 
1984; Maytal et al., 1987; Kumar, 2006).  
1.6.2. Clinical features of HC: 
The first clinical indication of HC in human infants is usually an enlarged head size at 
the time of birth or soon after birth (Figure 1.8). In infants HC usually occurs earlier 
to the cranial sutures closure and elimination of the fontanella that may lead to HC 
with disproportionate growth of the head. In addition to size of head, other clinical 
signs include fontanellae bulging, separation of the cranial sutures, scalp veins 
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prominence and “setting sun” eyes (Figure 1.8). Clinical features in elders are 
complex such as raised intracranial pressure, pain, vomiting and sleepiness. Visual 
obscurations and papilledema are more common in the elder. After the development 
of HC condition, cognitive impairment, poor concentration and behavioral changes 
occurred (Venkataramana, 2011). 
1.6.3. Diagnosis of HC: 
Majority of the HC cases diagnosed immediately by ultrasound scanning through the 
anterior fontanelle or by symptoms. HC can also be diagnosed by: 
Head Circumference: The size of the head calculated by taking the maximum 
circumference of head with the help of measuring tape (Rungachary and Wilkins, 
1985; Carey et al., 1994).  
Intracranial pressure monitoring: This method detect pattern of the pressure waves 
through a catheter inserted through the skull into the brain for measurement of 
intracranial pressure. 
Plain X rays: By the aid of this method an enlarged head, crainofacial disproportion, 
wide spread sutures and large anterior fontanelle to be observed (Sempere et al., 
2005). 
Isotopic cisternography: Isotopic cisternography monitored the absorption of CSF 
over a period of time (4 days). In this method, radioactive isotope injected into the 
lower back through a spinal tap then the absorption of CSF to be analysed. 
Computed Tomography (CT): CT is used to measure ventricular size, extracerebral 
spaces and site of obstruction in the CSF flow pathway. CT scan of the head utilizes 
an x-ray beam, which passes through the head and then allowing a computer to make 
a picture of the brain in slices. 
Magnetic Resonance Imaging (MRI): MRI is used for antenatal diagnosis of HC 
(Sempere et al., 2005). Small abnormalities such as cysts and abscesses are detected 
with MRI. MRI also helps the neurosurgeon to distinguish between communicating 
and noncommunicating HC. 
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1.6.4. Management of HC: 
In the last 50 years, despite the advancements in the diagnosis and treatment of HC, 
long-term health outcomes for individuals with HC remain unpredictable. HC 
managed by surgical and non-surgical procedures. 
a. Surgical management of HC:   
HC managed by the surgical procedures for examples choroid plexectomy, ventricular 
shunt and third ventriculostomy.  
i. Ventricular Shunt: 
The most common and effective procedure performed by neurosurgeons is surgical 
implantation of ventricular shunt. It includes the insertion of a one end of catheter into 
the cerebral ventricles to remove the excess CSF into peritoneal cavity. Most 
commonly, shunts drain the CSF from the ventricle into the peritoneal cavity but the 
other alternate sites include the pleural cavity, right atrium and gallbladder. The main 
purpose of shunt placement is to relief the intracranial pressure to reduce the risk of 
neurological deficit. In most cases shunt remain inserted into the ventricle for whole 
life period.  
Shunt complications: 
Despite the success rate of shunt, it also causes some potential problems. The most 
common complications including bacterial infection, shunt malfunctions or shunt 
failure. Cases of shunt failure are very common and number of patients having shunt 
multiple times within their life period is very high. Another complication sometimes 
occured after the insertion of shunt e.g., CSF drains more fastly than the production of 
CSF leads to difficulty in the prediction of overdrainage of CSF which bring 
complications in the treatment of HC.  
ii. Endoscopic Third ventriculostomy (ETV): 
Restricted number of hydrocephalic patients can be treated with endoscopic third 
ventriculostomy. In obstructive HC, endoscopic catheter through a small hole drilled 
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in the skull in the bottom of the third ventricle allows the CSF to move directly to the 
basal cisterns out of blocked ventricle.  
iii. Choroid plexectomy:  
Choroid plexectomy is dangerous and usually unsuccessful procedure. In this method, 
some portion of choroid plexus from the lateral ventricles is detached. The beginning 
of modern neuroendoscopy has led to a resurgence of interest in this approach but its 
application remains confined to very small number of patients (Levene et al., 1995). 
b. Non-surgical management of HC (drugs to reduce CSF production):   
Acetazolamide, isosobide, frusemide and glycerol can reduce the CSF production by 
inhibiting the enzyme carbonic anhydrase. Acetazolamide and frusemide can reduce 
ventricular and head expansion but their prolonged use is not recommended due to 
their short-lived action and side effect on important physiological systems (Guyton, 
1995; Levene et al., 1995).    
1.6.5. Genetics of HC: 
HC is multifactorial neurological disorders and genetics of HC is very complex. 
Despite of the genetics information of the HC in various animal models, still we have 
a very inadequate understanding about the molecular and genetics mechanisms of HC 
in human. In animals and humans models 43 mutants/loci reported that are associated 
with hereditary HC, uptill now nine genes have been recognized in animal models 
which are linked with HC, and only one gene in humans has been recognized which is 
linked with HC (Zhang et al., 2006). Molecular genetic studies reported gene for 
human CH is X-linked and located at Xq28 encodes L1CAM protein (L1 protein) 
(Jouet et al., 1993). L1 protein is expressed in the cells of the nervous system and 
plays a vital role in neuron-neuron adhesion, axonal elongation and axonal 
pathfinding (Kenwrick et al., 2000). The accurate mechanisms through which the 
mutation affects the function of L1 protein function is still under investigation 
(Fransen et al., 1995; Fransen et al., 1996). 
HC has been studied in many mammals (Robertson et al., 1966; Mori, 1968; Silson 
and Robinson, 1969; Taraszewska and Zaleska-Rutczynska, 1970; Yoon and Slaney, 
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1972; Leipold and Schalles, 1977; Park and Nowosielski-Slepowron, 1979; Kohn et 
al., 1984). Inherited HC was found in Hydrocephalic Texas (H-Tx) rat and first 
illustrated in 1981 (Kohn et al., 1981). H-Tx rat is a first and only natural model for 
early-onset HC. In H-TX rat, HC condition appears at gestational day 17–18 or 3–4 
days before birth comparable to mid-gestation periods of human (Somera and Jones, 
2004). There is a complicated type of inheritance in H-TX rat, dilation of the ventricle 
is accompanied with the abnormalities in the cerebral aqueduct and subcommissural 
(SCO) organ, these structures are very important for the normal flow of CSF (Jones et 
al., 2004). H-Tx rat present with large brain ventricles size, thinned cortical mantle 
and stretched internal capsule fibers. Histopathological resemblance of animal models 
with human is helpful for the better understanding of the pathology of human HC 
(Jones et al., 2000).  
1.6.6. Experimental models of HC: 
Many methods have since been developed to generate experimental hydrocephalic 
animals for better understanding of the abnormal circulation of CSF and underlying 
causes. Monkeys, dogs, cats and rabbits have often been used as a model of HC after 
injection of the foreign substances (irritating agents such as kaolin, indian ink, 
pantopaque, silastic or siliocone oil, blood, cotton, inflated foley catheter etc.) into the 
ventricular system which lead to block the drainage of CSF (Bering and Sato, 1963; 
Milhorat et al., 1970; Edwards et al., 1984; Hochwald, 1985). HC animal model was 
generated by an injection of kaolin into the cisterna magna, this model was one of the 
most reliable and best model for long period of time, and this method most commonly 
applied on different animals (monkeys, dogs, cats, rabbits, hamsters, rats, mice) for 
better understanding of pathophysiology of HC (Schurr et al., 1953; Bering and Sato, 
1963; Dohrmann, 1971; Del Bigio, 2001; Klinge et al., 2009; Lollis et al., 2009). 
However in all of these models obstruction of the CSF pathway accompanied with 
additional pathophysiological conditions (Hochwald, 1985). Most commonly used HC 
models are kaolin-induced subarachnoid space occlusion and the congenital H-Tx 
(hydrocephalus Texas) rat model. Hiryama (1980) concluded after survey of nine 
different animal models that age of the animal and mode of induction of HC are main 
factors in determining the pathology of HC. Johanson et al., (1999) described HC 
induction by injection of basic fibroblast growth factor (FGF-2) into the subarachnoid 
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space. Intrathecal injection or induced transgenic with high expression of 
transforming growth factor-ß1 also leads to HC in mice (Tada et al., 1994; Galbreath 
et al., 1995; Cohen et al., 1999). However injection of these growth factors could have 
direct effects on neuronal migration and potentially on synapse formation; but they 
may not be an ideal models of obstructive HC. H-Tx rat is a hereditary forms of HC 
arose as a spontaneous mutations in laboratory rodents (Bruni et al., 1988), H-Tx rat 
has been and continues to be extremely well studied model (Jones et al., 2000). 
1.6.7. Limitation in understanding the pathogenesis of HC:  
Numerous HC animal models are recognized each has its own advantages and 
disadvantages. Detailed study of more than one model is needed to understand the 
pathogenesis of HC. Additional knowledge is required for the understanding of the 
mechanism of axonal injury in periventricular tissue, changes in the extracellular 
compartment, water dynamics within the brain tissue and role of neurotrophic factors 
in HC (Del Bigio, 2001).  
1.7. Folate metabolisim and brain development: 
The folate metabolism pathway is a complex system, which is important for a balance 
of a variety of active transport pumps, carrier proteins, metabolic enzymes and the 
availability of various folate compounds. Folate metabolism is also essential in 
numerous physiological processes including DNA synthesis via purine and 
pyrimidine production, gene expression via DNA methylation, amino acid 
metabolism, myelin production and neurotransmitter synthesis (Djukic, 2007). Folate 
deficiency or its metabolism imbalance leads to numerous pathologies due to DNA 
damage and reduced cell proliferation (Lucock, 2000). Dietary folate is in the form of 
5MTHF (5-methyl tetrahydrofolate) acts as the methyl donor in the process of 
transformation of homocysteine to methionine then methionine is converted to S-
adenosylmethionine (SAM) by the activation of ATP. SAM acts as the universal 
methyl donor for a several methylation reactions including DNA methylation. The 
disturbance in the metabolism of folate has remarkable consequences on the cell 
(Blount et al., 1997; Jhaveri et al., 2001; Kruman et al., 2002) which eventually lead 
to decreased growth rate and impairment of the cell division (Borman and Branda, 
1989; Wagner, 1995; Chu and Allegra, 1996; Huang et al., 1999).  
Chapter 1                                                                                                   Introduction  
35 
 
1.7.1. Dietary source of folate: 
Dietry folates exist mainly as 5MTHF and formyl-THF (Thien et al., 1977). Folate is 
one of the form of vitamin, humans cannot synthesize and depends completely on the 
diet to obtain folate (Cooper, 1986). Sources of folate include yeast extracts, kidney, 
liver, citrus fruit, leafy green vegetables, potatoes, bread and dairy products (Berry et 
al., 1999; Botto et al., 2003; Hobbs et al., 2009).  
1.7.2. Folate transport in the central nervous system: 
5MTHF is a major food folate (Butterworth et al., 1963; Stokstad and Koch, 1967), 
dietry folate is taken up by gut and is oxidized to 5-methyl-5, 6-dihydrofolate (DHF) 
(Donaldson and Keresztesy, 1962). Under the slightly acidic state DHF rapidly 
degraded into 5MTHF. Ascorbic acid is the critical factor in the salvaging of acid 
labile DHF by reducing it back to stable form (Lucock et al., 1995). Three cellular 
mechanisms for the transport of folate are folate receptors (FR), reduced folate carrier 
(RFC) and proton-coupled folate transporter (PCFT) (Lee et al., 1992; Shen et al., 
1995; Antony, 1996; Sabharanjak et al., 2004). For the movement of the folate across 
the blood–central nervous system barrier, the main form of folate in plasma is 
5MTHF bounded with FR localized in choroid epithelial cells and after endocytosis 
folate transport to the CSF compartment and delivered to the neuronal tissues 
(Ramaekers and Blau, 2004). 
1.7.3. Folate association with developmental disorder: 
The association between folates and developmental disorders such as neural tube 
defects has been widely described (Butterworth and Bendich, 1996) and has resulted 
in the fortification of wheat flour with folic acid currently in over 60 countries 
including the United States and Australia. Fortification has reduced the prevalence of 
neural tube defects up to 61% in some countries (Castillo-Lancellotti et al., 2012), but 
has had little impact on the other neurological conditions including HC. The 
fortification program decreased the neural tube defect but it also created a problem of 
excess folic acid among the general population and raised the risk of occurance of 
other diseases in population (Wallis et al., 2009). Other diseases considered under the 
control of folate and folate-dependent enzymes include Alzheimer’s disease, Down’s 
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syndrome, pre-eclampsia, several types of cancer and cerebral folate deficiency 
(CFD) (Neymeyer et al., 1997; Lucock, 2000; Ramaekers and Blau, 2004; Gordon, 
2009). The positive effect of folic acid in neural tube defect prevention is associated 
with earlier phase of development, negative effect of excess folic acid possibly be 
related to distinct stages of brain development. There is a need to consider the 
developmental stage at which appropriate folate supplementation is given and detailed 
understanding of critical folate supply system. 
Abnormal folate status in the CSF can be caused by problems such as genetic 
abnormalities in specific folate enzyme or disorders acquired postnatally. CFD is a 
recently described condition in infants and children associated with a low level of 
5MTHF in the CSF but not in the serum. CFD is caused by the existence of 
autoantibodies against folate receptors in the serum of patients that appear to be 
preferentially targeted the choroid plexus but not receptors in the lungs, thyroid and 
kidneys (Ramaekers et al., 2005). Interestingly, a combination of a milk-free diet and 
folinic acid supplementation restores level of 5MTHF in the CSF and leads to 
significant recovery of symptoms (Hansen and Blau, 2005; Ramaekers et al., 2008; 
Steinfeld et al., 2009). Steinfeld et al., (2009) describe a brain-specific mutation in the 
folate receptor 1 (FR1) gene resulting in loss of function of the FRα receptor and a 
consequential drop in CSF 5MTHF levels. These patients presented with severe 
developmental and neurological problems. Folinic acid supplementation restored 
5MTHF in CSF and significantly improved clinical outcome.  
1.7.4. Folate metabolism pathway and HC: 
In cellular metabolism folate coenzymes role is well recognized, as they are involved 
in the transferring of one-carbon groups in several metabolic reactions (Wagner, 
1995). FDH (5-formyl tetrahydrofolate dehydrogenase, from the gene Aldh1L1) is a 
crucial and abundant enzyme in mammals. FDH is a key enzyme involved in 
maintaining the folate pool in balance, FDH is secreted into CSF from neural stem 
cells lining the ventricles (Krupenko and Oleinik, 2002). The substrate of FDH 10-
formyltetrahydrofolate represents a key folate in the folate pool in the cell (Horne et 
al., 1989). FDH transforms 10-formyl-THF to THF (tetrahydrofolate) and CO2 in a 
NADP+ dependent dehydrogenase reaction, binding of the FDH with THF occurs with 
high affinity (Figure 1.9) (Kim et al., 1996; Anguera et al., 2006). It was suggested 
Chapter 1                                                                                                   Introduction  
37 
 
that FDH acts as a binding protein capturing THF released from choroid plexus 
epithelial cells into CSF. The choroidal cells contain methionine synthase (MS) and 
convert 5MTHF to THF. FDH would thus stabilise THF for transport through the CSF 
pathway and delivery to the cells along the pathway. Generally FDH levels reduced in 
certain physiological and pathological states (Krupenko and Oleinik, 2002; Epperson 
et al., 2004; Leonard et al., 2006), while FDH elevation can produce antiproliferative 
effects (Krupenko and Oleinik, 2002). 
It was reported in previous study that FDH levels in the affected H-Tx fetuses were 
dramatically reduced compared to normal rat fetuses. Supplementation of folinic acid 
and THF to pregnant dams caused a marked decrease in congenital HC incidence, 
combination of tetrahydrofolic acid and 5-formyl tetrahydrofolic acid also reduced the 
occurrence of HC, in contrast, folic acid supplementation increased the incidence of 
HC (Cains et al., 2009). Cell cycle arrest of cortical progenitor cells and disruption in 
the folate metabolism in CSF was reported in H-TX rats (Owen-Lynch et al., 2003).  
1.8. Objectives of study: 
In the current study CSF samples were obtained from human infants that were normal 
or suffering from HC through different causes. Major objective of current study was 
to test whether human CSF also reflects a unique folate supply system and whether a 
similar folate imbalance exists in hydrocephalic infants as found in H-Tx rat fetuses. 
The second objective was to study the biomarkers in the CSF, which may be used as 
diagnostic standards for determining the incidence of HC as well as to understand the 
severity and pathophysiology of the HC condition.  
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Figure 1.7: Estimates of the ionic compositions of plasma, CSF and in the 
choroid plexus. Ionic composition of plasma and CSF are obtained from rabbits 
study (Davson and Segal, 1996), whereas ionic composition of choroid plexus are 
obtained from rats study (Murphy and Johanson, 1990). Na+, Cl-, HCO3- and H2O are 
secreted from the choroid plexus epithelium whereas net absorption of K+ occurs 
transcellularly (Adapted from: Damkier et al., 2010). 
 
Figure 1.8: Infant with HC condition showing enlarged head and sunset eyes 
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Figure 1.9: A flow chart showing the interaction between the substrates of folate 
metabolism. Arrows direction shows the direction of conversions between folate 
metabolites (10-formyltetrahydrofolate dehydrogenase, FDH; 5-
formiminotetrahydrofolate, 5-fmmTHF; 10-formyltetrahydrofolate, 10-fTHF; 5-
methyl-5, 6-dihydrofolate, DHF; 5-methyl tetrahydrofolate, THF) (Adapted from: 
Cains et al., 2009). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 Chapter 2                                                                                Materials and methods 
40 
 
CHAPTER 2 
MATERIALS AND METHODS 
2.1. Materials: 
Materials are categorized into three sections; chemicals, solutions and biological 
samples 
2.1.1. Chemicals: 
All general chemicals were supplied by Sigma Aldrich (Poole, Dorset, UK), 
Invitrogen (Paisley, UK), Biorad (Hercules, USA), PAA Laboratories (Somerset, 
Yeovil, UK) and BDH (Muscat, Sultanate of Oman) unless otherwise stated. 
Antibodies for western blotting and immunocytochemistry were purchased from 
Abcam (Cambridge, UK), Cell Signaling (Danvers, Massachusetts, USA), Thermo 
(Rockford, USA), Sigma (Poole, Dorset, UK) and Serotec (Kidlington, Oxford, UK), 
all antibodies were stored at -20°C until further use. Enhanced chemiluminescence 
(ECL) western blotting detection reagent and ECL hyperfilms were purchased from 
Amersham GE Health Care (Little, Chalfont, UK). Vectashield mounting medium 
with DAPI was purchased from Vector Laboratories (Peterborough, UK). Microaaray 
kit was purchased from Raybiotech (Norcross, Georgia, USA).  
2.1.2. Solutions: 
Solutions used in the present study are described below;  
a. Solutions used for SDS PAGE and western blotting: 
Running buffer: 
NuPAGE MES SDS Running Buffer (20x) (Invitrogn: NP0002) was supplied by 
Invitrogen. Diluted with water to 1x concentration before use. 
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4-12% Gel: 
4-12% NuPAGE Bis-Tris mini gels (1.0 mm 10 wells) (Invitrogn: NP 0321) were 
supplied directly from Invitrogen. 
2x Sample diluting buffer:  
Sample diluting buffer was prepared by adding 5 μl of 2-β mercaptoetanol (Biorad 
161-0710) in 95 μl of laemmli sample diluting buffer (Biorad: 161-0737). 
iBlot transfer stack: 
iBlot transfer stacks PVDF regular (Invitrogn:  IB4010-01) were purchased from 
Invitrogen. 
10x Phosphate Buffered Saline (PBS):  
To prepare 10x PBS, 80 g of NaCl, 14.4 g of Na2HPO4 , 2 g of KCl and 2.4 g of  
KH2PO4 were dissolved to 800 ml distilled H2O and the pH was adjusted to 7.4. The 
volume was adjusted to 1 L with addition of distilled H2O. 10x PBS was diluted to 1x 
in distilled water before use.  
Tween Buffer (0.1% PBS-Tween): 
1 ml Tween 20 (Sigma: P7949) was added in 1L of 1x PBS and sterilized by 
autoclaving. 
Blocking Solution with milk: 
5 g skimmed milk powder (Sigma: 70166) was added to 100 ml of PBS-Tween 
buffer. 
Blocking Solution with fish gelatin: 
5 ml of cold water fish skin gelatin (Sigma: G7765) was added to 100 ml of PBS-
Tween buffer. 
b. Solutions used for tissue culture: 
Poly-D-Lysine (PDL, 0.05mg/ml):  
PDL was prepared by dissolving 2.5 mg of PDL (Sigma: P6403) in 50 ml of sterile 
MilliQ water and then filtered through 0.45 μm filter. PDL solution was stored at -
20°C.  
Penicillin/Streptomycin (P/S):  
Penicillin-streptomycin solution (P/S, Sigma: P4333) composed of 10,000 units 
penicillin and 10 mg streptomycin/ml was used.  
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Dulbecco, s Phosphate Buffered Saline (PBS):  
PBS was purchased from Sigma (D 8662). 
Dulbecco's Modified Eagle Medium (DMEM): 
DMEM was purchased from Invitrogen (21885). 
DMEM 10:10:1 
10 ml of Fetal Bovine Serum (PAA Laboratories: A15-104), 10 ml of Horse Serum 
(Invitrogen: 26050) and 1 ml of P/S was added to DMEM medium.  
DMEM 5:5:1 
5 ml of Fetal Bovine Serum (PAA Laboratories: A15-104), 5 ml of Horse Serum 
(Invitrogen: 26050) and 1 ml of P/S was added to DMEM medium.  
Trypsin-EDTA Solution:  
Trypsin-EDTA solution was purchased from Invitrogen (R-001-100). 
c. Solutions used for fluorescence staining:       
Blocking solution:  
The blocking solution was prepared by mixing 100 μl of Triton X-100 (BDH: 
306324N) and 0.2 g of gelatin (BDH: 44045) in to 100 ml of PBS. This solution was 
then aliquoted and stored at -20°C.  
4% Paraformaldehyde (PFA): 
4 g of PFA (Sigma: 441244) was added to 100 ml of PBS (heated to 60°C) in the 
fume hood and stirred until completely dissolved. The pH was adjusted to 7.2-7.4 and 
then solution was allowed to cool, aliquoted and stored at -20°C until used.  
0.5% Triton X-100 
500 μl of Triton X-100 (BDH: 306324N) was added to 100 ml of PBS and stored at 
4°C until further used. 
2.1.3. Biological samples 
a. Human samples: 
Ethical Approvals:  
Prior to the commencement of the study, ethical approvals were obtained from the UK 
NRES and NHS (ethical approval ref: 08/H1015/43), Department of Biosciences, 
COMSATS Instituite of Information Technology (Islamabad, Pakistan) as well as the 
Faculty of Life Sciences, The University of Manchester (Manchester, England).  
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Cerebrospinal Fluid (CSF) samples collection: 
CSF samples were collected from Alder Hey Children’s Hospital (Liverpool, UK), St 
Mary’s Hospital (Manchester, UK), Leeds General Infirmary (Leeds, UK) and The 
Children’s Hospital (Lahore, Pakistan). Written informed consents for participation 
and demographic data including sex, age and ethnicity were obtained from each 
patient. A copy of the consent form is attached in the appendix at the end of this 
thesis.  
CSF samples were always collected by trained clinical staff either by lumbar puncture 
from normal infants presenting with mild fever and suspected meningitis or through 
insertions of catheters into the brain to drain fluid of infants with HC through shunt. 
These procedures were part of the routine clinical management of the patients and 
fluid excess to clinical test requirements was used for analysis. These samples were 
always frozen at -80⁰C within 30 minutes of the collection. For transfer to the 
University of Manchester laboratory, UK samples were transferred on dry ice and 
frozen upon collection at -80°C while the samples collected from Lahore Children 
Hospital Pakistan were lypholized (freeze dried) prior to shipment for analysis. 
Lypholized samples were reconstituted to the original volume using deionized water 
(Milli-Q) before analysis.  
Patient categorization: 
The study population consisted of 150 infants, 70 normal and 80 hydrocephalic 
infants varying in age from 1 week to 44 weeks. CSF samples from normal infants 
without neurological deficits who underwent lumbar puncture served as normal 
(control). All normal CSF samples were negative for meningitis. Practically it was 
difficult to obtain samples from same source in the study population 
(ventricular/lumbar). Ventricular CSF was obtained from hydrocephalic infants 
undergoing shunt surgery. Table 2.1 present the number of normal and hydrocephalic 
infants, sex, age, site of CSF collection and location (UK or Pakistan). Hydrocephalic 
CSF samples were categorized according to age of onset and the cause of HC into the 
groups described below: 
Group-1 Fetal-onset or congenital hydrocephalic (FOH) infants are born with the 
condition and show classically enlarged heads and associated neurological symptoms 
depending on the severity. 
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Group-2 Late-onset hydrocephalic (LOH) infants developed HC some days or weeks 
after birth due to some undetermined factors. 
Group-3 Posthaemorhagic hydrocephalic (PHH) infants acquired HC due to an 
intraventricular or subarachnoid bleed before, during or soon after birth. 
Group-4 Infants acquired HC condition with the spina bifida (neural tube closure 
defect) due to the blockage of the flow of CSF out of the fourth ventricle. 
b. Rat samples: 
Cerebral cortex of rat: 
In the present study 1-day old (P1) pups of Sprague Dawley rats from the Biological 
Service unit (University of Manchester, UK) were used. Pups were decapitated using 
sterile large scissors. Cerebral cortex cells of 1-day old post natal pups of Sprague 
Dawley rats were cultured for the isolation of pure astrocytes and microglial cells. 
2.2. Methods: 
2.2.1. Biochemical analysis: 
a. Measurement of total protein concentration: 
The total protein concentration of CSF samples of normal and HC human infants was 
measured by protein assay. Lowry method (Lowry, 1951) was used with some 
modifications as follows: 
 Prepared a stock solution of Bovine Serum Albumin (BSA, PAA Laboratories: 
K41-012) in sterile water to a final concentration of 5mg/ml.  
 Serial dilution of BSA was prepared by adding the appropriate volume of PBS to 
each Eppendorf tubes and diluted with BSA stock (Table 2.2).  
 Standards and CSF sample were added in 96 wells plate (Corning: 3300). 
Standards were added to the plate in triplicate 5µl/well and the samples were 
added to the plate in duplicate 5µl/well.  
 After adding standards and CSF samples into the 96 wells plate, 25 µl/well 
DCTM Protein Assay Reagent A (Biorad: 500-0113) and 200 µl/well of DC 
protein Assay reagent B (Biorad: 500-0114) were added. 
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 The plate was incubated at room temperature for 15 minutes. After incubation the 
absorbance was read at 750nm with a microplate reader (Tecan: Infinite F50).  
 Standard curve was constructed based on the absorbance of BSA standards and 
used to determine CSF samples protein concentration. 
 The results were expressed in mg/ml. 
b. Measurement of electrolytes: 
Flame photometry was carried out for cation (sodium, potassium, magnesium and 
calcium) concentration determination in the CSF samples against appropriate 
standards. Methodology opted in this regard is as follows: 
 The standard samples were made up in Nitric acid using concentrations of 5, 10, 
15 and 20 mg L-1. Initially standard samples were run through the flame 
photometer to act as control and to obtain a standard graph.  
 A volume of 50µl of CSF sample was added to 2.45ml of nitric acid (dilution 
factor of 50). The CSF samples ran after standard samples through the flame 
photometer separately for sodium, potassium, calcium and magnesium to obtain 
their absorbance reading.  
 The values of ions in mg L-1 were calculated by plotting on the graph of standard 
concentrations. This value was multiplied with 50 to eliminate the effect of 
dilution of sample.  
c. Measurement of Osmolarity: 
Total osmolarity of CSF samples (mOsm/Kg) was measured on a pre-calibrated 
osmometer (Gonotec: osmomat: 030). Each CSF sample tested was 30µl in volume.  
d. Measurement of pH: 
pH of CSF samples was measured by mirco pH electrode (Lazar Laboratories: pH-
146) which requires a 30 µl CSF sample volume for measurement. Before experiment 
micro pH electrode was submerged into pH 7 for 2 hours and then connected to a pH 
electrometer (Jenco: Jenco 60). pH calibrations were performed with precision buffers 
(pH = 4, pH= 7 and pH=10) before and after each experiment. After calibration a 
volume of 30μl of CSF sample was used to measure the pH. 
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2.2.2. Western blotting:  
Western blotting was carried out to determine the concentration of FDH, GFAP, 
Vimentin, CNPase and MBP in the CSF. The CSF samples were diluted in a 1:1 ratio 
in 2x sample diluting buffer. Samples were heated at 95⁰C for 7 minutes, and were 
centrifuged at 1000 r.p.m for 2 minutes. Equal volumes of CSF samples (5ul) were 
run on 4-12% NuPAGE Bis-Tris Mini Gel. Gels were run for 1 hour at 150V constant 
(with variable current, 55mA in the start and 40mA towards the end) following gel 
electrophoresis, proteins were transferred electrophoretically from the gel to the 
membrane. Gels were removed from the electrophoresis tank (Invitrogen: Novex 
minicell) and separated from gel cassette with the aid of gel separator. Proteins were 
transferred from the gel to PVDF by using iBlot transfer stack PVDF regular. 
Electroblotting was undertaken in iBlot dry blotting unit (Invitrogen: iBlotTM) by 
using P3 programme for 10 minutes.  
After briefly rinsing the membrane with PBS-Tween buffer , it was incubated in the 
blocking solution for 1 hour at room temperature. The membrane was then incubated 
in the primary antibody diluted in the blocking solution overnight at 4⁰C. The 
membrane was then removed and washed thrice for 15 minutes each with PBS-Tween 
buffer with agitation at room temperature. The washed membrane was then incubated 
in horseradish peroxidase-conjugated (HRP) IgG secondary antibody of the same 
species as the primary antibody diluted in blocking solution for 1 hour at room 
temperature. Working dilution of the primary and secondary antibodies and the 
suitable blocking solution worked with respective antibodies are listed in Table 2.3. 
After 1 hour of incubation the membrane washed thrice for 15 minutes each in PBS-
Tween buffer with agitation at room temperature.  
After washes antibody-antigen complex was detected by enhanced 
chemiluminescence (ECL) detection system. Drained the excess PBS-Tween buffer 
from the membrane and was placed protein side up on cling film, covered in 
Amersham ECL western blotting detection reagent. The two reagents were mixed in a 
1:1 mixture and pippeted the mixed detection reagent onto the membrane and 
incubated for 1 minute at room temperature.  Excess reagent was then drained, placed 
the membrane protein side down on to a fresh piece of cling film and the membrane 
was wrapped. Wrapped membrane was placed protein side up in an X-ray film 
cassette. Amersham hyperfilm ECL (GE Health care: 28906853) was placed on top of 
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the membrane in dark room and then closed the cassette for varying lengths of time 
(depending on the visualization of desired protein band with minimal background 
noise). Amersham hyperfilm ECL was placed in an automatic X-ray film processor 
(JPI: JP-33) which allows the protein bands detected on the film.  Film was then 
scanned using scanner (Epson, Perfection: 610) and the images were saved. Images 
were further analyzed using Image J Analyzer software (Version 1.33u, NIH) which 
allows the protein bands detected on the image to be quantified. After scanning of 
western blots films, image J was used to measure the protein density of each blot. 
First quantification of the density of protein bands of all CSF samples were done by 
image J then the relative density of protein bands was calculated. Where no bands 
were detected considered zero obvious a measure of the staining (presumably 
background) where the band would have been used for thos CSF samples. 
2.2.3. Microarray:  
The Cytokine antibody microarray kit (RayBiotech Inc: Quantibody array Cat# QAA-
CUST) was used for the quantitative determination of the concentration of; fas ligand, 
fas receptor, hepatocyte growth factor (HGF), interferon gamma (IFNγ), insulin 
growth factor- 1 (IGF-1), interleukin 6 (IL-6), stem cell factor (SCF), Tumor necrosis 
factor alpha (TNF α) and vascular endothelial growth factor (VEGF) in normal, FOH, 
LOH, PHH and SB/HC CSF samples. The principle of cytokine antibody microarray 
is based on sandwich immunoassay principle. Microarray is a highly sensitive 
technique for simultaneous detection of multiple cytokine expression levels from 
diverse sample types. In this assay, capture antibodies are printed in multiple identical 
arrays on a standard sized glass chip (histology slide, 75mm x 25mm). The protocol 
provided by the supplier was followed verbatim. 
2.2.4. Metabolome: 
Samples of normal, FOH, LOH and PHH CSF (6 normal and 8 of each affected 
group, total of 22) were analyzed for the content of relevant metabolites by LC-
MS/MS as described by Evans et al. (2009) using commercial services from 
Metabolon (Durham, NC, USA).  
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Table 2.1: Clinical variables of normal and hydrocephalic infants 
 
      
                                    Clinical variables 
N 
Age (days) 
Sex (male: female) Site of CSF collection Location (UK: Pakistan) Groups of neonates Mean SEM 
Normal 70 29.0 4.21 36:34 Lumber 0:70 
FOH 40 59.3 20.07 22:18 Lateral ventricle 8:32 
LOH 17 102.01 30.22 11:6 Lateral ventricle 0:17 
PHH 15 85.83 23.06 3:12 Lateral ventricle 15:0 
SB/HC 8 99.20 39.08 3:5 Lateral ventricle 8:0 
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Table 2.2: Serial dilution of BSA stock (5 mg/ml) 
 
Vial 
 
BSA Final Concentration 
(mg/ml) 
Volume of PBS to 
add (µl) 
Volume of Stock to 
add (µl) 
1 5 0 1000 
2 2.5 500 500 from 1 
3 2 200 800 from 2 
4 1.8 100 900 from 3 
5 1.6 111 889 from 4 
6 1.4 125 875 from 5 
7 1.2 143 857 from 6 
8 1 167 833 from 7 
9 0.9 100 900 from 8 
10 0.8 111 889 from 9 
11 0.7 125 875 from 10 
12 0.6 143 857 from 11 
13 0.5 167 833 from 12 
14 0.4 200 800 from 13 
15 0.3 250 750 from 14 
16 0.2 333 667 from 15 
17 0.1 500 500 from 16 
18 0 1000 0 
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Table 2.3: List of antibodies used for Western blotting 
 
Primary antibody  
 
Working 
dilution 
 
Secondary antibody 
(HRP - conjugated) 
 
Working 
dilution 
 
Blocking 
solution 
 
Anti FDH (polyclonal) 
(Krupenko Lab) 
 
1:5000 
 
Mouse 
(Cell Signalling: 7076) 
 
1:4000 
 
5% skim 
milk 
 
Anti GFAP (polyclonal) 
(Abcam: 7779) 
 
1:4000 
 
Rabbit 
(Cell Signalling: 7074) 
 
1: 5000 
 
5% skim 
milk 
 
Anti Vimentin (polyclonal) 
(Cell signalling: 3932) 
 
1:1000 
 
Rabbit 
(Cell Signalling: 7074) 
 
1:3000 
 
5% skim 
milk 
 
Anti MBP (polyclonal) 
(Thermo: PA1-18324) 
 
1:10, 000 
 
Rabbit 
(Cell Signalling: 7074) 
 
1:3000 
 
5% fish 
gelatin 
 
Anti CNPase (polyclonal) 
(Sigma: C9743) 
 
1:1000 
 
Rabbit 
(Cell Signalling: 7074) 
 
1:5000 
 
5% skim 
milk 
 
 
Table 2.4: List of antibodies used for fluorescence staining of cells 
 
Antibody name 
 
Working 
dilution 
 
Secondary antibody 
 
 
Working 
dilution 
 
Anti GFAP (polyclonal) 
(Sigma: G9269) 
 
1:500 
 
Anti-rabbit (Sigma: F6005) 
(FITC – conjugated) 
 
1:100 
 
OX-42 (polyclonal) 
(Serotec: MCA 275PE ) 
 
1:50 
 
Anti-mouse (Sigma: T5393) 
(TRITC – conjugated) 
 
1: 100 
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2.2.5. Tissue culture: 
In the current study, cerebral cortex cells of 1-day old post natal pups of Sprague 
Dawley rats were cultured as described below. Glass coverslips (5 mm diameter, 
Thermo)  after putting in a 96-well plate were coated with PDL for 20 minutes in 
an incubator at 37˚C , after incubation glass coverslips were rinsed three times with 
sterile MilliQ water and left to air dry in tissue culture hood before use. All cultures 
were maintained in a humified incubator at 37˚C with 5% carbon dioxide and 95% air 
atmosphere. 
Brain dissection: 
In the present study 1-day old (P1) pups of Sprague Dawley rats from the Biological 
Service unit (University of Manchester, UK) were used. The pups were decapitated 
using sterile large scissors. After removing the skin and skull cap, brain was removed 
by the help of microspatula. Brain was placed in 60 mm petri dish containing ice-cold 
sterile DMEM medium. Under a dissecting microscope (Leica Wild Heerbrug: M3Z) 
cerebellum hemispheres were separated by forceps and the meninges were gently 
removed from the individual cortical lobes. From the inside of each hemisphere after 
removing of choroid plexus all the forebrains were placed in a new petri dish 
containing cold DMEM medium.  
2.2.5.1.  Astrocytes and microglial culture: 
Tissue Digestion: 
In the tissue culture hood all the forebrains were transferred to a 50ml falcon tube and 
then ~0.5 ml of DMEM medium was added to the falcon tube. Nervous tissues were 
gently dissociated through sterile tips of decreasing bore (3mm, 2mm, and 1mm) until 
completely homogenized. After dissociation of tissue falcon tube was centrifuged for 
10 minutes at 1000 r.p.m. The supernatant was discarded by aspiration and the pellet 
was suspended in 20 ml of warm DMEM 10:10:1 per forebrain. 10 ml of cell 
suspension was plated in each PDL coated 75 cm2 flask. Flasks were placed in an 
incubator for 7-9 days without changing the culture medium during this time.  
Culture purification: 
After incubating the primary cultures for 7-9 days, flasks were placed horizontally on 
the orbital shaker (Staurt: SSL1) at 230 r.p.m for 4 hours at 37⁰C in order to separate 
the microglial cells from astrocytes.  
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a. Isolation of pure microglial cells 
After shaking of 4 hours cell suspension from the tissue culture flask was collected in 
a falcon tube and centrifuged for 10 minutes at 1000 r.p.m. After centrifugation, 
supernatant was removed by aspiration and the pellet was suspended in 1ml of warm 
DMEM 10:10:1. Number of viable cells were determined by Casy cell counter and 
analyzer (Roche Innovatis AG: model TT) and diluted the cell suspension to 1×106 
cells per ml concentration with warm DMEM 10:10:1. 5×104 cells per well were 
plated in PDL coated 96 wells plate to avoid clustering of the cells and incubated for 
24 hours. After incubation, microglial cells were treated with normal and 
hydrocephalic CSF (5%, 10% and 20%). The purity of cultures were determined by 
immunofluorescent staining and found to be about 90% pure.  
b. Isolation of pure astrocytes cells 
In order to obtain pure astrocytes after incubating the primary cultures for 7-9 days 
and shaking of flask on orbital shaker (Staurt: SSL1) at 230 r.p.m for 4 hours at 37⁰C, 
media from the flask was replaced with fresh 10ml of warm DMEM 10:10:1 and 
again flask placed on the orbital shaker for 1 hour. After 1 hour, culture media of the 
flask was replaced twice with 5 ml of warm PBS with gentle agitation. The PBS was 
then removed and 5ml of Trypsin-EDTA was added to the flask. Flask was placed in 
the incubator for 5-10 minutes then after gentle agitation 5ml of DMEM 5:5:1 was 
added to the flask. After gently mixing of DMEM 5:5:1, the supernatant was collected 
into a falcon tube and centrifuged for 10 minutes at 1000 r.p.m.  
After centrifugation, supernatant was removed by aspiration and the pellet was 
resuspended in 1ml of warm DMEM 5:5:1. The cell suspension was diluted to 5×104 
cells per ml concentration with warm DMEM 5:5:1. 5×103  cells were plated in PDL 
coated 96 wells plate and incubated for 24hours in the incubator. After incubation 
astroglial cells were treated with normal and hydrocephalic CSF (5%, 10% and 20%). 
The purity of cultures were determined by immunofluorescent staining and found to 
be about 90% pure.  
2.2.5.2. Cell proliferation assay: 
MTT (3-(4`, 5`-dimethylthiazol-2`-yl)-2, 5-dipheyltertazolium bromide) assay was 
used to measure the proliferation and viability of microglial cells and astrocytes. MTT 
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is a calorimetric assay based on the change of yellow colour to purple colour by an 
enzyme succinate tetrazolium reductase, this enzyme is active only in the 
metabolically active cells. After the appearance of purple formazan crystal, DMSO 
solution was added to dissolve the purple formazan crystal then wavelength was read 
on microplate plate reader. The previously reported protocol (Denizot and Lang, 
1986; Mosmann, 1983) was adapted with some modifications. 
Cells were plated in PDL coated 96-wells plate (Corning: 3300). Microglial cells were 
plated at a density of 5×104 cells per well (each with 100μl cell suspension) in 
DMEM 10:10:1 medium and astrocytes were plated at a density of 5×103 cells per 
well (each with 100µl cell suspension) in DMEM 5:5:1 medium. Cells were incubated 
in incubator at 37⁰C for 24 hours, after which the media was replaced with fresh 
media supplemented with 5%, 10% and 20% of normal, FOH and LOH CSF then 
incubated for 48 hours followed by determination of proliferation and viability of the 
cells using the MTT assay as follows:  
 MTT reagent solution (Invitrogen: M6494) in PBS (Sigma: D8662) was prepared 
to a final concentration of 5mg/ml and then filtered (0.45μm).  
 10µl MTT reagent was added to each well, mixed gently for one minute on an 
orbital shaker and then incubated in the incubator at 37⁰C for 4 hours. 
 After 4 hours of incubation, 100µl of DMSO (Dimethyl sulfoxide, Sigma: 
472301) was added per well and mixed thoroughly to dissolve the dark purple 
crystals.  
 After 10 minutes of incubation at room temperature to ensure that all crystals 
dissolved, the absorbance was read at 450nm with a microplate reader (Tecan:  
Infinite F50).  
 Results of the experiment were expressed as absorbance ±SEM. 
2.2.5.3. Fluorescence staining: 
Cells were plated on PDL coated glass coverslips (5 mm diameter, Thermo) placed in 
96-well plate (Corning: 3300). Microglial cells were plated at a density of 5×104 cells 
per well (each with 100μl cell suspension) in DMEM 10:10:1 medium and astrocytes 
were plated at a density of 5×103 cells per well (each with 100µl cell suspension) in 
DMEM 5:5:1 medium. Cells were incubated in incubator for 24hours, after which the 
medium was replaced with fresh media supplemented with 20% of normal, FOH and 
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LOH hydrocephalic CSF and maintained in the incubator for 48 hours in order to 
check the effect of normal and hydrocephalic CSF on microglia and astrocytes. After 
48 hours of incubation media was removed from the wells and cells were washed with 
PBS. Cells were fixed with 4% PFA for 15minutes, then permeabilized with 0.5% 
Triton X-100 for 15 minutes, cells were incubated with primary antibodies overnight 
(diluted in blocking buffer) (Table 2.4). Cells were incubated in secondary antibodies 
for 1 hour in the dark (Table 2.4). Cells were washed by dipping coverslips into PBS 
3 times after each of the steps described above. After the final wash, the coverslips 
were mounted in Vectashield mounting medium with DAPI (Vector Laboratories: H-
1200).  
Fluorescence microscopy and image Analysis:  
Cells were observed under fluorescent microscope (Leica: DMLB) at different 
magnifications and images were taken by cool snap digital camera (Princeton 
Scientific Instruments, Monmoth Junction, New Jesrsy, USA). Multiple images were 
taken of each condition for later analysis and comparison. Differentiation of each cell 
was assessed by the morphology of the cells and in particular the number of process 
extending from each cell. Fluroscence intensity of each image was assessed by using 
Image J Analyzer software (Version 1.33u, NIH). In order to calculate accurate GFAP 
and OX-42 fluroscence intensity for comparison between control and CSF treated 
groups within one experiment, all the staining steps and image acquisition were 
performed in parallel at the same time for all conditions. Ten images per condition for 
each experiment were taken, fluroscence intensity over different areas of each image 
were quantified by using Image J. 
2.3. Statistical analysis: 
Results of the experiments were expressed as Mean±SEM. The difference between 
the mean values among the experiment groups was evaluated by one way analysis of 
variance (ANOVA) and post hoc (Tukey) testing to identify significant differences 
between groups. Accordingly statistical software Graphpad Prism (Version 5) was 
used. Statistical analysis of metabolom was performed with Welch T test by using R 
program by Metabolom scientists (Durham, NC, USA) and delivered back to us in 
fully analyzed format. The value p<0.05 was considered significant. 
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CHAPTER 3 
FOLATE METABOLISM IMBALANCE IN CSF 
3.1. Introduction and objectives  
HC is a condition characterised by an abnormal CSF production or absorption (Zhang 
et al., 2006). HC can result in the deficient/abnormal cerebral cortex development and 
lifelong neurological deficits (Pattisapu, 2001). Currently the only treatment of HC is 
surgical fluid diversion through a shunt though it does not address the cause. The role 
of CSF in development is currently under considerable review (Gato and Desmond, 
2009; Buddensiek et al., 2009, 2010; Lehtinen and Walsh, 2011; Zappaterra and 
Lehtinen, 2012). It was reported in previous studies that CSF function as a growth 
medium for neural stem cells (Miyan et al., 2006; Lehtinen et al., 2011), because it is 
composed of several critical factors which plays an important role within the fetal 
brain during development (Bachy et al., 2008). Its abnormal composition leads to 
numerous physiological defects observed in developing cortex of H-Tx rats 
(Mashayekhi et al., 2002; Owen-Lynch et al., 2003) through an alteration in folate 
metabolism in the CSF (Cains et al., 2009). Low level of 10-formyltetrahydrofolate 
dehydrogenase (FDH) was reported in the H-Tx rats, FDH function as a folate binding 
protein indicates its association with HC. After supplementation of a mixture with a 
combination of tetrahydrofolic acid and 5-formyltetrahydrofolic acid to pregnant 
dams showed reduction in the incidence of HC and improvement in the development 
of the brain. On contrary, folic acid supplementation increased the prevalence of HC 
in H-Tx rats. 10-formyltetrahydrofolate dehydrogenase (FDH, from the gene 
Aldh1L1) is a key enzyme involved in maintaining the folate pool in balance, it is 
secreted into CSF from neural stem cells lining the ventricles. It was suggested that 
FDH acts as a binding protein capturing tetrahydrofolate (THF) released from choroid 
plexus epithelial cells into CSF. The choroidal cells contain methionine synthase 
(MS) and convert 5MTHF to THF. FDH would thus stabilise THF for transport 
through the CSF pathway and delivery to the cells along the pathway (Cains et al., 
2009). 
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The growth and development of the fetus requires large amounts of available folate. 
Folate in the diet is first taken up in the gut and then metabolised to 5-methyl-
tetrahydrofolate (5MTHF) form in the liver. Folate in the form of 5MTHF is 
transported into the blood and taken up by folate receptors and transporters in tissues 
through the choroid plexus into the CSF and brain (Wollack et al., 2008). Folate can 
either be stored in the choroid plexus epithelium upon polyglutamination or enter the 
CSF, either by passive diffusion or action of reduced folate carriers (Ramaekers et al., 
2002). The folate metabolic cycle is linked to methionine, choline-betaine-glycine, 
methylation and other metabolic and synthetic pathways, collectively they provide 
cells with products required for the synthesis of DNA, proteins, lipids and 
neurotransmitters (Blom et al., 2006) as well as for DNA methylation and gene 
expression. Imbalance in folate or folate deficiency can leads to DNA copy errors or 
inappropriate gene expression (Iskander et al., 2010)  
Objectives:  
The objective of present study was to analyse FDH and metabolites (involved in 1C 
metabolic pathway associated with folate, methionine and methylation reactions) in 
the CSF samples obtained from normal and hydrocephalic human infants.  
3.2. Results: 
3.2.1. Analysis of 10-formyltetrahydrofolate dehydrogenase (FDH) and 
metabolite imbalance in CSF from normal and HC infants: 
10-formyltetrahydrofolate dehydrogenase (FDH) in CSF:  
CSF samples from normal and HC infants were run on SDS-PAGE together with CSF 
samples from infants presented with a set of various neurological conditions (Spina 
bifida with hydrocephalus, dandy walker syndrome, posterior fossa arachnoid cyst, 
encephalocoele and asphyxia) difference was noticed in the concentration of the 
100KDa protein through a visual inspection. FDH band was identified by Western 
immunoblot in the CSF of HC and other neurological conditions (Figure 3.1 and 
Figure 3.2), where the intensity of this band was greatly reduced in CSF from FOH, 
LOH and asphyxia infants. In order to obtain semiquantitative estimates of the 
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relative amount of FDH, Image J analyser (NIH) was used to determine the relative 
band intensity across the lanes. Quantification of the Western blots showed that the 
amount of FDH was reduced in FOH and LOH conditions as compared to CSF from 
normal and PHH infants (Figure 3.1b). The data from the current study showed 
significant (P<0.001) decrease in FDH protein from CSF of FOH infants and highly 
significant (P<0.0001) FDH decrease in LOH infants compared to the normal infants. 
It was noticed that levels of FDH in CSF from PHH infants did not show significant 
difference compared to the normal group (Figure 3.1 a). It was reported in previous 
studies that FDH is found in extremely high concentration in erythrocytes so in 
present study FDH in PHH CSF samples might be the results of residual blood 
proteins from the haemmorhage. This possibility is supported after analysis of a CSF 
from PHH infants returning for a shunt revision after a significant period of the 
haemorrhage and showed reduced FDH in their CSF (Figure 3.2 a, PHH CSF sample 
analysis before and after shunt). CSF was also tested from a range of additional 
neurological conditions presenting with HC (lanes 1-5, Figure 3.2 b). These initial 
data indicate normal FDH levels in the CSF of infants with spina bifida, Dandy 
Walker variant, posterior fossa subarachnoid cysts (PFAC) and encephaloceles (lanes 
1-4, Figure 3.2 b), in contrast reduced FDH was detected in CSF of a birth asphyxia 
infant (lane 5, Figure 3.2 b).  
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   Figure 3.1: a. Western blot for 10-formyl tetrahydrofolate dehydrogenase (FDH) 
in the CSF obtained from normal and HC infants, b. Measurement of relative 
amount of band intensity across the lanes of Western blot.  Detection of reduced 
FDH protein (molecular weight 100 KDa) in CSF from FOH and LOH infants. FDH 
in CSF from FOH showed significant decrease (P<0.001) and highly significant 
(P<0.0001) decrease was found in CSF from LOH compared to normal infants. 
P<0.001*** P<0.0001**** 
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Figure 3.2: a. Western blot for FDH in the CSF obtained from PHH infants 
before and after shunt, b. Western blot for FDH in the CSF obtained from 
different neurological conditions (1. Spina bifida with hydrocephalus 2. Dandy 
Walker syndrome 3. Posterior fossa arachnoid cyst 4. Encephalocoele 5. Asphyxia). 
PHH patient returning for a shunt revision after a significant period of haemorrhage 
and showing reduced FDH in their CSF in PHH infants. In other neurological 
conditions FDH were found to have compareable level as normal CSF except 
asphyxia condition.  
 
 
 
 
 
 
 
 
 
 
 (a) 
(b) 
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3.2.2. Measurement of 1C metabolic pathway imbalance in CSF: 
Molecules involved in folate, methionine and methylation reactions were investigated 
in the CSF from normal and hydrocephalic infants using GC/MS and LC/MS/MS 
techniques. The samples were sent for analysis through a Metabolom (Durham, NC, 
USA). Samples of normal, FOH, LOH and PHH CSF (6 normal and 8 of each 
affected group, total of 30) were analysed for the content of relevant metabolites by 
LC-MS/MS as described by Evans et al., (2009) using commercial services from 
Metabolon (Durham, NC, USA). Statistical analysis was performed using R program 
by Metabolom scientists and delivered back to us in fully analysed formats which are 
displayed in the relevant figures. One carbon metabolism is required for methionine 
biosynthesis, ring-closing reactions (nucleotide biosynthesis) and methylation 
reactions. In current study metabolites related to 1C metabolism imbalance were 
found in CSF of HC infants. The levels of folate metabolites are shown in Table 3.1. 
The Welch’s t-test and/or Wilcoxon rank sum test were used for determining the level 
of significance. Red and green coloured numbers are shown in Table 3.1 which 
indicates the level of significance in hydrocephalus groups compared to normal 
infants (The values in red indicate that the mean values are significantly higher than 
normal while the green values indicate that the mean values are significantly lower).  
i. N-formyl methionine:  
The mean value of CSF N-formyl methionine was higher in HC infants compared to 
normal. CSF from FOH and LOH infants showed non significant (p>0.05) increase, 
while PHH group showed highly significant (p<0.0001) increase in N-formyl 
methionine compared to the normal group. N-formyl methionine in CSF increased 
significantly in PHH group compared to FOH and LOH group (Figure 3.3a, Table 
3.1).  
ii. N-acetyl methionine:  
The mean value of N-acetyl methione in the CSF was higher in hydrocephalic infants 
compared to normal infants. All HC groups showed elevated levels of N-acetyl 
methionine. N-acetyl methionine was increased significantly (p<0.05) in FOH group, 
however non significant (p>0.05) increase found in the LOH group while in PHH 
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group it increased significantly higher (p<0.0001) compared to the normal group 
(Figure 3.3b, Table 3.1). 
iii. Betaine: 
Mean CSF betaine increased in HC groups compared to normal. PHH has 
significantly (p<0.001) increased CSF betaine level while a non significant increase 
found in LOH  and FOH group compared to the normal group (Figure 3.4c, Table 
3.1).  
iv. Choline: 
CSF choline was significantly (p<0.05) increased in FOH and PHH group and non 
significant (p>0.5) increase found in LOH group compared to normal. LOH CSF 
samples showed variations in the levels of CSF metabolites and probably due to this 
reason metabolite levels did not show significant difference among groups (Figure 
3.4d, Table 3.1). 
v. Glycine: 
CSF glycine was elevated in FOH and reduced in LOH and PHH group compared to 
normal. The reduction in mean CSF glycine in LOH group was found to be non 
significant (p>0.05) compared to normal. PHH group showed highly significant (p< 
0.01) increase in CSF glycine compared to normal infants. The increase in FOH was 
non significant (p>0.05) compared to normal group probably due to inconsistency in 
the CSF samples used (Figure 3.4e, Table 3.1). 
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Table 3.1: Folate metabolites in CSF 
  
Normal vs. FOH 
 
Normal vs. PHH 
 
Normal vs. LOH 
  
Fold 
Change 
 
P 
value 
 
Fold 
change 
 
P value 
 
Fold 
change 
 
P value 
 
N-formylmethionine 
 
2.31 
 
p>0.05 
 
5.98 
 
p**** 
 
2.94 
 
p>0.05 
 
N-acetylmethionine 
 
3.82 
 
p* 
 
10.53 
 
p**** 
 
5.08 
 
p>0.05 
 
Choline 
 
2.09 
 
p* 
 
1.43 
 
p* 
 
1.68 
 
p>0.05 
 
Betaine 
 
1.89 
 
0.116 
 
2.03 
 
p*** 
 
1.80 
 
p>0.05 
 
Glycine 
 
1.59 
 
0.691 
 
0.36 
 
p** 
 
0.64 
 
p>0.05 
 
   Red and green coloured numbers indicate p < 0.05 
 Red indicates that the mean values are significantly higher than normal  
 Green indicates that the mean values are significantly lower than normal 
p<0.05* p<0.01** p<0.001*** p<0.0001**** 
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Figure 3.3. LC-MS/MS analysed folate metabolites (i). Comparative measurement 
of folate metabolites in CSF samples from Normal, FOH, LOH and PHH infants.  
a. N-formylmethionine b. N-acetylmethionine.  
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Figure 3.4. LC-MS/MS analysed folate metabolites (ii). Comparative measurement 
of folate metabolites in CSF samples from Normal, FOH, LOH and PHH infants.  
c. Betaine d. Choline e. Glycine.  
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3.3. Discussion: 
The aetiology of HC remains largely unknown and the mechanism leading to the 
neurological deficits in affected individuals are mainly attributed to increase in 
intracranial pressure as CSF accumulates (McAllister and Chovan, 1998; Pattisapu, 
2001). Current research has driven us to earlier stages of development to unravel the 
aetiology in order to identify specific pathways that might be used to prevent and/or 
treat this devastating condition. In the present study unique folate handling system has 
been identified that is spatially separated between choroid plexus and neural stem 
cells and connected through the CSF containing folate enzymes and binding proteins. 
The data presented in the current study are the first to demonstrate the presence of 
folate enzyme and folate metabolites in the CSF of normal and hydrocephalic human 
neonates. Furthermore in the present study human data matches and extends previous 
animal data, a decrease in FDH in the CSF of affected hydrocephalic humans very 
similar to that observed in hydrocephalic rats (Cains et al., 2009). Given the evidence 
that: 1. folic acid has no beneficial effect on incidence or outcome of hydrocephalus, 
2. folic acid may indeed have a negative effect on susceptible fetuses (Cains et al., 
2009), 3. there is a positive benefit of folinic acid on various neurological conditions 
(Ramaekers et al., 2003) and 4. a combination of folinic acid and THF has beneficial 
effects on the incidence and outcome of hydrocephalus (Cains et al., 2009), it can 
conclude that it is highly likely that human hydrocephalic fetuses would also benefit 
from the combination folate therapy and potentially improve cortical development. 
However, the underlying cause of disturbed folate metabolism remains to be 
elucidated.   
Given the reduction of HC in the H-Tx rats with a combination of folate supplement, 
it is assumed that problem is an early failure to secrete sufficient FDH in the CSF for 
capture/delivery of folate to the developing cerebral cortex. The fact that low FDH is 
a consistent marker of this condition also suggests that other mechanisms for folate 
delivery may not be present or are not able to compensate. 10-formyl-THF converts to 
THF in the prescence of FDH enzyme and also has proposed roles including the 
suppression of purine synthesis, maintenance of the THF pool as the donor for one-
carbon group and regulation of the one-carbon group flow towards methylation 
reaction ( Oleinik and Krupenko, 2003; Anguera et al., 2006). It is suggested that in 
the CSF FDH has non-enzymatic role and act as a folate binding protein to capture 
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THF and transport it to cells throughout the CSF pathway including the subarachnoid 
space. THF and folinic acid supplementation bypass reduced FDH levels presumably 
by supplying folate directly in usable forms. The mechanism for this rescue requires 
further investigation. 
Methionine, folic acid, vitamin B12 and choline plays an important role in the 
development and functioning of the central nervous system (Selhub, 2002; Mattson 
and Shea, 2003; Zeisel, 2004, 2006; Reynolds, 2006; Kovacheva et al., 2007) and is 
associated with one carbon metabolism (Selhub et al., 2000). One-carbon metabolism 
is a complex interconnected biochemical reaction in cells and plays an important role 
in de novo nucleotide biosynthesis, methionine biosynthesis and cellular methylation 
reaction (Mason, 2003). Lack of dietary nutrients can cause apoptosis and DNA 
damage. It may also responsible for the imbalance in the nervous system homeostasis 
and cellular dysfunction which leads to numerous pathological states (Mattson and 
Shea, 2003; Mattson, 2003). 1C transfers are important for the synthesis of 
methionine from homocysteine which can be used to make main cellular methyl 
donor S-adenosylmethionine (SAM). Methionine is acetylated to form N-acetyl 
methionine which has been shown to be bioavailable to animals and humans (Stegink 
et al., 1980; Smith et al., 2011). Two modified forms of methionine (N-formyl 
methionine and N-acetyl methionine) were greatly elevated in HC infants but this may 
not represent a reduced availability of methionine but rather an available form that 
limits specific metabolic pathways. Choline is a precursor in the synthesis of 
acetycholine and neuronal membrane phospholipids and is essential for normal brain 
function (Blusztajn and Wurtman, 1983). Choline is oxidized to form betaine which 
acts as an osmoregulator thereby controlling tissue integrity. Both metabolites are 
sources of one-carbon units which have important roles in development, 
cardiovascular disease and cancer (Ueland, 2011). Choline and betaine were elevated 
in the CSF of hydrocephalic infants.  
Glycine is an excitatory neurotransmitter and stimulates the response of the NMDA 
receptor to glutamate (Albers, 1990). Glycine is usually generated from serine but can 
also be generated from choline via betaine.  Glycine production from serine depends 
on THF, glycine can be metabolized by the glycine cleavage system to generate 
folate-activated one-carbon units. Glycine was found to be elevated in FOH and 
reduced in PHH and LOH groups. Reduced glycine may also reflect a lack of THF 
Chapter 3                                                                                                            Results 
67 
 
conversion to 5,10 methylene THF an important pathway to pyrimidine synthesis 
(Lucock, 2000) but these possibilities require further analysis.  
It is concluded from the current study that abnormal accumulation of CSF in the 
ventricle in HC condition caused the imbalance in folate metabolism and 1C 
metabolic pathway. Previously published data indicate that folate metabolism in the 
CSF plays an important function in the development of FOH condition. Yung et al. 
(2011) have proposed a potential cause for PHH through the lysophosphatidic acid 
(LPA) signalling pathway which is activated by LPA from blood entering the CSF 
through an intraventricular bleed. This is different to the mechanism as identified in 
the current study and may explain some of the differences found in PHH human CSF 
samples in this study. It was reported in previous studies that FDH is found in 
extremely high concentration in erythrocytes so in present study FDH in PHH CSF 
samples might be the results of residual blood proteins from the haemmorhage. This 
possibility is supported after analysis of a CSF from PHH infants returning for a shunt 
revision after a significant period of the haemorrhage and showed reduced FDH in 
their CSF. However current data indicate that problem is in CSF drainage from 
various causes result in a failure to release FDH into the CSF that lead to effective 
folate deficiency in the brain. Moreover absence of folate receptors in the brain, 
imbalance in distinctive folate usage system for the cerebral cortex development 
occured in a range of neurological conditions (Ramaekers et al., 2003; Moretti et al., 
2005; Malouf and Grimley, 2008; Steinfeld et al., 2009; Ramaekers et al., 2012). 
Many conditions have now been shown to respond to specific folate supplements or 
combinations but not to folic acid which has reported negative effects (Hyland et al., 
2010). It is clear from these and current studies that better understanding of the unique 
folate system operating in the brain will lead to better treatments and preventions of 
many neurological conditions. This work provides the first hope for a prevention and 
treatment for human HC through a replacement of folic acid with a combination of 
two natural folates (folinic acid and THF). 
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CHAPTER 4 
ELECTROLYTES, OSMOLARITY AND pH IMBALANCE IN CSF 
4.1. Introduction and objectives:  
CSF builds up in the brain due to an abnormality in the CSF formation, absorption or 
an obstruction in the CSF flow (Matsumoto and Tamaki, 1991; Rekate, 1997; 
McAllister and Chovan, 1998). The extent of ventricular dilation depends on the 
location of blockade and length of time of the blockade of CSF flow. The presence of 
symptoms does not indicate the nature or severity of the HC or brain damage. 
Improvements in prenatal diagnosis and treatment may raise the quality of life for 
children with HC through decreased mortality and morbidity. Much better 
understanding of the underlying etiology and biological basis of the HC is required. 
The role of CSF in development is currently under considerable review (Gato and 
Desmond, 2009; Lehtinen et al., 2011; Zappaterra and Lehtinen, 2012). CSF is an 
ionic solution low in protein, it circulates gradually from the brain ventricular flow 
pathway towards the subarachnoid space then absorbed into the venous sinuses across 
the arachnoid villi (Brodbelt and Stoodley, 2007; Johanson et al., 2008). Electrolytes 
are not simply organic salt in CSF, these have an important role in biological 
reactions (Mohammadiha, 1991). Electrolytes serve as cofactor in many 
enzymatically mediated metabolic reactions. de Rougemont et al., (1960) found solute 
content of the CSF varied from a plasma, levels of sodium, chloride and magnesium 
in CSF are little higher , whereas potassium, glucose and calcium are slightly lower as 
compared to plasma (Guyton and Hall, 2000). 
The choroid plexus provides an active ion transport system of electrolytes (Wright, 
1972; Pollay et al., 1973; Milhorat et al., 1975). There are different transporters 
expressed in choroid plexus for the transport of electrolytes. Transporters of 
electrolyte present at basolateral and apical membranes of the choroid plexus 
epithelium regulate CSF formation by altering ion movement (Johanson et al., 2008). 
There is no considerable gradient present for electrolytes at different regions of the 
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neural axis as has been found for CSF proteins. Water is transported through 
aquaporin channels across the choroid plexus epithelium from the blood side towards 
little hyperosmolar CSF (Speake et al., 2003; Boassa et al., 2006). CSF is 
accumulated in the ventricle but not capable to flow into the brain because brain is 
impermeable to CSF. On the other hand water is permeable to the brain due to the 
presence of ion channels and aquaporin channels. Thus water movement in and out of 
the ventricles might be control by the osmolarity of the CSF (Krishnamurthy et al., 
2009). Different levels of damage to the brain ventricle, ependymal cells and choroid 
plexus epithellium occurred in HC condition. It might be possible that damage to the 
blood brain barrier and blood CSF barrier is associated with the changes in the ion 
transport mechanism with alteration in the electrolyte levels in the CSF. It is thus 
important to examine the imbalance of CSF electrolytes levels in the human infants 
presenting with HC. 
Objectives:  
The objectives of current study was to examine the imbalance in CSF electrolytes 
(sodium, potassium, calcium and magnesium), osmolarity and pH in hydrocephalic 
infants and correlate these findings with the clinical features of HC infants so that it 
may be used to diagnose and assess the severity and damage in HC condition. 
4.2. Results: 
4.2.1. CSF electrolytes measurement of normal and HC infants:  
Levels of calcium, magnesium, sodium and potassium were determined in the CSF 
samples from normal and HC infants. Table 4.1 is a summary of data appearing in 
Figures 4.1 to 4.4 for both HC and normal infants.  
CSF sodium imbalance in HC condition:  
Data represented in Table 4.1 and Figure 4.1 showed mean CSF sodium levels in HC 
and normal infants. CSF sodium levels were significantly reduce in the FOH group 
vs. normal group (p <0.05, Figure 4.1) and highly significant (P<0.05) decrease was 
seen in LOH group vs. normal group (P<0.001, Figure 4.1). In contrast CSF sodium 
levels in PHH and SB/HC group were significantly increase compared to normal 
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group (Figure 4.1, p< 0.001). This data suggest that the imbalance of sodium ion 
occurred differently in FOH, LOH, PHH and SB/HC conditions. 
CSF potassium increased in PHH and SB/HC: 
Mean CSF potassium levels in normal and HC groups are shown in Table 4.1 and 
Figure 4.2. The levels of potassium in FOH and LOH CSF were comparable to 
normal CSF (group> 0.005, Figure 4.2). CSF from both PHH and SB/HC groups 
showed a significant increase in potassium levels compared to normal CSF (Figure 
4.2).   
CSF calcium and magnesium:   
Mean CSF calcium and magnesium levels in normal and HC groups are shown in 
Table 4.1, Figures 4.3 and 4.4. The CSF magnesium levels of all HC groups showed 
no significant differences as compared to normal group (Figure 4.3). Similarly the 
CSF calcium levels of HC groups were comparable to normal group (Figure 4.4).  
4.2.2. CSF pH and osmolarity measurements in HC and normal infants: 
Mean CSF pH values for HC and normal groups are given in Table 4.2, Figures 4.5 
and 4.6. 
CSF pH 
There was no significant (P>0.05) difference in CSF pH found between HC groups as 
compared to normal group (Figure 4.5).  
There is a decrease in osmolarity in the CSF of LOH 
Mean CSF osmolarity values of normal and HC groups are shown in Table 4.2. A 
significant reduction in CSF osmolarity found in LOH CSF compared to normal CSF 
(P<0.05, Figure 4.6). However, no significant (P>0.05) difference in CSF osmolarity 
was found in FOH, PHH and SB/HC groups in comparison with normal infants.  
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Table 4.1: CSF electrolytes levels in the normal and HC groups 
Values in parentheses represent the number of infants in group 
P<0.05*, P<0.01**, P<0.001*** 
Mean ± SEM 
  
Hydrocephalic groups 
 
Normal FOH LOH PHH SB/HC 
      (21)        (8)         (5)       (5)       (4) 
Calcium (Ca2+ ) (mmol/l) 2.13 ± 0.18  1.94 ± 0.23 1.52 ± 0.15  1.42 ± 0.06  1.20 ± 0.23  
Magnesium (Mg2+) (mmol/l) 1.57 ± 0.10  1.25 ± 0.13  1.12 ± 0.05 1.27 ± 0.07  1.30 ± 0.05  
Potassium (K2+) (mmol/l) 1.21 ± 0.07 0.97 ± 0.12  1.05 ± 0.16  1.80 ± 0.07*** 1.89 ± 0.07*** 
Sodium (Na+) (mmol/l) 89.79 ±4.23 70.83 ±3.97* 57.96 ±2.97 ** 128.15 ±6.10 ***  137.92 ±3.88 ***  
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Table 4.2: CSF Osmolarity and pH in normal and HC groups 
 
 
Values in parentheses represent the number of infants in group 
P<0.05*  
Mean ± SEM 
 
  
  Hydrocephalic groups 
 Normal 
FOH LOH PHH SB/HC 
 
( 4) ( 4) (4) (4) (7) 
Osmolarity (mOsm/Kg) 292.5 ± 13.76 265.0 ± 28.43 195.0 ± 25* 280.0 ± 7.0 268.30 ± 7.92 
pH [H+] (mmol/l) 
 
 
5.12×10-5 ± 1.01×10-5 
 
 
 
6.15×10-5 ± 1.07×10-5 
 
 
2.61×10-5 ±  7.45×10-6 
 
 
2.14×10-5 ± 5.29×10-6 
 
 
3.51×10 -5 ±  1.38×10-5 
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Figure 4.1: Flame Photometry measured sodium in CSF. Comparative sodium 
levels in CSF samples from FOH, LOH, PHH, SB/HC and normal groups.  
 
 
 
Figure 4.2: Flame Photometry measured potassium in CSF. Comparative 
potassium levels in CSF samples from FOH, LOH, PHH, SB/HC and normal groups.  
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Figure 4.3: Flame Photometry measured magnesium in CSF. Comparative 
magnesium levels in CSF samples from FOH, LOH, PHH, SB/HC and normal groups.  
 
 
 
Figure 4.4: Flame Photometry measured calcium in CSF. Comparative calcium 
levels in CSF samples from FOH, LOH, PHH, SB/HC and normal groups.  
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Figure 4.5: Mini pH electrode measured pH of CSF. Comparative pH levels in 
CSF samples from FOH, LOH, PHH, SB/HC and normal groups.  
 
 
Figure 4.6: Osmometer measured osmolarity of CSF. Comparative osmolarity in 
CSF samples from FOH, LOH, PHH, SB/HC and normal groups.  
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4.3. Discussion:  
The aetiology of HC remains largely unknown and the mechanism leading to the 
neurological deficits in affected individuals are mainly attributed to increase in 
intracranial pressure as CSF accumulates (McAllister and Chovan, 1998; Pattisapu, 
2001). The normal rate of CSF production and reabsorption results in normal 
intracranial pressure, blood flow and osmolarity of plasma (Ames et al., 1965). Ionic 
distributions in the CSF and plasma during brain development have shown a gradual 
appearance of different ion gradients (Bradbury et al., 1972).There is a lack of 
literature regarding the ionic distribution in the CSF in human infants after birth, and 
the levels of ions, osmolarity and pH of CSF in hydrocephalic conditions with 
different aetiologies. The current study has been specially designed for this purpose.  
Analysis of sodium, potassium, calcium and magnesium distribution in the CSF in 
normal, FOH, LOH, PHH and SB/HC infants has been carried out in current 
investigation. In current study CSF sodium was reduced significantly in FOH and 
LOH group compared to normal group. Sodium is the most important ion in the CSF, 
it plays an important role in the osmoregulation and transport of CSF (Crone and 
Christensen, 1981). Very limited references are available about CSF electrolytes 
levels in HC condition. Li and Desmond, (1991) observed smaller ventricular size in 
chick embryos after treatment with Oubain. Accordindly Alonso et al., (1998) 
observed the hyper-expanded ventricles with increase of sodium in the ventricles after 
treatment with β-D-xyloside. Cerda et al., (1985) found no significant difference in 
sodium levels in the CSF from nontumoral obstructive hydrocephalic infants. Nagy et 
al., (1979) found significant increase in the levels of CSF sodium in adult pateints 
with old head injuries, chronic alcholisim or electric shock treatment. In current study 
low level of CSF sodium in FOH and LOH group indicates impaired function of the 
choroid plexus epithellium while increase of CSF sodium in PHH and SB/HC human 
infants indicates damaged central nervous system tissue. It is suggested that increase 
of sodium might be due to the release of sodium from the cell in to the CSF. 
Potassium concentration is very important for the function of the neurons and 
neurotransmitters release. Potassium ion concentration is lower in CSF than in plasma 
(Rosenberg, 1990). In current study CSF potassium was higher in PHH and SB/HC 
group compared to normal group but no significant difference was observed in FOH 
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and LOH group. Nagy et al., (1979) reported elevated levels of potassium in the CSF 
of NPH (normal pressure HC) adults. In contrast Cerda et al., (1985) found significant 
decrease of potassium in the CSF from nontumoral obstructive hydrocephalic infants. 
In present study increase in the CSF potassium levels in PHH and SB/HC conditions 
could be due to alteration of the active transport system of choroid plexus, decrease of 
potassium reabsorption from the brain and release of sodium from the cells into CSF 
due to the damage of neural tissues in PHH and SB/HC condition.  
Alteration in calcium concentration in plasma have modest effect on calcium levels of 
brain (Cerda et al., 1985). Slightly higher concentrations of magnesium was observed 
in CSF than in plasma and both calcium and magnesium plays a vital role in the 
conduction of neurons (Fenstermacher and Rall, 1972). In the current study non 
significant decrease found in calcium and magnesium in the CSF of HC infants 
compared to normal infants. Maren, (1992) found increase calcium and magnesium 
levels in CSF in the adult hydrocephalic pateints. Nagy et al., (1979) reported increase 
in CSF calcium and magnesium in HC infants having high intracranial pressure and 
older than one month surgical treatment. Current data are somewhat different to these 
published studies but include conditions not studied previously and thus stand on their 
own.  
Acute changes in plasma osmolarity directly affect the CSF formation; hypo-osmotic 
increase and hyper-osmotic reduce CSF output respectively. The correlation between 
osmolarity and CSF formation is almost linear. 1% alteration in plasma osmolarity 
leads to 7% change in the rate of CSF formation (Cohn et al. , 1938). Hyperosmotic 
solutions infused into the ventricles result in ventricular enlargement possibly due to 
water influx through the choroid plexus and/or from the brain in order to normalize 
the osmotic gradient (Cerda et al. , 1985). The osmolarity of CSF and serum is 
principally formed by electrolytes and primarily by sodium (Bell, 1995). In current 
study CSF osmolarity was only changed in LOH while other hydrocephalus 
conditions did not exhibit changes. The decreased CSF osmolarity in LOH indicates a 
significant effect of this condition on ion homeostasis and a highly significant 
decrease in sodium was found in LOH. Why this condition results in such major 
osmolarity changes and not other hydrocephalus conditions requires further 
investigation.  
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Mechanisms to control CSF electrolytes, pH and osmolarity are present in human 
infants but are disturbed in hydrocephalus conditions. Metabolic changes in the tissue 
might affect ion concentrations in the CSF irrespective of any active or passive 
transport between blood and CSF (Krishnamurthy et al. , 2009). The results of present 
study suggest that the decrease in sodium and osmolarity in LOH and the increase in 
sodium and potassium in PHH and SB/HC might be of prognostic value in 
hydrocephalic infants. For example, the administration of mannitol for infants with 
LOH might be useful to draw excess water from the CSF, normlising CSF osmolarity 
and rescue the LOH brain from the consequences of the dramatic change in sodium 
and osmolarity. Further studies required to investigate the physiological effects of the 
changes in CSF composition to cells of the developing brain in these different 
hydrocephalic conditions. 
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CHAPTER 5 
CYTOKINES ANALYSIS IN CSF 
5.1. Introduction and objectives: 
Protein is the most studied component of CSF (Birge et al., 1974; Dziegielewska et 
al., 1980b), concentration of protein in the CSF is closely linked with the severity of 
brain damage (Dang et al., 2005; Lai et al., 2006; Kirchoff et al., 2006). Usually an 
increased protein in the CSF is observed in infection, multiple sclerosis, intracranial 
hemorrhage, malignancy, some medication use, hormonal imbalance and 
inflammation (Dougherty and Roth, 1986; Khurana, 1996). CSF contains cytokines, 
growth factors and other proteins; cytokines in CSF are an indicator of central 
nervous system infection and linked closely with the severity of disease (Schoniger et 
al., 2002).  
The mechanism leading to neuro-degeneration in HC are not known in detail, the 
identification of mediators of HC is very important in order to improve understanding, 
prevention and better treatment of HC. Protein concentration and other metabolic 
factors varied in the CSF, dependent on the underlying cause of disease (Gerber et al., 
1998). However, it still remains unclear to what extent central nervous system is 
immunologically involved in HC. Present study designed to evaluate total protein and 
cytokines concentration in CSF from the patients with HC for better understanding the 
inflammation and damage as well to identify further distinguishing features associated 
with the different etiologies. 
Objectives:  
The objective of current study was to investigate the presence of total protein, and 
cytokines in the CSF of infants with HC from different etiologies. sFas ligand, sFas 
receptor, IL- 6, IGF-1, HGF, SCF, VEGF and TNF-α was investigated. IL-β and IF γ 
concentration in CSF were below the detection limits in all the CSF samples tested 
and these two cytokines were therefore not considered further for this analysis. 
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5.2. Results: 
Experiments to investigate the CSF protein and cytokine levels in CSF  
5.2.1. CSF total Protein concentration in normal and HC infants:  
Mean CSF total protein levels in normal and HC groups are shown in Table 5.1 and 
Figure 5.1. The CSF total protein concentration in the LOH group showed significant 
(P<0.05) increase compared to the normal group (Figure 5.1) while the differences 
shown by the FOH, PHH and SB/HC infants were non-significant (P>0.05) and 
comparable to normal (Figure 5.1).  
5.2.2. CSF cytokines concentration in normal and HC infants: 
Mean levels of various CSF cytokines in normal and HC groups are shown in Table 
5.1, Figure 5.2 and Figure 5.3. 
i. sFas receptor:  
Mean sFas receptor levels in the CSF of normal and HC groups are shown in Table 
5.1. In comparison to the normal group the CSF revealed significantly (P<0.05) 
elevated levels of CSF sFas receptor in both PHH and SB/HC infants (Figure 5.2a). 
ii. sFas ligand: 
Mean sFas ligand levels in the CSF of normal and HC groups are shown in Table 5.1. 
sFas ligand levels in CSF of HC infants were not significantly (P>0.05) different as 
compared to the normal group (Figure 5.2b). This was probably due to large 
variability between CSF samples.  
iii. Stem cell factor (SCF): 
Mean SCF levels in the CSF of normal and HC groups are shown in Table 5.1. 
SB/HC group had significantly (P<0.05) increased levels of CSF SCF compared to 
normal group (Figure 5.2c). In other HC groups non significant (P> 0.05) difference 
in CSF SCF levels was observed as compared to normal group (Figure 5.2c). 
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iv. Hepatocyte growth factor (HGF): 
Mean HGF levels in the CSF of normal and HC groups are shown in Table 5.1. The 
PHH group showed highly significant (P<0.01) increase levels of CSF HGF 
compared to the normal group. The other HC (FOH, LOH and SB/HC) groups also 
showed increase CSF HGF levels, but due to inconsistency between CSF samples, the 
mean was not statistically significant (Figure 5.2d).  
v. Vascular endothelial growth factor (VEGF): 
Mean VEGF levels in the CSF of normal and HC groups are shown in Table 5.1. CSF 
VEGF level was increased significantly (P<0.05) in the SB/HC group, while highly 
significant (P<0.01) increased levels were noticed in the PHH group compared to the 
normal group (Figure 5.3a). In contrast to the above, FOH and LOH groups did not 
show any significant differences in CSF VEGF levels as compared to normal group 
(Figure 5.3a). 
vi. Insulin growth factor 1(IGF-1): 
Mean IGF-1 levels in the CSF of normal and HC groups are shown in Table 5.1. IGF-
1 in the CSF was below the detection limit in all normal and PHH infants, and was 
detected in very few FOH, LOH and SB/HC infants (Figure 5.3b). Due to the large 
variation of IGF-1 levels between CSF samples, non significant (P>0.05) differences 
in the levels of CSF IGF-1 were found in FOH, LOH and SB/HC groups as compared 
to the normal group (Figure 5.3b).  
vii. Tumor necrosis factor alpha (TNF-α): 
Mean TNF-α level in the CSF of normal and HC groups are shown in Table 5.1. TNF-
α in CSF was below the detection limit in all normal infants, and was detected in very 
few FOH, LOH, PHH and SB/ HC infants. Non significant (P>0.05) increase was 
observed in the level of CSF TNF-α in all HC groups compared to the normal group, 
due to the large variation of IGF-1 levels between CSF samples in which TNF-α was 
detected (Figure 5.3c). 
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viii. Interleukin 6 (IL-6): 
Mean IL-6 levels in the CSF of normal and HC groups are shown in Table 5.1. CSF 
IL-6 showed non significant (P>0.05) elevated levels in LOH and SB/HC infants 
compared to the normal infants (Figure 5.3d). The increase in IL-6 levels was not 
statistically significant in LOH group due to the variation between the CSF samples. 
Some FOH and PHH infants did show detectable levels of CSF IL-6, IL-6 was below 
the detection limit in the CSF of normal infants (Figure 5.3d). 
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Figure 5.1: Total protein in CSF analysed by Lowry assay. Comparative CSF 
protein levels in the normal and HC groups.  
P<0.05* 
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Values in parentheses represent the number of infants in group 
P<0.05*, P<0.01** 
Mean ± SEM 
Table 5.1: CSF total protein  and cytokines levels in normal and HC groups 
                                                                          Hydrocephalic groups 
                Normal 
 
FOH LOH PHH SB/HC 
(7) (7) (7) (6) (8) 
Protein (mg/ml) 0.44 ± 0.16 0.34 ± 0.08 2.4 ± 0.80* 0.66 ± 0.07 0.22 ± 0.06  
sFas receptor (pg/ml) 3.6 ± 2.33 10.56 ± 8.29 7.02 ± 4.52  41.52 ± 16.53* 39.42 ± 14.31* 
sFas ligand (pg/ml) 38.3 ± 17.97 1.87 ± 0.67 12.83± 6.29 5.78 ± 2.50  8.36 ± 5.69 
SCF (pg/ml) 5.26 ± 3.85 2.24 ± 1.62 18.26 ± 11.93 17.73 ± 6.980 74.65 ± 24.233* 
HGF (pg/ml) 269.6 ± 131.24 1753.87 ± 933.13 7359.50 ± 5452.82 3320.28 ± 861.964** 8047.19 ± 3358.99 
VEGF (pg/ml) 16.91 ± 8.72 235.79 ± 122. 87 610.85 ± 325.03 828.62 ± 208.433** 777.01 ± 274. 50* 
IGF-1 (pg/ml) 0 ± 0 609.16 ± 609.16 913.11 ± 913.11  0 ± 0 1824.19 ± 985.25 
TNF-α (pg/ml) 0 ± 0 3.82 ± 3.82 3.28 ± 3.28 1.07 ± 1.07 6.38 ± 3.21 
IL-6 (pg/ml) 0 ± 0 16.74 ± 13.53 77.53 ± 37.51 8.27 ± 4.09 55.72 ± 26.55 
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Figure 5.2: Microarrays measured cytokines in CSF (i). Comparative cytokines 
levels in the normal and HC groups a. Fas receptor b. Fas ligand  
P<0.05* 
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Figure 5.3: Microarrays measured cytokines in CSF (ii). Comparative cytokines 
levels in the normal and HC groups c. SCF d. HGF e. VEGF  
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Figure 5.4: Microarrays measured cytokines in CSF. (iii) . Comparative cytokines 
levels in the normal and HC groups f. IGF-1 g. TNF α h. IL-6  
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5.2. Discussion: 
In current study cytokines and protein in the CSF of infants with HC of different 
origins was analysed. It was observed in the present study that CSF protein levels 
showed great variation in the CSF samples even within the groups, showing 
problematic nature of this study. However even with these issues present study found 
some significant measurements. In the current study, significant increase in CSF total 
protein concentration was observed in the LOH group compared to normal group. 
Increased CSF total protein levels may be attributed to undetermined causes, such as 
inflammation, an obstruction in the subarachnoid space or  tumor causes (Reiber, 
1994).  
Fas ligand (37 kDa) is a type II membrane protein, soluble Fas (sFas) ligand (26-kDa) 
is truncated from of Fas ligand (Tanaka et al., 1998). Fas receptor to Fas ligand 
system plays a main role in the modulation of immunity by induction of apoptotic cell 
death (Nagata and Golstein, 1995; Lynch et al., 1995). sFas receptor act as negative 
feedback system of apoptosis by indicating the activation of Fas receptor to Fas ligand 
system mediated apoptosis and inhibiting the interaction between Fas receptor and 
Fas ligand (Cheng et al., 1994; Hughes and Crispe, 1995; Marsik et al., 2003). The 
Fas to Fas ligand membrane system plays an important role in cytotoxicity of natural 
killer cells (Oshimi et al., 1996) and T lymphocytes (Hanabuchi et al., 1994; Lowin et 
al., 1994), cell death of T lymphocytes (Ju et al., 1995) and oligodendrocytes (Casha 
et al., 2001; Demjen et al., 2004; Yoshino et al., 2004; Casha et al., 2005; Ackery et 
al., 2006). Moreover, it was suggested that Fas receptor and Fas ligand is involved in 
angiogenesis by apoptosis of leukocytes that supply angiogenic growth factors 
(Kaplan et al., 1999; Volm et al., 1999; Lee and Ferguson, 2003; Panka and Mier, 
2003). Previous studies provide evidence that Fas to Fas ligand system is involved in 
various central nervous system related diseases, sFas has been detected in a number of 
diseases such as an autoimmune disorder, neurodegenerative and malignant diseases 
(Mogi et al., 1996; Zipp et al., 1998; Streffer et al., 1998). Objective of current study 
was to analyse the sFas receptor and Fas ligand in the CSF of HC neonates with 
different etiologies to elucidate the pathological relevance of Fas ligand and sFas 
receptor in HC. It was observed in current study sFas receptor concentration increase 
significantly in PHH and SB/HC group compared to the normal group. Kafadar et al., 
(2008) observed high levels of sFas and Fas ligand in CSF of pateints after 
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subarachnoid haemmorhage. Felderhoff-Mueser, (2001) reported increase 
concentration of sFas in CSF of infants with HC condition. In acute bacterial 
meningitis pateints Fassbender et al., (1999) observed high CSF sFas concentration. 
In PHH condition parenchymal damage may be linked with haemorrhagic infarction 
and little gray matter damage (Gopinath et al., 1979; Harris et al., 1994; Fukumizu et 
al., 1995) but one of the components of blood, Lysophosphatidic acid (LPA), seems to 
have a direct role in ependymal denudation and etiology of PHH (Yung et al., 2011). 
Raised Fas receptor in PHH might therefore be associated with periventricular 
damage induced by blood proteins components and parenchymal damage, raised Fas 
receptor in SB/HC may be a response to neural tube defect. 
HGF is a cytokine with mitogenic and morphogenic functions specifically on the 
epithelial cells (Ozden et al., 2004). HGF and its receptor are expressed in the 
developing and adult mammalian brain (Kern et al., 2001) in neurons and non-
neuronal cells including microglial cells and Schwann cells (Di Renzo et al., 1993; 
Krasnoselsky et al., 1994). HGF is neurotrophic (Tsuzuki et al., 2000) and 
neuroprotective factor and also play an essential role in the survival and/or maturation 
of neurons in vivo (Maina and Klein, 1999). There are many neurological disease 
studies in which changes in CSF HGF were found (Nayeri et al., 2000). In current 
investigation HGF increased significantly in PHH condition compared to normal 
group, while in FOH, LOH and SB/HC group CSF HGF was comparable to normal 
group. Mashayekhi and Salehi, (2007) reported increase levels of CSF HGF in HC 
children. Similarly Nanba et al., (2004) reported increase levels of HGF in the CSF of 
children with Myoma disease. HGF production up-regulates in case of brain injuries 
and involves in neuronal repair and recovery of damaged nerve cells in children with 
HC. This would explain why CSF HGF concentrations in PHH group are raised, 
where such mechanisms may be triggered as part of the pathophysiology, and not in 
others. 
SCF is in two distinct forms; one is soluble and the other is membrane bound (Cheng  
and Flanagen, 1994). In the normal adult brain, most of the SCF is predominantly 
produced by neurons in the soluble form (Zhang and Fedoroff, 1997; Das et al., 
2004). SCF plays an important role in neural stem cells proliferation as well 
differentiation (Das et al., 2004). SCF is important in neural cell survival (Zhang and 
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Fedoroff, 1997; Erlandsson et al., 2004), neural stem cell migration and neurogenesis 
(Jin et al., 2002). An increased SCF has also been reported in neural cells after brain 
injury (Zhang and Fedoroff, 1997). In the present study SCF levels increased 
significantly in the SB/HC infants compared to the normal. Mashayekhi and Salehi, 
(2007) reported increase in CSF SCF in children with meningitis. The finding of the 
current study of raised SCF SB/HC may be a response to the neural tube defect and 
may be involved in the attempted recovery of damaged nerve cells in children with 
SB/HC.  
VEGF is a potent angiogenic factor that can be produced by malignant and non-
malignant cells (Senger et al., 1986; Berse et al., 1992). VEGF regulate angiogenesis 
process after tissue injury (Ferrara, 2000; Tonnesen et al., 2000). VEGF is expressed 
in astrocytes, neurons, endothelium, and inflammatory cells (Jin et al., 2000; 
Matsuzaki et al., 2001).  In current study VEGF showed a significant increase in PHH 
and SB/HC infants compared to the normal. Similarly Madsen et al., (2009) reported 
increase CSF VEGF-A in communicating HC. It can be suggested that VEGF 
involves in the angiogenesis of injured nerve cells in infants with PHH and SB/HC.  
The IL-6 is an effective mediator in infection and injury of brain (Dinarello, 1998). 
IL-6 produced mainly by astrocytes in the central nervous system (Gruol and Nelson, 
1997), IL-6 overproduction leads to disruption of BBB (Brett et al., 1995). In the 
current investigation detectable levels of IL-6 were found in all HC groups, 
specifically profound increase in CSF IL-6 was found in LOH and SB/HC infants. 
McAllister et al., (2009) reported an increase in CSF IL-6 in frontal and parietal 
cortices of 21 days old Sprague Dawley hydrocephalic rats (HC induced by intra-
cisternal injection of 25% kaolin). In current study non-significant increase was 
observed in IL-6 levels in LOH and SB/HC infants, raised IL-6 must indicate an 
underlying inflammatory process which in LOH is likely to be an infection while in 
SB/HC may be the neural tube defect and/or the extension of the cerebellar tonsils. 
TNF-α released from macrophages and glial cells in the central nervous system, and 
involves in inflammation (Gruol and Nelson, 1997; Benveniste, 1998). In the current 
investigation CSF TNF-α concentration was variable and detected only in a few 
samples with no compareable difference in the CSF TNF-α concentration in HC 
infants compared to normal. Tarkowski et al., (2003) observed increase in TNF-α in 
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the CSF of normal Pressure HC (NPH) patients compared to normals and the author 
suggested that TNF-α is involved in the degradation of white matter. Leinonen et al., 
(2011) reported low CSF TNF-α concentrations in idiopathic NPH (iNPH) patients. 
McAllister et al., (2009) reported an increase in CSF TNF-α in frontal and parietal 
cortices in Sprague Dawly HC rats (HC generated by intra-cisternal injection of 25% 
kaolin). 
IGF-1 exerts mitogenic effects and important in the development of cerebellum 
(Torres-Aleman et al., 1998; Werther et al., 1998). It was observed in mice that under 
express IGF-1 or the IGF-1 receptor leads to small brains (Beck et al., 1995), in 
contrast IGF-1 over-expression results in an increase of brain growth (Schoenle et al., 
1986). In the current investigation no significant difference found in the CSF IGF-1 
levels in HC groups compared to normal. IGF was below the limit of detection in 
most of the CSF samples in this study. Thus, IGF-1 is unlikely to be triggered in 
neonatal HC either as part of the pathophysiology or repair process. 
Neuroinflammation occurred as result of ventriculomegaly and due to the 
pathophysiology of HC. In our study difference in the expression of cytokines in HC 
groups (categorized on the base of age onset and cause of HC) with different cause 
and age indicated that an inflammatory response come with progressive ventricular 
enlargement, mode of induction of HC and stage of HC. 
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CHAPTER 6 
BRAIN DAMAGED PROTEIN BIOMARKERS IN CSF 
6.1. Introduction and objectives: 
HC results in mechanical stretching and compression of brain parenchyma, elevated 
intracranial pressure, anoxia, blood brain barrier destruction, ischemia and cerebral 
edema (Rekate, 1997; McAllister and Chovan, 1998; Pattisapu, 2001; Crews et al., 
2004). Clinical symptoms and signs cannot assess severity of HC such as enlarged 
head. The intracranial pressure-monitoring and CT-scanning are valuable diagnosis 
methods of HC (Hale et al., 1992). The possible neurological deficits caused by HC 
(Hale et al., 1992; Mori et al., 1995) leads to poor development of the cerebral cortex.  
The most common treatment of HC is shunt surgery, this can repair the HC only by 
draining the CSF but does not repair the damage to the brain tissue which already 
occured. The rate of response of patients to shunt surgery reveals a diagnostic 
problem and therefore an improved understanding of the underlying pathophysiology 
of HC may leads to better diagnostic measure for better clinical treatment. 
Appropriate diagnostic tests are available for the understanding and diagnosis of 
hydrocephalic conditions; however the brain damaged markers area has so far been 
unnoticed. As described in chapter 1 proteins expressed in neurons, astrocytes, 
oligodendrocytes and microglial cells, these proteins can be released into the CSF and 
blood in case of acute brain damage, barrier dysfunction or injury in brain 
(McKeating et al., 1998).  
The enlarged ventricles with high intracranial pressure lead to mechanical stretching 
and compression of brain parenchyma and a destruction of brain tissues. Due to the 
damage of the central nervous system tissues could cause leakage of the proteins into 
the CSF (Sternberger et al., 1978). Determination of brain damage product 
concentrations in CSF might be helpful for diagnosing the cause, aetiology and/or 
assessing the severity of the neurological damage in patients with HC. 
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Objectives: 
The goal of present study was to demonstrate the prescence of glial cell specific 
proteins in hydrocephalic CSF in order to determine the brain damage in HC 
condition. In present study GFAP, vimentin, MBP and CNPase was examined in the 
CSF of hydrocephalic infants.  
6.2. Results: 
6.2.1. Experiments to investigate the brain damaged protein markers in 
the CSF from normal and HC infants:  
a. Glial Fibrillary Acidic Protein (GFAP):  
CSF was analyzed from normal and HC infants using SDS PAGE. Protein with 
53KDa molecular weight was detected in the CSF from PHH and SB/HC group and 
not detected in normal, FOH and LOH infants. Western blotting was done for the 
confirmation of the prescence of GFAP protein (Figure 6.1). In order to obtain 
semiquantitative estimate of relative amount of 53KDa GFAP, image J analyzer was 
used to determine the relative intensity of the band. GFAP was increased in PHH and 
SB/HC condition when compared with CSF from normal, FOH and LOH infants 
(Figure 6.2). The data from the current study showed significant (P<0.05) increase in 
GFAP protein in CSF of PHH infants and non significant increase in GFAP was 
found in SB/HC infants compared to normal. 
b. Vimentin: 
CSF analysis for vimentin protein was carried out in normal and HC infants using 
SDS PAGE. A Western blot analysis was done for confirmation of the presence of 
vimentin (Figure 6.3). The vimentin 55 KDa protein was observed in the CSF from 
LOH infants but undetectable in normal, FOH, PHH and SB/HC infants. Semi 
quantitative estimation of the relative amount of vimentin was done by using image J 
analyzer to determine the relative band intensity of the band.  
Non-significant (P>0.05) increase in vimentin protein was found in CSF from LOH 
infants compared to normal infants (Figure 6.4). The increased in vimentin in LOH 
infants was non-significant due to inconsistency in the CSF samples in which it was 
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analysed. A greater sample number is needed to test if vimentin is generally present in 
LOH or not. 
c. Myelin basic protein (MBP): 
CSF analysis was carried out from normal and HC infants using SDS PAGE. 40 KDa 
MBP protein was seen on the gel in the CSF from PHH and SB/HC condition and 
MBP was not seen in the CSF of normal, FOH and LOH infants. A Western blotting 
was done for the confirmation of the prescence of MBP (Figure 6.5). Image J analyzer 
was used for semi quantitative estimation of the relative amount of MBP to analyse 
the relative intensity of the bands in an individual lanes.  
The data from the present study showed highly significant (P>0.0001) increase in 
MBP protein from the CSF of PHH and SB/HC infants as compared to normal, FOH 
and LOH infants (Figure 6.6). Levels of MBP in PHH and SB/HC infants showed no 
variation in CSF samples.  
d. 2’, 3’-cyclic nucleotide 3’-phosphodiesterase (CNPase): 
CSF analysis for CNPase protein was carried out from normal and HC infants using 
SDS PAGE. A Western blotting was done for the confirmation of the prescence of 45 
KDa CNPase (Figure 6.7). Image J analyzer was used for semi quantitative estimation 
of relative amount of CNPase to analyse the relative intensity of the bands in an 
individual lanes. CNPase was reduced in LOH and FOH condition as compared to 
CSF from normal, PHH and SB/HC infants (Figure 6.8).  
Data from the present study demonstrated the significant (P<0.05) decrease in 
CNPase in LOH infants and non significant decrease in CSF from FOH infants 
compared to normal, PHH and SB/HC infants. CSF sample from FOH and LOH 
infants showed variation in the CNPase levels. Due to the variability larger numbers 
of CSF samples with more clinical details required for clear understanding of HC.  
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Figure 6.1: Western blot for GFAP. 10 lane precast gels were used. Each lane had 
an individual 5µl sample of CSF from the categories of patients shown. A single 
53KDa band was labelled using the antibody to GFAP and only found in PHH and 
SB/HC samples as shown in this representative gel.  
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Figure 6.2: Semi-quantitative analysis of the 53KDa band labelled with anti-
GFAP antibody. Only PHH showed a significant difference from normal which had 
undetectable levels so that the difference was effectively from zero protein. SB/HC 
also shows an increase but this was not significantly different from normal.  
Normal n= 8, FOH n= 4, LOH n= 4, PHH n= 5, SB/HC n= 4 
P<0.05* 
Mean ± SEM 
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Figure 6.3: Western blot for Vimentin. 10 lane precast gels were used. Each lane 
had an individual 5µl sample of CSF from the categories of patients shown. A single 
55KDa band was labelled using the antibody to vimentin and only detected in 2 of the 
4 LOH samples as shown in these representative gels.  
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Figure 6.4: Semi-quantitative analysis of the 55KDa band labelled with anti-
vimentin antibody. No significant differences were found. No significant differences 
to normal were detected in any group even LOH where 2 samples had this protein and 
2 not.  
Normal n= 8, FOH n= 4, LOH n= 4, PHH n= 4, SB/ HC n= 4 
Mean ± SEM 
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Figure 6.5: Western blot for MBP. 10 lane precast gels were used. Each lane had an 
individual 5µl sample of CSF from the categories of patients shown. A single 40KDa 
band was labelled using the antibody to myelin basic protein and only detected in 
PHH and SB/HC samples as shown in this representative gel.  
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Figure 6.6: Semi-quantitative analysis of the 40KDa band labelled with anti-
MBP antibody. MBP was increased significantly (P<0.001) in PHH and SB/HC 
compared to undetectable levels in normal, FOH and LOH infants.  
Normal n= 4, FOH n= 4, LOH n= 4, PHH n= 4, SB/HC n= 4 
P<0.001*** 
Mean ± SEM 
 
 
 
 
 
0.0
0.4
0.8
1.2
1.6
2.0
Normal FOH LOH PHH SB and HC
M
BP
 in
 C
SF
 (r
el
at
iv
e 
ba
nd
 in
te
ns
ity
)
M
ea
n 
±
SE
M
GROUPS
  SB/HC 
      ***       *** 
Chapter 6                                                                                                            Results 
 
101 
 
 
Figure 6.7: Western blot for CNPase. 10 lane precast gels were used. Each lane had 
an individual 5µl sample of CSF from the categories of patients shown. A single 
45KDa band was labelled using the antibody to CNPase and was detected in all 
samples as shown in these representative gels.  
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Figure 6.8: Semi-quantitative analysis of the 45KDa band labelled with anti-
CNPase antibody.  Levels of CNPase were detected in normal CSF in FOH, PHH 
and SB/HC but in the LOH group significant reduction (P<0.05) was observed 
compared to normal and other hydrocephalic groups. In the LOH blot 3 of the 4 
samples show reduced CNPase compared to normal and 1 sample not.  
Normal n= 4, FOH n= 4, LOH n= 4, PHH n= 4, SB/HC n= 4 
P<0.05* 
Mean ± SEM 
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6.3. Discussion: 
The present study determined CSF levels of GFAP, vimentin, MBP and CNPase in 
human neonatal HC with different aetiologies compared to CSF from neonates with 
no neurological abnormalities. Although significant differences as well as non-
significant indications of differences have been found, the number of samples 
analysed is limiting to reaching clear conclusions. The study does show that 
differences are likely to exist and a larger study is urgently needed.  
GFAP is a specific marker originating in astrocytes (Bartosik-Psujek and Stelmasiak, 
2001; Malmestrom et al., 2003). In the current study increased levels of GFAP was 
observed in the CSF of PHH and SB/HC infants compared to normal, FOH and LOH 
infants. McAllister et al., (2009) reported an increase CSF GFAP in frontal and 
parietal cortices in neonatal HC induced by intracisternal injection of 25% kaolin. 
Tullberg et al., (1998) reported increase GFAP in NPH patients compared with 
neurologically healthy age-matched controls. Albrechtsen et al., (1985) reported 
increase CSF GFAP concentration in NPH patients. In the current study increased 
CSF GFAP in the CSF from PHH and SB/HC condition indicates an irreversible 
damage to astrocytes.  
Vimentin is the cytoskeletal protein which maintained the integrity of cell and cells 
without vimentin are very soft (Goldman et al., 1996). Astrocytes are involved in the 
glial response during neuroinflammation and closely interact with microglia (Minagar 
et al., 2001).Vimentin is found in astrocytes during the early postnatal period and re-
expressed in reactive astrocytes after central nervous system injury (Eddleston and 
Mucke, 1993). Microglial cells also express vimentin, vimentin expression after brain 
damage has been detected in activated microglia (Graeber et al., 1988). In the current 
study increased levels of vimentin was found in the CSF from LOH group compared 
to normal group. The increased levels of vimentin in the LOH infants must be a direct 
consequence of the infection affecting the brain but the lack of GFAP in LOH 
indicates that the source is unlikely to be glial so may be microglial, endothelial or 
leptomeningeal. This requires further analysis as it indicates a very different 
pathophysiology in LOH patients compared to those with other aetiologies of HC. 
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MBP is an indicator of damage specifically associated with demyelination as this 
protein is expressed in oligodendrocytes (Levin et al., 1985; Miller et al., 2004). MBP 
is a marker to examine the level of the pathological process, since many structural and 
functional neurological deficits associated with HC are linked with lack of 
myelination. In the current investigation highly significant elevated levels of CSF 
MBP indicating that demyelination is likely to be occurring in the brain in PHH and 
SB/HC condition. Abnormal build up of CSF in PHH and SB/HC condition may 
results in damaging raised pressure within the brain and the bleeding in PHH 
condition is also contribute directly to brain damage. Sutton et al., (1983) found MBP 
protein in the CSF of HC patients and author suggested that HC due to the mechanical 
compression and stretching of the brain parenchyma leads to demyelination. Increased 
intracranial pressure results in the myelination during brain development that effects 
the early development of cortex (Hanlo et al., 1997). 
CNPase protein is approximately 4% of myelin protein content (Vogel and 
Thompson, 1988; Reinikainen et al., 1989) and it is synthesized in the 
oligodendrocyte cell bodies from where it starts formation of myelin (De Angelis and 
Braun, 1996). In the current study significantly decrease levels of CNPase was found 
in the CSF from LOH and FOH group compared to normal. The exact physiological 
role of CNPase is not completely understood yet, but it is considered to be involved in 
membrane expansion of oligodendrocyte and migration of oligodendrocytes during 
the initial stages of axonal ensheathment (Yin et al., 1997). Its presence in normal 
CSF as well as in HC infants suggests a potential role in global brain myelination not 
previously considered. This requires further study but may prove to be an important 
tool in promoting myelination in affected brains. 
Taken together, the findings of this study indicate that different aetiologies leading to 
HC are associated with different pathophysiological mechanisms affecting different 
cell types, at least in the initial stages where intracranial pressure may not be 
pathologically raised. Differential diagnosis is therefore possible and the potential for 
more effective treatment of these different conditions may emerge from further 
research. Furthermore, current study has focused on glial cell effects but additional 
data on neuronal status is also needed in differentiating between the different 
aetiologies leading to HC. This study demonstrates that different aetiologies can likely 
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be differentiated which presents an important step in understanding this devastating 
neurological condition. 
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CHAPTER 7 
EFFECT OF HUMAN CSF ON GLIAL CELLS 
7.1. Introduction and objectives: 
CSF is not simply a fluid with mechanical and physiological function, it controls the 
central nervous system development and neural stem cells function (Rodriguez, 1976; 
Xia et al., 2000; Vigh et al., 2004; Gato et al., 2005; Sawamoto et al., 2006; Miyan et 
al., 2006; Buddensiek et al., 2009, 2010; Lehtinen and Walsh, 2011; Lehtinen et al., 
2011). CSF is composed of different proteins, growth factors and cytokines. CSF 
serves as a growth medium for neural stem cells, progenitor cells and germinal matrix 
of the cortex during development (Zappatera et al., 2007; Zougham et al., 2008; 
Parvas et al., 2008; Salehi et al., 2009; Lehtinen et al., 2011).  Abnormal composition 
of the CSF leads to numerous neurological conditions (Mashayekhi et al., 2002; Owen 
Lynch et al., 2003; Bannister et al., 2005; Moretti et al., 2005; Cains et al., 2009; 
Main et al., 2010; Frye et al., 2013). CSF from different ages of rat fetus acts in an 
age-dependent manner on the differentiation and proliferation of primary cortical cells 
(Miyan et al., 2006). Nabiuni et al., (2012) found a significantly increased 
proliferation of PC12 cells after treatment with E18 CSF. CSF abnormal composition 
leads to physiological defects in the brain as observed in the development of  
hydrocephalic cerebral cortex (Mashayekhi et al., 2002; Owen-Lynch et al., 2003) 
inducing a termination of cell cycle in the cortical progenitor cells (Owen-Lynch et 
al., 2003) through an alteration in folate metabolism in the CSF (Cains et al., 2009). 
However the role of CSF on non-neuronal cells has been studied to a lesser degree 
specifically in the HC condition. HC occurred as a result of congenital/developmental 
defects, infection, trauma or intraventricular haemorrhage. Microglia and astrocytes 
produce inflammatory and immune-regulatory molecules in response to injury and 
infection but their role in neonatal HC has not been studied. In HC condition, 
obstruction of the CSF circulation leads to brain ventricles enlargement and brain 
tissue distortion. In the postnatal brain, accumulation of CSF has damaging effects 
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which include demyelination, inflammation, altered clearance of toxins and proteins, 
damage of neurons and glial cells (McAllister and Chovan, 1998; Del Bigio and 
McAllister, 1999; Del Bigio, 2001, 2004; Williams et al., 2007; Del Bigio, 2010). 
These destructive effects are associated with several disorders including less 
intelligence and memory, disabilities in learning and psychological problems (Fernell 
et al., 1987). However the underlying mechanisms of all of these disorders are not 
accurately known. Reactive astrocytosis and microgliosis are important features of the 
pathophysiology of HC that could stimulate the neuroinflammation, slow down 
regeneration of neurons and disturbed the biomechanical pathway (McAllister and 
Miller, 2010). In chapter 3 folate imbalance was observed in the CSF of 
hydrocephalic infants furthermore in chapter 6 increased levels of total protein and 
variable levels of cytokines was found in the CSF of hydrocephalic infants, all of 
these findings has led us to believe that abnormal composition of CSF may be 
associated with the pathophysiology of HC in infants.  
Objectives: 
The objective of present study was to investigate the effect of normal and 
hydrocephalic CSF (FOH and LOH) on the proliferation, viability and morphology of 
postnatal P1 astrocytes and microglial cells growing in cell culture. 
Experiment to investigate the effects of CSF: 
Effect of hydrocephalic CSF was investigated in culture of rat glial cells at P1 stage 
(see 2.2.3 section in chapter2). The cell culture were incubated with different 
percentages of CSF from normal, FOH and LOH infants for 48 hours, then 
proliferation analysis and immunocytochemistry was done as mentioned in chapter 2. 
All the cell culture experiments were repeated at least three times. In the current study 
proliferation and viability of astrocytes and microglial cells were analysed after 
treatment with 5%, 10% and 20% of CSF from normal, FOH and LOH infants 
whereas iimmunocytochemical characteristics of astrocytes and microglial cells were 
observed after treatment with only 20% of CSF from normal, FOH and LOH group.  
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a. Groups for measurement of proliferation and viability of astrocytes and 
microglial cells after 48 hours treatment with CSF (5%, 10% and 20%) from 
normal and HC infants: 
Group-1: Postnatal rat astrocytes cells were grown only in DMEM medium 
(Control). 
Group-2: Postnatal rat astrocytes or microglial cells were grown in 5% 
normal CSF samples. 
Group-3: Postnatal rat astrocytes or microglial cells were grown in 10% 
normal CSF samples. 
Group-4: Postnatal rat astrocytes or microglial cells were grown in 20% 
normal CSF samples. 
Group-5: Postnatal rat astrocytes or microglial cells were grown in 5% FOH 
CSF samples. 
Group-6: Postnatal rat astrocytes or microglial cells were grown in 10% FOH 
CSF samples. 
Group-7: Postnatal rat astrocytes or microglial cells were grown in 20% FOH 
CSF samples. 
Group-8: Postnatal rat astrocytes or microglial cells were grown in 5% LOH 
CSF samples. 
Group-9: Postnatal rat astrocytes or microglial cells were grown in 10% LOH 
CSF samples. 
Group-10: Postnatal rat astrocytes or microglial cells were grown in 20% 
LOH CSF samples. 
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b. Groups for determination of morphology of astrocytes and microglial cells 
after 48 hours treatment with CSF (20%) from normal and HC infants: 
Group-1: Postnatal rat astrocytes cells were grown only in DMEM medium 
(Control). 
Group-2: Postnatal rat astrocytes or microglial cells were grown in 20% 
normal CSF samples. 
Group-3: Postnatal rat astrocytes or microglial cells were grown in 20% FOH 
CSF samples. 
Group-4: Postnatal rat astrocytes or microglial cells were grown in 20% LOH 
CSF samples. 
7.2. Results: 
7.2.1. Effects of CSF on the proliferation and viability of astrocytes and 
microglial cells:  
a. Proliferation and viability of astrocytes:  
Astrocytes were treated for 48 hours in culture with 5%, 10% and 20% of CSF from 
normal, FOH and LOH infants. Proliferation and viability was measured by MTT 
assay as in Figure 7.1. Astrocytes treated with CSF from FOH (5%, 10% and 20%) 
and LOH ((5% and 10%) infants showed no compareable difference in the viability 
and proliferation compared to astrocytes treated with normal (5%, 10% and 20%) 
CSF. Significant increase in the proliferation and viability of astrocytes in culture was 
observed after treatment with 20% CSF from LOH infants compared to normal (5%, 
10% and 20%), FOH (5%, 10% and 20%) and LOH ((5% and 10%) CSF treated 
astrocytes. 20% LOH CSF treated astrocytes showed no difference in the proliferation 
and viability compared to astrocytes in media alone. 
b. Proliferation and viability of microglial cells:  
 Microglial cells were treated for 48 hours in culture with 5%, 10% and 20% of CSF 
from normal, FOH and LOH infants. Proliferation and viability was measured by 
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MTT assay as in Figure 7.2. CSF treatment showed non significant (P>0.05) increase 
in the viability and proliferation of microglial cells.  
7.2.2. Morphology of astrocytes and microglial cells after treatment with 
CSF:  
a. Astrocytes: 
Figure 7.3 shows the morphology of astrocytes treated for 48 hours in culture with 
20% of CSF from normal, FOH and LOH infants. Nuclei were immunostained with 
DAPI and astrocytes were immunostained with GFAP antibody to observe 
morphological changes after treatment with CSF. Small sized astrocytes with few 
cytoplasmic outgrowths were observed after treatment with 20% FOH CSF (Figure 
7.3). Astrocytes after treatment with 20% LOH CSF in culture showed numerous 
cytoplasmic outgrowths (Figure 7.3).  Astrocytes treated with media alone also 
showed numerous cytoplasmic outgrowths (Figure 7.3) in contrast astrocytes treated 
with normal and FOH CSF showed very few cytoplasmic outgrowths. 
b. Microglial Cells 
Figure 7.4 shows the morphology of microglial cells treated for 48 hours in culture 
with 20% CSF from normal, FOH and LOH infants. Nuclei were immunostained with 
DAPI and microglial cells were immunostained with OX-42 antibody to observe 
morphological changes after treatment with CSF. Rounded microglial cells without 
cytoplasmic outgrowth was observed after treatment with 20% normal and FOH CSF 
(Figure 7.4). Normal and FOH CSF treated microglial cells showed no difference in 
the morphology of microglial cells compared to microglial cells in media alone 
(Figure 7.4).  Microglial cells after treatment with 20% LOH in culture showed 
numerous cytoplasmic outgrowths (Figure 7.4).   
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Figure 7.1: MTT assay measured the survival and proliferation of astrocytes. 
Survival and proliferation rate of rat astrocytes when cultured with human CSF 
from normal, FOH and LOH infants. MTT reduced to formazan and the 
absorbance of formazan was measured. Astrocytes were cultured with different 
percentages of CSF and measured after 48 hours in culture. Results are represented as 
a percentage of control (cultures without added CSF). Astrocytes culture with added 
CSF from normal (5%, 10% and 20%), FOH (5%, 10% and 20%) and LOH (5 and 
10%) human infants showed no significant difference in the viability and proliferation 
of astrocytes. Astrocytes culture with 20 % CSF from LOH infants showed significant 
difference (P<0.05) in the viability and proliferation of astrocytes compared to other 
CSF treated astrocytes groups.   
 
n=9 
P<0.05* 
Mean ± SEM 
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Figure 7.2: MTT assay measured the survival and proliferation of microglial 
cells. Survival and proliferation rate of rat microglial cells when cultured with 
human CSF from normal, FOH and LOH infants. MTT reduced to formazan and 
the absorbance of formazan was measured. Microglial cells were cultured with 
different percentages (5%, 10% and 20%) of CSF and measured after 48 hours in 
culture. Results are represented as a percentage of control (microglial cells cultured 
without added CSF). All cultures with added CSF from normal, FOH and LOH 
human infants showed no significant (ns) difference (P>0.05) in the viability and 
proliferation of microglial cells. 
 
n=9 
Mean ± SEM 
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Figure 7.3: Fluroscence microscopy image showing the affect of 20% CSF 
(Normal, FOH and LOH) treatment on the morphology of astrocytes.   
Row I: DAPI nuclear staining Row II: GFAP staining for astrocytes Row III: 
Composite image generated by superimposition of image in Row I and Row II, 
Column I:  Control (cultured astrocytes in media only) Column II:  20% Normal 
CSF treated astrocytes Column III: 20% FOH CSF treated astrocytes Column IV: 
20% LOH CSF treated astrocytes (magnification x200).  
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Figure 7.4: Fluroscence microscopy image showing the affect of 20% CSF 
(Normal, FOH and LOH) treatment for 48 hours on the morphology of 
microglial cells.  
Row I: DAPI nuclear staining Row II: OX-42 staining for microglial cells Row III: 
Composite image generated by superimposition of image in Row I and Row II, 
Column I:  Control (cultured microglial cells in media only) Column II:  20% 
Normal CSF treated microglial cells Column III: 20% FOH CSF treated microglial 
cells Column IV: 20% LOH CSF treated microglial cells (magnification x200).  
 
 
 
 
 
 
 
Chapter 7                                                                                                            Results       
 
115 
 
7.3. Discussion: 
In current study in addition to an understanding of the pathophysiology of HC in 
infants with specific aetiology, a further goal of this study was to observe the effect of 
human CSF from normal, FOH and LOH infants on astrocytes and microglial cells. 
Astrocytes and microglia differ in their origin in the central nervous system, microglia 
cells originated from bone marrow while astrocytes derived from neuroectoderm. 
Microglial cells function primarily as phagocytic and neuroprotective function while 
astrocytes function mainly as detoxifiers, metabolic buffers and provides support to 
endothelial cells (Schiess et al., 2010). Astrocytes have influence on the function of 
neurons by blood flow regulation, plasticity and synaptic function. It was suggested in 
previous studies that astrogliosis occurred in several disease of the central nervous 
system (Sofroniew, 2009). In current study effect of human hydrocephalic CSF on rat 
glial cells was observed which is expected to contain specific cytokines, growth 
factors and different proteins depending on the aetiology and progression of HC 
condition, to study whether this may be responsible for changes in the morphology, 
proliferation, viability and damage of glial cells in HC condition.  
Astrocytes in culture were treated with different percentages (5%, 10% and 20%) of 
CSF from normal, FOH and LOH infants. Treatment with 20% CSF from LOH 
infants caused profound effect on the proliferation of astrocytes. Treatment with CSF 
from normal, FOH and LOH infants caused non-significant (P>0.05) increase in the 
proliferation and viability of microglial cells. In kaolin induced hydrocephalic rats 
Olopad et al., (2012) observed a non-significant increase in astrocytes count in mild 
HC but at later stage in severe HC with the expansion of the ventricle significantly 
reduced proliferation of astrocytes was found. The authors suggested that neuro 
inflammatory processes diminish with the progress of HC. Mangano et al., (1998) 
found elevation in the proliferation of microglial cells in the auditory cortex and 
sensorimotor regions in H-Tx rats with mild HC condition.  
Morphology of astrocytes after treatment with 20% CSF from normal, FOH and LOH 
infants for 48 hours in culture was observed. FOH treated astrocytes were small and 
without cytoplasmic outgrowths while LOH treated astrocytes were with numerous 
cytoplasmic outgrowths (reactive astrocytes). Gliosis is most often linked with HC, in 
previous studied in H-Tx rat models upto 5 days of age reactive astrocytes were 
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observed in the periventricular regions and periaqueductal regions, while at 12 to 21 
days of age reactive astrocytes were observed in the sensorimotor cortex region of the 
brain (Mangano et al., 1998; Miller and McAllister, 2007). Similarly in kaolin 
induced HC rats high count of reactive astrocytes was observed throughout the cortex 
(McAllister and Miller, 2010; Deren et al., 2010), while minocycline treatment (an 
anti-inflammatory agent) caused reduction in the number of  immunoreactive 
astrocytes in HC rats (McAllister and Miller, 2010).  
Morphology of microglial cells after treatment with 20% CSF from normal, FOH and 
LOH infants for 48 hours in culture was observed. 20% FOH CSF treated microglial 
cells were round and without cytoplasmic outgrowths while LOH CSF treated 
microglial were small oval with numerous cytoplasmic outgrowths (reactive 
microglial cells). In the kaolin induced HC postnatal rat Deren et al., (2010) found 
high number of reactive microglial cells. In previous studied in H-Tx rat models upto 
5 days of age reactive microglial cells were observed in the periventricular regions 
and periaqueductal regions, while at 12 to 21 days of age reactive microglial cells 
were observed in the sensorimotor cortex region of the brain (Mangano et al., 1998; 
Miller and McAllister, 2007). In kaolin induced HC rat model Olopad et al., (2012) 
reported distinctive changes in the morphology of microglial cells while McAllister 
and Miller, (2010) found increase count of reactive microglial cells. 
Altered composition of CSF adversely affect the development of the brain 
(Mercimek-Mahmutoglu and Stockler-Ipsiroglu, 2007; Meiniel, 2007; Parada et al., 
2008; Juranek et al., 2008; Bachy et al., 2008; Gato and Desmond, 2009; Steinfeld et 
al., 2009; Holman et al., 2010; Sankaranarayani et al., 2010; Frye et al., 2013). In the 
developing brain CSF is a mixture of cytokines, growth factor and others proteins 
which is necessary for the development of brain, CSF composition responsible for 
pathophysiological changes occurred in the HC condition. Current study demonstrates 
that CSF is critically involved in the inflammatory changes involving in the reactivity 
of astrocytes and microglia in LOH condition. Composition of CSF mixture is altered 
due to the CSF production and/or blockage problem. Further research is required to 
analyse the precise mechanism of the action of CSF. 
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CHAPTER 8 
GENERAL DISCUSSION 
8.1. Discussion: 
The central nervous system at an early stage developed around a tube filled with 
amniotic fluid which later continues into the adult brain and the ventricular system. At 
first neural tube forms a sealed cavity filled with amniotic fluid later tube modified by 
secretions from a mesencephalon which transports the component of the blood into 
the neural tube fluid (Parvas et al., 2008). During early development CSF is a medium 
for growth of neural stem cells, differentiation and proliferation of spinal cord and 
brain stem (Gato et al., 2005; Parada et al., 2008; Gato and Desmond, 2009; Martin et 
al., 2009). CSF is critical for the formation of cerebral cortex, the initiation of cerebral 
cortex development coincides with the changes in the source of secretion of CSF as 
CSF flow along its circulatory pathway (Pourghasem et al., 2001; Miyan et al., 2003). 
Choroid plexus produced CSF, choroid plexus is situated in the lateral, third and 
fourth ventricles (Redzic et al., 2005; Chen et al., 2009). CSF flow is unidirectional 
from the lateral ventricle into the third ventricle and then in the fourth ventricle where 
it exits from the ventricle into the subarachnoid space. The fluid then drain into the 
facial lymphatics and/or superior sagittal sinus via arachnoid villi (Perez-Figares et 
al., 2001; Miyan et al., 2003; Koh et al., 2005; Koh et al., 2007; Holman et al., 2010; 
Gupta et al., 2010). As CSF flow to downstream carries signals from different sites 
along its pathway (Nicholson, 1999). Previous studies have revealed that CSF 
pathway blockage results in change in the components of CSF that leads to block of 
cell cycle and effect the cortical development (Mashayekhi et al., 2002; Owen-Lynch 
et al., 2003). 
The precise role of CSF in development is currently under considerable review (Gato 
and Desmond, 2009; Buddensiek et al., 2009, 2010; Lehtinen and Walsh, 2011; 
Zappaterra and Lehtinen, 2012). Fetal CSF effects the replication and survival of 
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 precursor cells of rat cortex (Miyan et al., 2006). Reduced drainage of the CSF from 
the ventricular system causes significant abnormalities in the neuronal organization of 
the developing brain (Desmond and Jacobson, 1977).  
Embryonic CSF contains a higher concentration of protein as compared to CSF in the 
adult in many species (Adinolfi and Haddad, 1977; Dziegielewska et al., 2000; Gato 
et al., 2004) which reflects its ability in the proliferation and survival of primary 
cortical cells in vitro (Gato et al., 2005; Miyan et al., 2006; Buddensiek et al., 2009, 
2010; Lehtinen and Walsh, 2011) as well as stimulating proliferation and 
neuronal/glial differentiation in PC12 cells (Nabiuni et al., 2012). CSF has a crucial 
part in brain function during entire life though its precise role in adult brain is largely 
unresolved. CSF plays a specific role during specific developmental stage i.e., 
embryonic, fetal and grown up (including juvenile, adult and aged) as well as role is 
different in different brain locations during different stages of life. 
HC is a pathological condition not disease, resulting from abnormal accumulation of 
the CSF within the ventricle of the brain and/or in the subarachnoid space. CSF 
accumulation may be due to an abnormality either between the amount of CSF 
production or CSF absorption or to an obstruction in the flow of CSF at any point 
along its pathway (Matsumoto and Tamaki, 1991; Rekate, 1997; McAllister and 
Chovan, 1998) making HC more complex than other neurological disorders of CSF 
circulation (Czosnyka et al., 2003). The most severe form of HC in humans is fetal or 
early onset HC which affects between 1:500 to 1:5000 live births (Pattisapu, 2001; 
Sipek, 2002) and is linked with defective development of the cerebral cortex resulting 
to several neurological disorders (Cains et al., 2009). The aetiology of HC is unclear 
although some evidence of genetic predisposition has been reported (Zhang et al., 
2006). The age onset and method of induction of HC are major factors in 
understanding the pathophysiology of HC (Hirayama, 1980). The extent of ventricular 
dilation depends on the location of blockage and length of the time of the block of 
CSF flow. HC cannot currently be prevented and surgical diversion to drain CSF is 
the only treatment option through insertion of a shunt or third ventriculostomy. 
Surgery for shunt placement costs nearly a billion dollars worldwide even with variety 
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of neurological damage (i.e. anoxia and ischemia, blood brain barrier dysfunction and 
cerebral edema) and consequent neurological deficits may persist in pateints.  
In the current study CSF samples were categorized into five groups; one normal and 
four hydrocephalic groups (FOH, LOH, PHH and SB/HC), hydrocephalic infants 
were categorized according to the cause and age onset of HC. Cains et al., (2009) 
found reduction of HC condition in the H-Tx rat with a combination of folate 
supplement, one objective of current study was to test whether human CSF reflects a 
unique folate supply system or a similar folate imbalance exists in the condition 
resulting in HC. If a similar abnormality exists then it may be possible to significantly 
reduce the incidence of human HC with a similar combination folate therapy that was 
effective in rats as reported in Cains et al., (2009) study. Second objective was to 
investigate CSF from normal and hydrocephalic infants with different aetologies in an 
attempt to better understanding the underlying pathophysiology of HC in human 
infants.                                                                                                                                                                                                          
Current research has driven us to earlier stages of development to unravel the 
aetiology in order to identify specific pathways that might be used to prevent and/or 
treat this devastating condition. Working hypothesis of current study is that the 
presence of the folate enzyme/binding protein (FDH) in the CSF is required primarily 
for transport and delivery of the specific folate to downstream sites including the 
subarachnoid space where the production and function of draining cells (part of the 
arachnoid membrane with archnoid villi projecting into the superior sagittal venous 
sinus) is a necessary perquisite for normal CSF flow and drainage (Pourghasem et al., 
2001; Miyan et al., 2001; Miyan et al., 2003; Grzybowski et al., 2007). FDH converts 
10-formyl-THF to THF and thought to be involved in the suppression of purine 
synthesis, maintenance of the THF pool as the donor for one-carbon groups and as a 
whole regulation of the flow of one-carbon groups towards methylation reactions 
(Oleinik and Krupenko, 2003; Anguera et al., 2006). Given the reduction of HC in the 
H-Tx rat with a combination of folate supplement it is assumed that problem is an 
early failure to generate sufficient FDH in the CSF for delivery of folate to the 
subarachnoid space as it opens and thus an immediate imbalance between production 
and drainage of CSF occurred. The precise role of FDH is yet to be unravelled 
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especially in the CSF. Present study has confirmed the findings of rat model with 
similar reduced levels of FDH in human hydrocephalic condition compared to normal 
infants. Failure to transport folate is a presumed consequence of the lack of FDH in 
the CSF would undoubtedly result in a drainage issue when CSF output begins at the 
start of cortical development.  
As well as being vital to the integrity and survival of all living cells electrolytes serve 
as cofactors in many enzymatically mediated metabolic reactions, maintenance of pH 
of body fluids and osmotic pressure (Stogdale, 1981; Amir, 1991). In the current 
study electrolytes, osmolarity and pH were investigated in CSF samples of human 
infants. Current analysis of human neonatal hydrocephalic CSF showed a significant 
reduction of sodium in FOH and LOH with a significant increase of sodium in PHH 
and SB/HC infants compared to normal. Sodium is important in the osmoregulation 
and transport of CSF, sodium concentration in the CSF and plasma are very close 
(Crone and Christensen, 1981). The current study has shown significant reduction in 
osmolarity in LOH while other HC conditions do not exhibit changes in osmolarity 
compared to normal. Decreased osmolarity might be due to highly significant low 
levels of sodium in LOH CSF. The osmolarity of CSF and serum is principally 
formed by electrolytes and primarily by sodium (Ganong, 1975). In present study 
decreased CSF sodium in FOH and LOH indicate potentially decreased function of 
the choroid plexus epithellium while increased CSF sodium in PHH and SB/HC 
infants indicating possible damage of central nervous system tissue. Raised potassium 
levels were found in the PHH and SB/HC infants compared to normal, in present 
study increase in potassium could be due to decrease of potassium reabsorption by the 
brain and release of potassium from cells into CSF due to damage of neural tissue in 
PHH and SB/HC conditions. Mechanisms to control CSF electrolytes, pH and 
osmolarity are present in normal infants but are disturbed in HC conditions. Metabolic 
changes in the tissue might affect the concentrations of ions in the CSF without any 
active or passive transport between blood and CSF (Krishnamurthy et al., 2009). The 
results of current study indicate that the decrease in sodium and osmolarity in LOH 
and the increase in sodium and potassium in PHH and SB/HC might be of prognostic 
value in the hydrocephalic infants. 
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CSF proteins are the most studied component of CSF. Proteins are low in normal 
conditions but rise dramatically in any condition affecting the brain (Birge et al., 
1974; Dziegielewska et al., 1980b). There is close association between the 
concentration of proteins in the CSF and the severity of brain damage (Dang et al., 
2005; Lai et al., 2006; Kirchoff et al., 2006). Elevated CSF proteins are diagnostic in 
multiple sclerosis, infections, intracranial hemorrhages, endocrine abnormalities, 
malignancies, medication use and inflammatory conditions (Dougherty and Roth, 
1986; Khurana, 1996). The present study confirmed high protein concentrations in the 
CSF from LOH infants compared to normal. Variation in protein concentration across 
hydrocephalic CSF samples might be linked with the severity of HC, brain damage 
and/or infection in the infants presenting with HC condition.  
Cytokines in the CSF are an indicator of infection and inflammation in the central 
nervous system and linked closely with the severity of disease/condition (Schoniger et 
al., 2002). Inflammation is mediated by cytokines, these play an essential role in the 
pathophysiology linked with the inflamed and infected central nervous system (Eng et 
al., 1996; Benveniste, 1997). In the current study sFas receptor, Fas ligand, HGF, 
SCF, VEGF, IL-6, TNF-α and IGF-1 were investigated in the CSF of hydrocephalic 
infants. sFas receptor and Fas ligand system plays a main role in the modulation of 
immunity by induction of apoptotic cell death (Nagata and Golstein, 1995; Lynch et 
al., 1995). sFas act as negative feedback system of apoptosis by indicate the activation 
of Fas to Fas ligand system mediated apoptosis and inhibit the interaction between 
Fas receptor and Fas ligand (Cheng et al., 1994; Hughes and Crispe, 1995; Marsik et 
al., 2003). Increased sFas receptor concentration was found in the CSF from PHH and 
SB/HC infants compared to normal indicating the parenchymal damage associated 
with haemorrhagic infarction. In previous studies increased in sFas was found in the 
adult and developing brain of rodents after hypoxia–ischaemia (Matsuyama et al., 
1995; Martin-Villalba et al., 1999; Felderhoff-Mueser et al., 2000). Kafadar et al., 
(2008) observed high levels of sFas and Fas ligand in CSF of pateints after 
subarachnoid haemmorhage. In the current study HGF increase was found in PHH 
compared to normal infants while HGF level in CSF from FOH, LOH and SB/HC 
infants was comparable to normal infants. Mashayekhi and Salehi, (2007) also found 
increased HGF in hydrocephalic CSF. Brain injuries upregulate HGF production 
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indicating its role in neuronal repair as a neurotrophic factor (Tsuzuki et al., 2000). 
Nanba et al., (2004) reported increase HGF levels in CSF from Myoma disease 
patients. Furthermore SCF increase was also found in SB/HC infants as compared to 
normal infants. SCF regulates the differentiation and survival of neurons and it may 
also be involved in the recovery of damaged nerve cells in infants with SB/HC. 
In the present study IL-6 showed increase in hydrocephalic infants compared to 
normal, with the highest level found in LOH and SB/HC infants. McAllister et al., 
(2009) reported increase IL-6 in frontal and parietal cortices in neonatal HC. 
Furthermore very low or no detectable levels of TNF-α and IGF-1 found in CSF 
sample. Ventriculomegaly leads neuroinflammation and is the main factor in the 
pathophysiology of HC. Cytokine expression was thus consistent with 
neuroinflammatory response, ventriculomegaly and brain parenchymal damage in the 
human infants. 
The enlargement of the ventricle noticed in the children with high intracranial 
pressure reveals both an accumulation of CSF and damage of parenchymal tissues of 
brain. Disruption of tissue and accumulation of CSF in the brain may cause the 
leakage of proteins into the CSF (Sternberger et al., 1978). CSF composition may 
reflect changes occurring in the brain parenchyma, specifically in the periventricular 
white matter (Wikkelso and Blomstrand, 1982). Neurons, astroglia or oligodendroglia 
expressed specific proteins that can be released into the brain parenchyma and 
interstitial fluid and enter in to the CSF and blood. These proteins associated with the 
brain damage and disruption of barrier or injury of brain (McKeating et al., 1998). 
Ultrastructural examination of the brain in the HC condition confirmed the prescence 
of damaged oligodendrocytes and neurons in the cortex (Del Bigio, 1993; Del Bigio et 
al., 1994; Harris et al., 1994; McAllister and Chovan, 1998; Del Bigio and Zhang, 
1998). In the present study CSF levels of GFAP, vimentin, MBP and CNPase were 
investigated in the CSF of hydrocephalic infants. Increased GFAP was found in the 
CSF from PHH and SB/HC infants indicating an unalterable damage to astrocytes. 
Similarly McAllister et al., (2009) reported increase GFAP in frontal and parietal 
cortices in neonatal HC. Albrechtsen et al., (1985) and Tullberg et al., (1998) reported 
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increase GFAP in NPH patients compared with neurologically healthy age-matched 
controls.  
In the present study high levels of MBP in CSF were found in PHH and SB/HC 
infants indicating the loss of oligodendrocytes and/or possible demyelination in the 
brain. Sutton et al., (1983) found MBP protein in the CSF of hydrocephalic patients 
with different causes and suggested that in HC mechanical stretching of the brain 
parenchyma is associated with periventricular demyelination. Furthermore in current 
study decreased levels of CNPase were found in the CSF from FOH and LOH infants 
compared to normal. The exact role of CNPase in the brain is not understood but it is 
expected that it is functionally involved in the oligodendrocytes surface membrane 
expansion and migration during the initial stages of axonal ensheathment (Yin et al., 
1997) so it can be suggested that in FOH and LOH conditions production of new 
oligodendrocytes in the brain has been inhibited as the result of reduction in CNPase. 
Specific proteins which are released from brain cells aid in predicting the extent of 
neurodegeneration. Moreover, brain damage products in CSF can potentially be used 
in the early prognosis of HC and in the differential diagnosis of HC condition.  
CSF is composed of growth factors, morphogenetic factors, cytokines, metabolites, 
folates and other proteins in CSF during development of brain that disturbed due to 
the problem in CSF drainage. Alteration in the CSF composition reflects the 
pathophysiological changes occurring in HC condition. An important feature of the 
pathophysiology of HC is astrocytosis and microgliosis that could aggravate the 
neuroinflammation, delay neuronal regeneration, impair cerebral perfusion and 
modify the biomechanical properties (McAllister and Miller, 2010). In the current 
study effects of in vitro exposure of postnatal glial cells to CSF from FOH and LOH 
were observed. Astrocytes and microglial cells in culture were treated with different 
percentages (5%, 10% and 20%) of CSF from normal, FOH and LOH infants. 
Treatment with normal (5%, 10% and 20%), FOH (5%, 10% and 20%) and LOH (5% 
and 10%) CSF caused no profound effect on the viability and proliferation of 
astrocytes and microglial cells compared to cells in media alone while treatment with 
20% CSF from LOH infants caused significant increase in the proliferation and 
viability of astrocytes. In the present study alteration in the levels of the cytokines, 
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imbalance in the electrolytes, osmolarity and imbalance in folate metabolic pathway 
in the CSF of hydrocephalic infants was noticed, all of these changes might be 
responsible for the observed effect of LOH CSF on astrocytes and microglial cells. 
Current study demonstrates that CSF role is critical and it effect differentially on the 
developing brain depending on the cause and age onset of HC in human infants. 
Detection of CSF component which are responsible for pathophysiological changes 
occurring in the HC condition will be important to develop potential treatment 
strategies to prevent the unalterable damage.  
Many questions remain to be answered about the precise process occurring during the 
progress of HC in human infants. The present study has uncovered many interesting 
findings that need further investigations for their importance in the neurological 
deficit observed in HC. This fact still doesn’t understand the mechanism of imbalance 
of the components of CSF in HC condition or how HC itself causes disturbance in the 
composition of CSF. New research findings will open new windows to advance the 
understanding of brain development in HC and with this may come a new approach 
for the management, prevention or treatment of HC.  
8.2. Conclusions: 
From the present study it is clear that in hydrocephalic infants an imbalance in the 
folate metabolites pathway, electrolytes, osmolarity, total protein, cytokines and 
prescence of brain damaged protein markers in CSF occurred due to abnormal 
accumulation of CSF in the brain ventricular system. HC is a problem of CSF 
drainage and therefore the most appropriate definitive treatment is one that corrects 
the problem directly. Shunting and third ventriculostomy are effective ways of 
rerouting CSF around the site of obstruction. All the medical treatments are directed 
toward altering the CSF dynamics and preventing the effects of the enlarging 
ventricles. Improvements in prenatal diagnosis and treatment may raise the quality of 
life for children with HC through decreased mortality and morbidity. It is also clear 
that folate supplementation can ‘rescue’ a range of disorders based in development, 
although significantly folic acid has never been reported to have similar benefits. 
Earlier studies in the rats have shown that the incidence of HC is associated with a 
specific folate imbalance in the fetal CSF which can be fixed by supplementing the 
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pregnant mother with a combination of folate metabolites resulting in significantly 
decreased incidence of HC and improved brain development. As a similar imbalance 
was found to exist in human infants with HC, the same supplement to mothers may 
lead to similar decline the incidence of HC in human infants. The current study is the 
first hope for a prevention/treatment for HC, a major problem in Asia where 
termination is restrictive and/or not practiced and treatment is expensive with low take 
up.  
Better treatment will come from a better understanding of the biological basis of the 
neurological deficit in HC and the role of CSF composition in the progress and 
severity of the HC condition. A considerable improvement in the understanding of the 
role of CSF in the developmental and pathological progress of HC has been made in 
this project and paves the way for further research to define the identified changes in 
physiological factors in CSF and their specific roles in HC. Monitoring of cytokines, 
electrolytes, osmolarity and brain damage proteins in the CSF provide better 
understanding of the disease in cases where clinical symptoms are less clear. HC is a 
complex multifactorial disorder that inflicts damage on the brain through multiple 
simultaneously acting mechanisms from fetal period to adult age so it is difficult to 
study in depth. Current investigations may lead to the development of a prognostic 
marker for HC in human infants. In the present study CSF osmolarity changed only in 
LOH while other HC conditions did not exhibit changes. The decreased CSF 
osmolarity in LOH indicates a significant effect of this condition on ion homeostasis 
and a highly significant decrease in sodium was found in LOH. Why this condition 
results in such major osmolarity changes and not other HC conditions requires further 
investigation.  
8.3. Future aims:  
The findings of the current study have pointed out to several directions where the 
work may be continued further and few of them are as follows: 
1. While investigating the aetiology of HC and the associated neurological deficits, 
maternal factor should be considered for analysis in order to identify the 
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contribution of the mother in the development of congenital HC and in the risk 
factors for acquired HC in human infants.  
2. Earlier studies in H-Tx rats have shown that the incidence of HC is associated 
with a specific folate imbalance in the fetal CSF which can be fixed by 
supplementing the pregnant dams with folate combinations resulting in 
significantly reduced incidence of HC in the new born. The same imbalance was 
found to exist in HC human infants. A clinical trial may be designed to test the 
efficacy of the same supplement for the mothers to be expecting the same 
reduction of the incidence of HC in humans. 
3. The results of current studies have suggested a decrease in osmolarity in LOH 
infants. In future, the administration of mannitol for infants with LOH might be 
useful to draw excess water from the CSF, normalising CSF osmolarity and 
rescuing the LOH brain from the consequences of the dramatic changes in sodium 
and osmolarity. 
4. Neonatal serum and CSF analysis should be done to see the extent of imbalance in 
CSF and serum and degree of the correlation of imbalance between CSF and 
serum in HC. This would give an indication of blood-brain-barrier function. 
5. The neonatal developmental stage is a critical process because of adaptation of 
neonates from intra to extra-uterine life. The immune system is not well 
developed in earlier stage and mainly suffers to the problems of adaptation. In 
infants the timing of stages of maturation and functional activity of the immune 
system is not precisely known. There is a need to determine this in order to define 
the contribution of inflammatory and immune processes in neonatal 
pathophysiology of brain. 
6. Present study found increased cytokines concentration in CSF from HC infants 
that indicate the neuroinflammation in the central nervous system. A major effort 
is needed to determine the efficacy of anti-inflammatory agents as supplements 
with CSF shunting surgery. 
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Appendices 
Appendix one 
Standard Electrolytes Data 
1. Magnesium:  
 
2. Sodium: 
 
 
 
The standard graphs of magnesium (Mg2+) and sodium (Na+) generated by the Flame 
photometry for the calculation of Na+ and Mg2+ concentration in the CSF samples. 
ICPS= Ion count per second 
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3. Potassium: 
 
 
4. Calcium: 
 
 
The standard graphs of calcium (Ca2+) and potassium (K+) generated by the Flame 
photometry for the calculation of Ca2+   and K+ concentration in the CSF samples. 
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Appendix two 
Standard cytokines data 
Fas               
Concentration 
(pg/ml) 0 16 49 148 444 1333 4000 
Signal-BKG 0 181 607 1779 5629 17253 51417 
Log (Concentration) 1.22 1.69 2.17 2.65 3.12 3.60 
Log (Signal-BKG) 2.26 2.78 3.25 3.75 4.24 4.71 
  Slope     Intercept       
Linear 
regression 12.86     0.00       
log-log 
regression 1.03     1.03       
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Fas L               
Concentration 
(pg/ml) 0 8 25 74 222 667 2000 
Signal-BKG 0 5 20 74 327 1169 4301 
Log (Concentration) 0.92 1.39 1.87 2.35 2.82 3.30 
Log (Signal-BKG) 0.69 1.30 1.87 2.51 3.07 3.63 
  Slope     Intercept       
Linear regression 2.10     0.00       
log-log regression 1.24     -0.43       
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HGF               
 
Concentration 
(pg/ml) 0 16 49 148 444 1333 4000 
Signal-BKG 0 4 17 67 265 1030 4483 
 
Log (Concentration) 1.22 1.69 2.17 2.65 3.12 3.60 
Log (Signal-BKG) 0.60 1.22 1.82 2.42 3.01 3.65 
  Slope     Intercept       
Linear regression 1.08     0.00       
log-log regression 1.27     -0.94       
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IFNg               
 
Concentration 
(pg/ml) 0 82 247 741 2222 6667 20000 
Signal-BKG 0 1525 4893 15996 52414 44318 54158 
 
Log (Concentration) 1.92 2.39 2.87 3.35 3.82 4.30 
Log (Signal-BKG) 3.18 3.69 4.20 4.72 4.65 4.73 
  Slope     Intercept       
Linear regression 23.34     0.00       
log-log regression 1.07     1.12       
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IGF-I               
 
Concentration (pg/ml) 0 823 2469 7407 22222 66667 200000 
Signal-BKG 0 50 92 164 305 560 946 
 
Log (Concentration) 2.92 3.39 3.87 4.35 4.82 5.30 
Log (Signal-BKG) 1.70 1.96 2.21 2.48 2.75 2.98 
  Slope     Intercept       
Linear regression 0.01     0.00       
log-log regression 0.54     0.13       
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IL-1b                
 
Concentration 
(pg/ml) 0 8 25 74 222 667 2000 
Signal-BKG 0 50 227 968 4447 17257 15235 
 
Log (Concentration) 0.92 1.39 1.87 2.35 2.82 3.30 
Log (Signal-BKG) 1.70 2.36 2.99 3.65 4.24 4.18 
  Slope     Intercept       
Linear 
regression 25.14     0.00       
log-log 
regression 1.34     0.49       
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IL-6                
Concentration 
(pg/ml) 0 8 25 74 222 667 2000 
Signal-BKG 0 36 138 567 2545 11542 49613 
Log (Concentration) 0.92 1.39 1.87 2.35 2.82 3.30 
Log (Signal-BKG) 1.56 2.14 2.75 3.41 4.06 4.70 
  Slope     Intercept       
Linear regression 23.90     0.00       
log-log regression 1.32     0.31       
 
 
 
 
                
 
 
 
 
 
     Appendix 2 
Appendices 
SCF               
Concentration 
(pg/ml) 0 16 49 148 444 1333 4000 
Signal-BKG 0 45 261 1306 6910 30241 47240 
Log (Concentration) 1.22 1.69 2.17 2.65 3.12 3.60 
Log (Signal-BKG) 1.65 2.42 3.12 3.84 4.48 4.67 
  Slope     Intercept       
Linear 
regression 21.80     0.00       
log-log 
regression 1.48     -0.12       
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TNFa               
Concentratio
n (pg/ml) 0 8 25 74 222 667 2000 
Signal-BKG 0 34 128 630 2424 
982
9 40545 
Log (Concentration) 
0.9
2 
1.3
9 1.87 2.35 2.82 3.30 
Log (Signal-BKG) 
1.5
3 
2.1
1 2.80 3.38 3.99 4.61 
  
 
 
Slop
e     
Intercep
t       
Linear 
regression 
19.6
1     0.00       
log-log 
regression 1.29     0.34       
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VEGF               
Concentration 
(pg/ml) 0 82 247 741 2222 6667 20000 
Signal-BKG 0 8 33 180 1016 5269 29473 
Log (Concentration) 1.92 2.39 2.87 3.35 3.82 4.30 
Log (Signal-BKG) 0.91 1.52 2.26 3.01 3.72 4.47 
  Slope     Intercept       
Linear 
regression 1.39     0.00       
log-log 
regression 1.50     -2.03       
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       Performa for CSF samples collection 
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  
    
     
    
    
               
      

             
               
                  
              
              
                   
             
              
              
               
                
               
             
              
               
               
                 
         
   
  
          
     
            


                     
         
          
          

 
       
     

           
         
      
            
    

       
         
       
         
       
       
    
       
        
       
       
      
      
         
         

       
      
     
       
          
          
         
         
         
       
       
        
       
       
         
      
       
        
        
      

        
       
       
        
         
       
        
      
         
      
 
       
        
     
 
      
       
   
 
       
   
  
      
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